0001493152-23-028379.txt : 20230814 0001493152-23-028379.hdr.sgml : 20230814 20230814160046 ACCESSION NUMBER: 0001493152-23-028379 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEA Industries Inc. CENTRAL INDEX KEY: 0001482541 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 273911608 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41266 FILM NUMBER: 231169501 BUSINESS ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-993-5271 MAIL ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Surna Inc. DATE OF NAME CHANGE: 20100128 10-Q 1 form10-q.htm
0001482541 false --12-31 Q2 Yes Yes 0001482541 2023-01-01 2023-06-30 0001482541 CEAD:CommonStock0.00001ParValueMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-06-30 0001482541 2023-08-14 0001482541 2023-06-30 0001482541 2022-12-31 0001482541 2023-04-01 2023-06-30 0001482541 2022-04-01 2022-06-30 0001482541 2022-01-01 2022-06-30 0001482541 us-gaap:CommonStockMember 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-03-31 0001482541 2023-03-31 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 us-gaap:CommonStockMember 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-03-31 0001482541 2022-03-31 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 2021-12-31 0001482541 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001482541 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001482541 us-gaap:CommonStockMember 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-06-30 0001482541 us-gaap:CommonStockMember 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-06-30 0001482541 2022-06-30 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-06-30 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-06-30 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-06-30 0001482541 CEAD:DirectorAndStaffMember 2022-01-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2023-04-01 2023-06-30 0001482541 CEAD:MiscellaneousMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember CEAD:BookedSalesOrdersFromThreeCustomersMember 2023-06-30 0001482541 CEAD:OneCustomerMember 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2023-04-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2023-04-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2023-01-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2023-01-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2023-01-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2022-04-01 2022-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2022-04-01 2022-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2022-01-01 2022-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2023-01-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2023-01-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerThreeMember 2023-01-01 2023-06-30 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2022-01-01 2022-12-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2022-01-01 2022-12-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-04-01 2023-06-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-04-01 2022-06-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-06-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-04-01 2023-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-04-01 2022-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-04-01 2023-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-04-01 2022-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2022-04-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2022-01-01 2022-06-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2023-06-30 0001482541 CEAD:TwoThousandAndTwentyFourMember 2023-06-30 0001482541 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001482541 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-04-01 2023-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-04-01 2022-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-04-01 2023-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-04-01 2022-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-07-28 0001482541 2022-01-01 2022-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001482541 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001482541 us-gaap:VehiclesMember 2023-06-30 0001482541 us-gaap:VehiclesMember 2022-12-31 0001482541 us-gaap:PropertyPlantAndEquipmentMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001482541 us-gaap:PropertyPlantAndEquipmentMember CEAD:InventoryMember 2023-01-01 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyThreeMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-02 2023-01-03 0001482541 srt:DirectorMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:AuditCommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 CEAD:CommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember 2023-01-01 2023-06-30 0001482541 2022-01-12 2022-01-17 0001482541 2021-12-30 0001482541 srt:BoardOfDirectorsChairmanMember 2023-06-30 0001482541 2022-02-14 2022-02-15 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-15 0001482541 2022-06-20 2022-06-21 0001482541 2022-06-21 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:NonQualifiedStockOptionMember 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:FiveEmployeesMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionMember 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:IncentiveStockOptionMember 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-06-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-06-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-06-30 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-16 2023-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2023-01-01 2023-06-30 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2022-01-01 2022-06-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:DirectorsMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001482541 CEAD:WarrantsRangeMember 2023-06-30 0001482541 CEAD:WarrantsRangeMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsRangeOneMember 2023-06-30 0001482541 CEAD:WarrantsRangeOneMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-06-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-06-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-01-01 2023-06-30 0001482541 CEAD:OwnershipMember 2023-06-30 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2022-10-12 2022-10-13 0001482541 CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember 2022-01-01 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-19 2022-12-20 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2023-01-01 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft CEAD:integer CEAD:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-41266

 

CEA INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

 

Nevada   27-3911608

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

385 South Pierce Avenue, Suite C

Louisville, Colorado 80027

  80027
(Address of principal executive offices)   (Zip code)

 

(303) 993-5271

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value   CEAD   Nasdaq Capital Markets
Warrants to purchase common stock   CEADW   Nasdaq Capital Markets

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller Reporting Company
    Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO

 

As of August 14, 2023, the number of outstanding shares of common stock of the registrant was 8,076,372.

 

 

 

 

 

 


CEA Industries Inc.

Quarterly Report on Form 10-Q

For the Quarterly Period Ended June 30, 2023

 

Table of Contents

 

  Page
Cautionary Statement ii
   
PART I — FINANCIAL INFORMATION  
   
Item 1. Financial Statements (Unaudited)  
   
Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022 2
   
Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2023 and June 30, 2022 3
   
Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three and Six Months Ended June 30, 2023 and June 30, 2022 4
   
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 and June 30, 2022 5
   
Notes to the Condensed Consolidated Financial Statements 6
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 25
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 34
   
Item 4. Controls and Procedures 34
   
PART II — OTHER INFORMATION  
   
Item 1. Legal Proceedings 35
   
Item 1A. Risk Factors 35
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35
   
Item 3. Defaults Upon Senior Securities 35
   
Item 4. Mine Safety Disclosures 35
   
Item 5. Other Information 36
   
Item 6. Exhibits 36
   
SIGNATURES 37
   
EXHIBIT INDEX 38

 

i

 

 

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the “Company”, “we”, “us” or “our” refer to CEA Industries Inc. and, where appropriate, its wholly owned subsidiary.

 

CAUTIONARY STATEMENT

 

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical fact but are based on current management expectations that involve substantial risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance. We generally identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other similar words. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives of management for future operations; any statements regarding current or future macroeconomic or industry-specific trends or events and the impact of those trends and events on us or our financial performance; any statements regarding pending investigations, legal claims or tax disputes; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing.

 

These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment in which we operate. Important factors that could cause those differences include, but are not limited to:

 

  our business prospects and the prospects of our existing and prospective customers;
     
 

our overall financial condition, including the impact of higher interest rates and inflation, business disruption due to the COVID-19 pandemic, the Ukraine war, and the supply chains on which we depend;

 

 

the impact on our business from our restructuring and cost containment actions taken in the first quarter of 2023 and continuing thereafter;

 

  the inherent uncertainty of product development and product selection to meet client requirements;
     
  regulatory, legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;
     
  increasing competitive pressures in the CEA (Controlled Environment Agriculture) industry and our engineering service and product supply position within the industry;
     
  the ability to effectively operate our business, including servicing our existing customers and obtaining new business;
     
  our relationships with our customers and suppliers;

 

ii

 

 

  the continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments from our customers;
     
  general economic conditions, our customers’ operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we operate;
     
  the business disruptions that are happening in the CEA industry, including bankruptcies and shifting market demands, that are having an adverse impact on the demand for our engineering services and construction solutions and, consequently, our revenues;
     
  the supply of products from our suppliers and our ability to complete contracts, some of which depend on other actors for a comprehensive project completion;
     
  changes in our business strategy and development plans, and in our plans for seeking strategic alternatives;
     
  our ability to attract and retain qualified personnel;
     
  our ability to raise equity and debt capital, as needed from time to time, to fund our operations and business strategy, including possible strategic alternatives and acquisitions;

 

  our ability to identify, complete and integrate potential strategic alternatives and acquisitions;
     
  future revenue being lower than expected;
     
  The substantial changes in the amount and current size of our backlog and our ability to convert backlog into revenue in a timely manner, or at all; and
     
  our intention not to pay dividends.

 

These factors should not be construed as exhaustive and should be read with the other cautionary statements in this report.

 

Although we believe that we use reasonable assumptions for these forward-looking statements, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”). You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The forward-looking statements and projections contained in this Quarterly Report on Form 10-Q are intended to be within the meaning of “forward-looking statements” in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”).

 

iii

 

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CEA Industries Inc.

Condensed Consolidated Balance Sheets

(in US Dollars except share numbers)

 

   June 30,   December 31, 
   2023   2022 
    (Unaudited)      
ASSETS          
Current Assets          
Cash and cash equivalents  $14,197,485   $18,637,114 
Accounts receivable, net   293,767    2,649 
Inventory, net   397,155    348,411 
Prepaid expenses and other   520,256    1,489,921 
Total Current Assets   15,408,663    20,478,095 
Noncurrent Assets          
Property and equipment, net   53,225    68,513 
Intangible assets, net   1,830    1,830 
Deposits   14,747    14,747 
Operating lease right-of-use asset   409,981    462,874 
Total Noncurrent Assets   479,783    547,964 
           
TOTAL ASSETS  $15,888,446   $21,026,059 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
LIABILITIES          
Current Liabilities          
Accounts payable and accrued liabilities  $798,624   $1,207,258 
Deferred revenue   625,911    4,338,570 
Accrued equity compensation   -    89,970 
Current portion of operating lease liability   122,272    118,235 
Total Current Liabilities   1,546,807    5,754,033 
           
Noncurrent Liabilities          
Operating lease liability, net of current portion   319,247    376,851 
Total Noncurrent Liabilities   319,247    376,851 
           
TOTAL LIABILITIES   1,866,054    6,130,884 
           
Commitments and Contingencies (Note 6)   -    - 
           
SHAREHOLDERS’ EQUITY          
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding   -    - 
Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively   81    80 
Additional paid in capital   49,426,065    49,173,836 
Accumulated deficit   (35,403,754)   (34,278,741)
Total Shareholders’ Equity   14,022,392    14,895,175 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $15,888,446   $21,026,059 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2

 

 

CEA Industries Inc.

Condensed Consolidated Statements of Operations

(in US Dollars except share numbers)

(Unaudited)

 

   2023   2022   2023   2022 
   For the Three Months Ended June 30,   For the Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Revenue, net  $1,063,714   $3,014,885   $5,746,287   $4,759,312 
                     
Cost of revenue   985,021    2,708,646    4,814,318    4,362,565 
                     
Gross profit   78,693    306,239    931,969    396,747 
                     
Operating expenses:                    
Advertising and marketing expenses   33,091    309,690    235,414    560,705 
Product development costs   74    56,577    76,487    195,495 
Selling, general and administrative expenses   750,156    1,080,094    1,770,858    2,391,871 
Goodwill impairment charges   -    631,064    -    631,064 
Total operating expenses   783,321    2,077,425    2,082,759    3,779,135 
                     
Operating loss   (704,628)   (1,771,186)   (1,150,790)   (3,382,388)
                     
Other income (expense):                    
Other income (expense), net   2,074    -    7,778    185,000 
Interest income (expense), net   8,979    10,600    17,999    13,860 
Total other income (expense)   11,053    10,600    25,777    198,860 
                     
Loss before provision for income taxes   (693,575)   (1,760,586)   (1,125,013)   (3,183,528)
                     
Income taxes   -    -    -    - 
                     
Net loss  $(693,575)  $(1,760,586)  $(1,125,013)  $(3,183,528)
                     
Convertible preferred series B stock dividends   -    -    -    (35,984)
Deemed dividend on convertible preferred series B stock on down round   -    -    -    (439,999)
                     
Net loss available to common shareholders  $(693,575)  $(1,760,586)  $(1,125,013)  $(3,659,511)
                     
Loss per common share – basic and diluted  $(0.09)  $(0.23)  $(0.14)  $(0.59)
                     
Weighted average number of common shares outstanding, basic and diluted   8,076,372    7,801,211    8,074,064    6,220,600 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

 

CEA Industries Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity

For the Three and Six Months Ended June 30, 2023 and June 30, 2022

(in US Dollars except share numbers)

(Unaudited)

 

   Number of Shares   Amount  

Paid in

Capital

   Accumulated Deficit   Shareholders’ Equity 
   Common Stock   Additional         
   Number of Shares   Amount  

Paid in

Capital

   Accumulated Deficit   Shareholders’ Equity 
Balance March 31, 2023   8,076,372   $81   $49,410,899   $(34,710,179)  $14,700,801 
Fair value of vested stock options granted to employees   -    -    15,166    -    15,166 
Net loss   -    -    -    (693,575)   (693,575)
Balance June 30, 2023   8,076,372   $81   $49,426,065   $(35,403,754)  $14,022,392 

 

 

   Common Stock   Additional         
   Number of Shares   Amount    Paid in Capital   Accumulated Deficit   Shareholders’ Equity 
Balance December 31, 2022   7,953,974   $80   $49,173,836   $(34,278,741)  $14,895,175 
Fair value of vested stock options granted to employees   -    -    150,914    -   $150,914 
Common shares issued in settlement of restricted stock units issued to directors   122,398    1    (1)   -   - 
Fair value of restricted stock units issued to directors   -    -    101,316    -   $101,316 
Net loss   -    -    -    (1,125,013)  $(1,125,013)
Balance June 30, 2023   8,076,372   $81   $49,426,065   $(35,403,754)  $14,022,392 

 

   Common Stock   Additional         
   Number of Shares   Amount   Paid in Capital   Accumulated Deficit   Shareholders’ Equity 
Balance March 31, 2022   7,784,444   $78   $48,958,618   $(30,204,508)  $18,754,188 
Fair value of vested stock options granted to employees   -    -    126,635    -    126,635 
Fair value of restricted stock units issued to directors   -    -    6,245    -    6,245 
Cashless exercise of prefunded warrants   169,530    2    (2)   -    - 
Net loss   -    -    -    (1,760,586)   (1,760,586)
Balance June 30, 2022   7,953,974   $80   $49,091,496   $(31,965,094)  $17,126,482 

 

   Common Stock   Additional         
   Number of Shares   Amount    Paid in Capital   Accumulated Deficit   Shareholders’ Equity 
Balance December 31, 2021   1,600,835   $16   $25,211,017   $(28,781,566)  $(3,570,533)
Fair value of vested stock options granted to employees   -    -    159,573    -    159,573 
Fair value of vested stock options granted to directors   -    -    29,656    -    29,656 
Common shares issued in settlement of restricted stock units issued to directors   3,367    -    24,994    -    24,994 
Fair value of restricted stock units issued to directors   -    -    11,173    -    11,173 
Issuance of common shares to round up partial shares following reverse split   6,798    -    -         - 
Common shares and warrants issued for cash   5,811,138    58    21,711,073    -    21,711,131 
Common shares and warrants issued on conversion of series B preferred stock   362,306    4    1,979,996    -    1,980,000 
Dividends on series B preferred stock   -    -    (35,984)   -    (35,984)
Cashless exercise of prefunded warrants   169,530    2    (2)   -    - 
Net loss   -    -    -    (3,183,528)   (3,183,528)
Balance June 30, 2022   7,953,974   $80   $49,091,496   $(31,965,094)  $17,126,482 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

CEA Industries Inc.

Condensed Consolidated Statements of Cash Flows

(in US Dollars except share numbers)

(Unaudited)

 

   2023   2022 
   For the Six Months Ended
June 30,
 
   2023   2022 
Cash Flows From Operating Activities:          
Net loss  $(1,125,013)  $(3,183,528)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and intangible asset amortization expense   14,988    16,697 
Share-based compensation   162,260    225,396 
Provision for doubtful accounts   2,096    (9,182)
Provision for excess and obsolete inventory   60,574    (34,417)
Loss on disposal of assets   100    4,060 
Amortization of operating lease ROU asset   52,893    51,061 
Goodwill impairment charges   -    631,064 
           
Changes in operating assets and liabilities:          
Accounts receivable   (293,214)   48,153 
Inventory   (109,318)   10,986 
Prepaid expenses and other   969,665    (1,692,816)
Accounts payable and accrued liabilities   (408,634)   (317,453)
Deferred revenue   (3,712,659)   3,095,431 
Operating lease liability, net   (53,567)   (39,870)
Accrued equity compensation   -    (37,251)
Net cash provided by (used in) operating activities   (4,439,829)   (1,231,669)
           
Cash Flows From Investing Activities          
Purchases of property and equipment   -    (13,948)
Proceeds from the sale of property and equipment   200    2,250 
Net cash provided by (used in) investing activities   200    (11,698)
           
Cash Flows From Financing Activities          
Payment of dividends on series B preferred stock   -    (35,984)
Redemption of series B preferred stock   -    (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses   -    21,711,131 
Net cash provided by financing activities   -    19,695,147 
           
Net change in cash and cash equivalents   (4,439,629)   18,451,781 
Cash and cash equivalents, beginning of period   18,637,114    2,159,608 
Cash and  cash equivalents, end of period  $14,197,485   $20,611,388 
           
Supplemental cash flow information:          
Interest paid  $-   $- 
Income taxes paid  $-   $- 
           
Non-cash investing and financing activities:          
Unpaid purchases of equipment and other assets  $-   $16,400 
Conversion of series B preferred stock   -   $1,980,000 
Deemed dividend on series B preferred stock arising on down round   -   $439,999 
Cashless exercise of prefunded warrants       $2 
Options issued for accrued equity compensation liability  $89,970   $83,625 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

6

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

7
 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of June 30, 2023, the balance in the Company’s accounts was approximately $14,197,000, consequently approximately $13,947,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of June 30, 2023, and June 30, 2022, there were respectively, 8,009,889 and 7,882,061, potentially dilutive equity instruments outstanding in respect of warrants options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both June 30, 2023 and June 30, 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 386,117 and 252,289 potentially dilutive equity instruments outstanding as of June 30, 2023 and June 30, 2022, respectively, related to options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

8

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

Revenue Recognition

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $899,748   $2,791,141   $5,296,574   $4,433,713 
Engineering and other services   103,232    192,076    227,643    278,125 
Shipping and handling   4,775    31,668    17,335    47,474 
Miscellaneous   55,959    -    204,735    - 
Total revenue  $1,063,714   $3,014,885   $5,746,287   $4,759,312 

 

Miscellaneous revenue of $55,959 and $204,735 recognized during the three and six months ended June 30, 2023, respectively, represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

9

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

10

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of June 30, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of June 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $625,911 and $4,338,570, respectively.

 

For the three and six months ended June 30, 2023, the Company recognized revenue of $45,716 and $3,898,622, respectively, related to the deferred revenue at January 1, 2023 For the three and six months ended June 30, 2022, the Company recognized revenue of $1,030,830 and $2,193,204, respectively, related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

11

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of June 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $1,066,000. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer and smaller new contracts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at June 30, 2023, includes booked sales orders of $250,000 from three customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $279,000 (26% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   816,000    250,000    1,066,000 
Total remaining performance obligations  $816,000   $250,000   $1,066,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of June 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $193,498 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

 

12

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the six months ended June 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and June 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $5,104   $4,898   $5,895 
Advertising and marketing expenses   -    4,080    1,113    6,842 
Product development costs   -    4,961    3,570    4,961 
Selling, general and administrative expenses   15,166    81,482    152,679    170,446 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $95,627   $162,260   $188,144 

 

13

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Included in the expense for the three and six months ended June 30, 2022, is an accrual for $46,374 and $46,374, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.

 

Concentrations

 

Two customers accounted for 64%, and 10% of the Company’s revenue for the three months ended June 30, 2023. Three customers accounted for 44%, 23% and 14% of the Company’s revenue for the six months ended June 30, 2023. Two customers accounted for 53% and 12% of the Company’s revenue for the three months ended June 30, 2022 and one customer accounted for 47% of the Company’s revenue for the six months ended June 30, 2022.

 

Three customers accounted for 69%, 17%, and 12% of the Company’s accounts receivable as of June 30, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

14

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

15

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

June 30, 2023

 
Operating lease right-of-use asset  $409,981 
Operating lease liability, current  $122,272 
Operating lease liability, long-term  $319,247 
      
Remaining lease term   3.6 years 
Discount rate   3.63%

 

   For the Six Months Ended June 30, 2023 
Operating cash outflow from operating lease  $62,138 

 

Future annual minimum lease payments on the New Facility Lease as of June 30, 2023 are as follows:

 

As of June 30, 2023    
     
Years ended December 31,    
2023 (excluding the six months ended June 30, 2023)  $62,759 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   472,032 
Less imputed interest   (30,513)
Present value of minimum lease payments  $441,519 

 

Note 3 – Inventory

 

Inventory consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Finished goods  $398,455   $270,555 
Work in progress   -    155 
Raw materials   130,180    148,608 
Allowance for excess & obsolete inventory   (131,480)   (70,907)
Inventory, net  $397,155   $348,411 

 

16

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Overhead expenses of $15,055 and $12,770 were included in the inventory balance as of June 30, 2023, and December 31, 2022, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $10,000 and $1,176,000 in advance payments for inventory for the periods ended June 30, 2023, and December 31, 2022, respectively.

 

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (237,769)   (224,876)
Property and equipment, net  $53,225   $68,513 

 

Depreciation expense was $14,988 for the six months ended June 30, 2023. For the six months ended June 30, 2023, $1,749 was allocated to cost of sales, $437 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

  

   June 30,   December 31, 
   2023   2022 
Accounts payable  $280,763   $311,162 
Sales commissions payable   2,061    25,951 
Accrued payroll liabilities   231,182    465,094 
Product warranty accrual   193,498    180,457 
Other accrued expenses   91,120    224,594 
Total  $798,624   $1,207,258 

 

17

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Note 6 – Commitments and Contingencies

 

Litigation

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

Note 7 – Stockholders’ Equity

 

As of June 30, 2023, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of June 30, 2023, 8,076,372 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock vested on January 17, 2023. 1,684 shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

18

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Revised Compensation Plan

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The Plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.

 

The plan is divided into two phases: from the Effective Date of the Plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).

 

Pre-uplist phase: The Company paid its independent directors an annual cash fee of $15,000, payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

The Company pays the Audit Committee Chairman an additional annual fee of $10,000, payable quarterly in advance, for services as the Audit Committee Chairman.

 

The Company pays the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services as a Committee Chairman.

 

There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.

 

Post-uplist phase: The Company will pay its independent directors an annual cash fee of $25,000, payable quarterly in advance on the first business day of each quarter. All other terms remain the same.

 

Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.

 

The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.

 

18

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.

 

Employee directors do not receive separate fees for their services as directors.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

An additional 6,798 shares of common stock were issued to round up partial shares following the reverse split.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,224 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Warrant Exercise

 

On June 21, 2022, the Company issued 169,530 shares of its common stock in connection with the cashless exercise of 170,382 prefunded conversion warrants.

 

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

19

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

During the six months ended June 30, 2023, no shares or options were issued, or cancelled under the 2017 Plan.

 

As of June 30, 2023, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 147,132 options remain outstanding, and 22,509 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

During the six months ended June 30, 2023, the Company issued 122,398 shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.

 

During the six months ended June 30, 2023, 138,489 non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $0.8955. An expense of $89,970 in respect of this issuance had been accrued in 2022. An additional expense of $32,376 was recognized in 2023 upon management and board finalization and approval of the awards.

 

As of June 30, 2023, of the 666,667 shares authorized under the 2021 Equity Plan, 132,568 shares have been issued in settlement of restricted stock units, awards relating to 198,170 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 295,113 shares remain available for future equity awards.

 

There was $30,753 in unrecognized compensation expense for unvested non-qualified stock options, and incentive stock options at June 30, 2023 which will be recognized over approximately 2 years.

 

20

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the six months ended June 30, 2023, are presented in the table below:

  

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $- 
Granted   138,489   $0.90    6.6   $- 
Exercised   -   $-    -   $- 
Forfeited   (1,567)  $4.15    8.9   $- 
Expired   -   $-    -   $- 
Outstanding, June 30, 2023   328,995   $5.58    6.5   $- 
Exercisable, June 30, 2023   303,905   $5.61    6.4   $      - 

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the six months ended June 30, 2023, are presented in the table below:

 

  Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2022   28,756   $4.73   $-   $135,932 
Granted   138,489   $0.88   $-   $121,870 
Vested   (141,822)  $0.92   $-   $(131,094)
Forfeited   (333)  $6.67   $-   $(2,222)
Expired   -   $-   $-   $- 
Nonvested, June 30, 2023   25,090   $4.98   $       -   $124,486 

 

For the six months ended June 30, 2023 and June 30, 2022, the Company recorded $60,944 and $75,947 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

21

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the six months ended June 30, 2023, are presented in the table below:

  

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $- 
Granted   -    -    -   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, June 30, 2023   57,122   $9.44    5.5   $- 
Exercisable, June 30, 2023   57,122   $9.44    5.5   $      - 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the six months ended June 30, 2023.

 

During the six months ended June 30, 2023 and June 30, 2022, the Company incurred $0 and $29,656 respectively, as compensation expense related to 0 and 6,250 fully vested options issued to directors, respectively.

 

Restricted Stock Units

 

Effective January 3, 2023, the Company issued a total of 119,032 restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.

 

Effective January 17, 2023, the Company settled 3,366 RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock

 

During the six months ended June 30, 2023 and June 30, 2022, the Company recorded $101,316 and $36,168, respectively, as compensation expense related to vested RSUs issued to directors.

 

  Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
            
Outstanding, December 31, 2022   3,366   $7.42   $- 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, June 30, 2023   -   $-   $       - 

 

22

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June 30, 2023:

  

           Weighted   Weighted    
   Warrants  

Average

Exercise

  

Average

Remaining Life

  

Aggregate

Intrinsic

 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49    - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at June 30, 2023   7,623,772    7,623,772   $5.14    43           - 

 

The following table summarizes information about warrants outstanding at June 30, 2023:

  

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    15 
                  
$10.40    34,737    34,737    16 
                  
$5.00    7,105,496    7,105,496    44 
                  
$5.16    290,557    290,557    44 
                  
      7,623,772    7,623,772    43 

 

Note 10 – Income Taxes

 

As of June 30, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $27,074,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

23

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of June 30, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

Note 11 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the six months ended June 30, 2023 and June 30, 2022, the Company paid $18,273 and $9,884, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March 2023 of $3,577 increasing the total of the second sales order to $14,477. During the six months ended June 30, 2023, the Company received $14,035 in cash payments for these contracts. Revenue of $16,977 was recorded in the six months ended June 30, 2023 in respect of these agreements.

 

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date of issuance of these financial statements issued and determined no material subsequent events occurred after June 30, 2023 for which disclosure was required.

 

24

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, which include additional information about our accounting policies, practices, and the transactions underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Cautionary Statements” appearing elsewhere herein and the risks and uncertainties described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated from time to time in the Company’s filings with the SEC, and Part II, Item 1A of this Quarterly Report entitled “Risk Factors.”

 

Non-GAAP Financial Measures

 

To supplement our financial results on U.S. generally accepted accounting principles (“GAAP”) basis, we use non-GAAP measures including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. For purposes of this Quarterly Report, (i) “adjusted net income (loss)” and “adjusted operating income (loss)” mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) “net bookings” means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including cancellations and change orders during the quarter.

 

Our backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.

 

Overview

 

CEA Industries, through our subsidiary, Surna Cultivation Technologies LLC, is a company focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture (“CEA”) industry. The CEA industry aims to optimize the use of horticultural resources such as water, energy, space, capital, and labor, to create an agriculture business that is more efficient and more productive than those that use traditional farming methods. Typically, the CEA industry is focused on indoor agriculture and vertical farming.

 

Headquartered in Colorado, we leverage our experience in the CEA industry to bring our customers a variety of value-added technology solutions that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. We do this by offering our customers a variety of principal service and product offerings that include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting and climate control, and (viii) preventative maintenance services, through our partnership with a certified service contractor network, for CEA facilities.

 

25

 

 

Our revenue stream is currently derived primarily from supplying our products, services and technologies to licensed commercial indoor facilities operating in the cannabis industry. Our customers include state and provincial-regulated CEA growers located primarily in the U.S., Canada. We recently have developed customers in the non-cannabis CEA market to expand our market reach. Customers use our services for building new CEA facilities and expanding or retrofitting existing CEA facilities.

 

CEA growers currently face a challenging business environment that includes high energy costs, water usage and conservation issues, continuously evolving waste removal regulations, inflationary pressures, and labor shortages. In addition to these issues, our cannabis growing customers face increasingly rigorous quality standards and declining cannabis prices in a growing industry whose standards are constantly evolving. The part of the CEA industry focused on food related crops is also facing disruption from evolving market demand, competition, and reorganization, including the lack of growth capital and several noteworthy bankruptcies.

 

We support our clients by providing integrated mechanical, electrical, and plumbing (“MEP”) engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. Over our 16 years in business, we have served hundreds of commercial indoor CEA facilities.

 

We believe our customers partner with us because we have the reputation and experience to help them make cost-conscious and effective decisions on the design and engineering of their indoor cultivation facilities. CEA facilities are resource intensive, and a growing list of states have implemented building code changes that limit energy consumption in cultivation facilities. Energy and resource efficiency is a high priority to us as engineers, and the senior engineers on our team hold the Leadership in Energy and Environmental Design (“LEED”) credential. We believe this sustainability-focused technical experience is crucial in the value we provide to our customers.

 

We have three core assets that we believe will support us as we pursue our business strategy. First, we enjoy strong relationships with relevant stakeholders in the CEA industry. Largely focused in the cannabis segment, our partnerships include relationships with new and existing growers, capital providers, consultants, independent contractors, and numerous other providers in the segment. These partnerships include agreements reached in 2022 with Merida Capital and Hydrobuilder Holdings LLC. In June we announced a marketing arrangement with Merida Capital, a cannabis-focused private equity firm, whereby Merida will use CEA Industries Inc. as its sole provider of certain products and services for its indoor cultivation facilities. This relationship resulted in a new contract in October 2022 with one of Merida’s Connecticut based clients. In November of 2022 we announced a strategic alliance with Hydrobuilder Holdings that we believe will result in more project opportunities.

 

Second, our experience in this industry over time has built up specialized engineering know-how and experience. We have been serving indoor cultivators since 2006 and designing CEA cultivation facilities since 2016. Since then, we have tested and solidified best practices from designing environmental control systems for CEA cultivation facilities.

 

Third, we have a line of proprietary environmental control products that support the specific growing environments that our customers want. We believe these products offer significant benefits to our customers.

 

Shares of our common stock and warrants currently are traded on the Nasdaq Capital Markets under the ticker symbols “CEAD” and “CEADW”, respectively.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to have adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital. Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

26

 

 

Impact of Ukrainian Conflict

 

We believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending for the Ukraine and funding of our country’s response. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

Our Bookings, Backlog and Revenue

 

During the three months ended June 30, 2023, we executed new sales contracts with a total contract value of $234,000. During this same period, we had cancellations of $29,000. After adjustments for these cancellations, our net bookings in the three months ended June 30, 2023 were $205,000, representing a decrease of $621,000 (or 75%) from net bookings of $826,000 in the first quarter of 2023.

 

Our backlog at June 30, 2023 was $1,066,000, a decrease of $803,000, or 43%, from March 31, 2023. The decrease in backlog is the result of lower bookings in the fourth quarter of 2022 and the first six months of 2023. Our backlog at June 30, 2023 includes booked sales orders of $250,000 (23% of the total backlog) from three customers that we do not expect to be realized until 2024, if at all. Included in the projected revenue is one booked sales order of $279,000 (26% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. We believe the sales orders in these portions of our backlog have an elevated level of risk and may, ultimately, be delayed or cancelled by our customers. Therefore, investors should not view backlog as earned revenue.

 

Our backlog has declined for several quarters. The primary reason for the decline has been fewer new order bookings. Other reasons include our ability to complete portions of contracts due to improvements in our supply chain and our ability to deliver products with fewer delays. The final reason is contract cancellations.

 

The following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the period for which we received an initial deposit, net of any adjustments including cancellations and change orders during the period), (iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings, less recognized revenue). Based on the current economic climate and our cost cutting measures, there is no assurance that we will be able to continue to obtain the level of bookings that we have had in the past and or fulfill our current backlog, and we may experience contract cancellations, project scope reductions and project delays.

 

Our recognized revenue for the quarter ended March 31, 2023, in the table below, excludes $148,776 in revenue arising from the forfeiture of non-refundable deposits from former customers on previously cancelled contracts. Our recognized revenue for the quarter ended June 30, 2023, in the table below, excludes $55,959 in revenue arising from the forfeiture of non-refundable deposits from former customers on previously cancelled contracts. The contracts were removed from the backlog at the time of cancellation.

 

27

 

 

   For the quarter ended 
   June 30, 2022   September 30, 2022   December 31, 2022   March 31, 2023   June 30, 2023 
 Backlog, beginning balance  $11,179,000   $9,698,000   $6,832,000   $5,577,000   $1,869,000 
 Net bookings, current period  $1,534,000   $2,197,000   $206,000   $826,000   $205,000 
 Recognized revenue, current period  $3,015,000   $5,063,000   $1,461,000   $4,534,000   $1,008,000 
 Backlog, ending balance  $9,698,000   $6,832,000   $5,577,000   $1,869,000   $1,066,000 

 

The completion of a customer’s new build facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation systems; (vii) the availability of power; and (viii) delays that are typical in completing any construction project.

 

As has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition of our backlog as of June 30, 2023.

 

We have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining performance obligations (i.e., our Q2 2023 backlog), using separate time bands, with respect to engineering only paid contracts and partial equipment paid contracts. There continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q2 2023 backlog. Refer to the Revenue Recognition section of Note 1 in our condensed consolidated financial statements, included as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance obligations.

 

Our backlog, remaining performance obligations, and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized revenue, deferred revenue, and remaining performance obligations. Further, we can provide no assurance as to the profitability of our contracts reflected in remaining performance obligations, backlog and net bookings.

 

Results of Operations

 

Comparison of Three Months Ended June 30, 2023 and June 30, 2022

 

Revenues and Cost of Goods Sold

 

Revenue for the three months ended June 30, 2023 was $1,064,000, compared to $3,015,000 for the three months ended June 30 2022, representing a decrease of $1,951,000, or 65%. The decrease was primarily due to a decrease in bookings in the last nine months. We believe the lower bookings are due to the suppression of capital expenditures in the cannabis market environment as a result of the prolonged effects of pricing and inflationary pressure.

 

28

 

 

Cost of revenue decreased by $1,724,000, or 64%, from $2,709,000 for the three months ended June 30, 2022 to $985,000 for the three months ended June 30, 2023. The decrease was primarily due to a decrease in revenue and a decrease in variable costs, offset by higher fixed costs as a percentage of revenue, as discussed below.

 

Our gross profit for the three months ended June 30, 2023 was $79,000 compared to $306,000 for the three months ended June 30, 2022, a decrease of 74%. Gross profit margin decreased by 2.8 percentage points from 10.2% for the three months ended June 30, 2022 to 7.4% for the three months ended June 30, 2023 primarily due to lower revenue and an increase in fixed costs as a percentage of revenue, partially offset by a decrease in variable costs as a percentage of revenue, as described below. Additionally, total revenue in the three months ended June 30, 2023 includes $60,000 from forfeited, non-refundable deposits from former customers on previously cancelled contracts.

 

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $320,000, or 30% of total revenue, for the three months ended June 30, 2023 as compared to $450,000, or 15% of total revenue, for the three months ended June 30, 2022. The decrease of $130,000 was primarily due to a decrease in salaries and benefits (including stock-based compensation) of $92,000 and a decrease in fixed overhead of $33,000.

 

Our variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled $665,000, or 63% of total revenue, during the three months ended June 30, 2023, as compared to $2,259,000, or 75% of total revenue, in the three months ended June 30, 2022. The decrease in variable costs was primarily due to: (i) a decrease in equipment costs of $1,493,000 driven by higher revenue and higher equipment margins, (ii) a decrease in outside engineering costs of $71,000, and (iii) a decrease in travel of $39,000, offset by slightly higher warranty expense.

 

We continue to focus on gross margin improvement through a combination of efforts, including more disciplined pricing, better absorption of our fixed costs as we convert our bookings into revenue, and the implementation over time of lower-cost supplier alternatives.

 

Operating Expenses

 

Operating expenses decreased to $783,000 for the three months ended June 30, 2023, from $2,077,000 for the three months ended June 30, 2022, a decrease of $1,294,000, or 62%. The operating expense decrease consisted of: (i) a decrease of $631,000 for goodwill impairment charges, (ii) a decrease in selling, general and administrative expenses (“SG&A expenses”) of $330,000, (iii) a decrease in advertising and marketing expenses of $277,000, and (iii) a decrease in product development of $57,000.

 

Our decrease in SG&A expenses for the three months ended June 30, 2023 compared to the three months ended June 30, 2022, was primarily due to: (i) a decrease of $175,000 in salaries and benefits (including stock-based compensation) and other employee related costs, (ii) a decrease in accounting and other professional fees of $42,000, (iii) a decrease in commissions and other sales related expense of $40,000, (iv) a decrease in travel of $33,000, (v) a decrease of $22,000 for facility and office expenses, and (vi) a decrease in insurance of $14,000.

 

The decrease in advertising and marketing expenses was primarily due to (i) a decrease in salaries and benefits (including stock compensation of $116,000, (ii) a decrease in advertising and promotion of $60,000, (iii) a reduction in outside services and other marketing expenses of $58,000, and (iv) a decrease in trade show related expenses of $42,000.

 

The decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock-based compensation) of $42,000, (ii) a decrease in R&D consulting and materials expense of $10,000, and (iii) a decrease in travel of $5,000.

 

Operating Income (Loss)

 

We recognized an operating loss of $705,000 for the three months ended June 30, 2023, as compared to an operating loss of $1,771,000 for the three months ended June 30, 2022, a decrease of $1,067,000 or 60%. The operating loss for the three months ended June 30, 2023 included $15,000 of non-cash, stock-based compensation, and $7,000 of depreciation expense, compared to $96,000 of non-cash, stock-based compensation, $7,000 of depreciation expense, and $631,000 for a goodwill impairment charge for the three months ended June 30, 2022. Excluding these non-cash items, our operating loss decreased by $355,000.

 

29

 

 

Other Income (Expense)

 

We recognized other income (net) of $11,000 for the three months ended June 30, 2023, compared to other income (net) of $11,000 for the three months ended June 30, 2022. Other income for the three months ended June 30, 2023 and the three months ended June 30, 2022 both primarily consisted of interest income on a money market account.

 

Net Income (Loss)

 

Overall, we recognized a net loss of $694,000 for the three months ended June 30, 2023, as compared to a net loss of $1,761,000 for the three months ended June 30, 2022, a decrease of $1,067,000 or 61%. The net loss for the three months ended June 30, 2023 included $15,000 of non-cash, stock-based compensation, and $7,000 of depreciation expense, compared to $96,000 of non-cash, stock-based compensation, $7,000 of depreciation expense, and $631,000 for a goodwill impairment charge for the three months ended June 30, 2022. Excluding these non-cash items, our net loss decreased by $356,000.

 

Comparison of Six Months Ended June 30, 2023 and June 30, 2022

 

Revenues and Cost of Goods Sold

 

Revenue for the six months ended June 30, 2023 was $5,746,000, compared to $4,759,000 for the six months ended June 30 2022, representing an increase of $987,000, or 21%. The increase was primarily due to improvements in our supply chain and the ability to deliver products with fewer delays on contract fulfillment and revenue recognition on existing contracts during the first quarter.

 

Cost of revenue increased by $452,000, or 10%, from $4,363,000 for the six months ended June 30, 2022 to $4,814,000 for the six months ended June 30, 2023. The increase was primarily due to an increase in revenue and a decrease in variable and fixed costs as a percentage of revenue.

 

Our gross profit for the six months ended June 30, 2023 was $932,000 compared to $397,000 for the six months ended June 30, 2022, an increase of 135%. Gross profit margin increased by 8 percentage points from 8% for the six months ended June 30, 2022 to 16% for the six months ended June 30, 2023 primarily due to higher revenue and a decrease in fixed and variable costs as a percentage of revenue, as described below. Additionally, total revenue in the six months ended June 30, 2023 includes $205,000 from forfeited, non-refundable deposits from former customers on previously cancelled contracts.

 

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $710,000, or 12% of total revenue, for the six months ended June 30, 2023 as compared to $808,000, or 17% of total revenue, for the six months ended June 30, 2022. The decrease of $98,000 was primarily due to a decrease in salaries and benefits (including stock-based compensation) of $66,000 and a decrease in fixed overhead of $31,000.

 

Our variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled $4,104,000, or 71% of total revenue, during the six months ended June 30, 2023, as compared to $3,554,000, or 75% of total revenue, in the six months ended June 30, 2022. The increase in variable costs was primarily due to: (i) an increase in equipment costs of $643,000 driven by higher revenue, (ii) an increase in excess and obsolete inventory expense of $31,000, (iii) an increase in warranty of $19,000, offset by (iv) a decrease in outside engineering costs of $88,000, and (v) a decrease in travel of $52,000.

 

We continue to focus on gross margin improvement through a combination of efforts, including more disciplined pricing, better absorption of our fixed costs as we convert our bookings into revenue, and the implementation over time of lower-cost supplier alternatives.

 

30

 

 

Operating Expenses

 

Operating expenses decreased to $2,083,000 for the six months ended June 30, 2023, from $3,779,000 for the six months ended June 30, 2022, a decrease of $1,696,000, or 45%. The operating expense decrease consisted of: (i) a decrease of $621,000 in selling, general and administrative (“SG&A expenses”) (ii) a decrease of $631,000 for goodwill impairment charges, (iii) a decrease in advertising and marketing expenses of $325,000, and (iv) a decrease in product development of $119,000.

 

Our decrease in SG&A expenses for the six months ended June 30, 2023 compared to the six months ended June 30, 2022, was primarily due to: (i) a decrease of $377,000 in salaries and benefits (including stock-based compensation) and other employee related costs, (ii) a decrease in accounting and other professional fees of $170,000, (iii) a decrease in travel of $53,000, (iv) a decrease of $34,000 for facility and office expenses, and (v) a decrease in commissions and other sales related expenses of $29,000, offset by (i) an increase in investor relations expenses of $16,000, (ii) an increase in bad debt expense of $11,000, and (iii) an increase in board fees of $10,000.

 

The decrease in advertising and marketing expenses was primarily due to (i) a decrease in trade show related and other marketing expenses of $67,000, (ii) a decrease in outside services of $12,000, (iii) a reduction in advertising and promotion of $9,000, offset by an increase in salaries and benefits (including stock compensation) of $14,000 (related to severance payments for our reduction in force in February).

 

The decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock-based compensation) of $28,000, (ii) a decrease in R&D consulting and materials expense of $5,000, and (iii) a decrease in travel of $2,000.

 

Operating Income (Loss)

 

We recognized an operating loss of $1,151,000 for the six months ended June 30, 2023, as compared to an operating loss of $3,382,000 for the six months ended June 30, 2022, a decrease of $2,231,000 or 66%. The operating loss for the six months ended June 30, 2023 included $162,000 of non-cash, stock-based compensation, and $13,000 of depreciation expense, compared to $188,000 of non-cash, stock-based compensation, $14,000 of depreciation expense, and $631,000 for a goodwill impairment charge for the six months ended June 30, 2022. Excluding these non-cash items, our operating loss decreased by $1,574,000.

 

Other Income (Expense)

 

We recognized other income (net) of $26,000 for the six months ended June 30, 2023, compared to other income (net) of $199,000 for the six months ended June 30, 2022. Other income for the six months ended June 30, 2023 consisted of interest income on a money market account of $18,000 and $8,000 for adjustments to our ERC credit and unclaimed property liability. Other income for the six months ended June 30, 2022 primarily consisted of $185,000 for an insurance settlement and interest income on a money market account of $14,000.

 

Net Income (Loss)

 

Overall, we recognized a net loss of $1,125,000 for the six months ended June 30, 2023, as compared to a net loss of $3,184,000 for the six months ended June 30, 2022, a decrease of $2,059,000 or 65%. The net loss for the six months ended June 30, 2023 included $162,000 of non-cash, stock-based compensation, and $13,000 of depreciation expense, compared to $188,000 of non-cash, stock-based compensation, $14,000 of depreciation expense, and $631,000 for a goodwill impairment charge for the six months ended June 30, 2022. Excluding these non-cash items, our net loss decreased by $1,401,000.

 

31

 

 

Financial Condition, Liquidity and Capital Resources

 

Cash, Cash Equivalents

 

As of June 30, 2023, we had cash and cash equivalents of $14,197,000, compared to cash and cash equivalents of $18,637,000 as of December 31, 2022. The $4,440,000 decrease in cash and cash equivalents during the six months ended June 30, 2023, was the result of cash used in operations. Our cash is held in bank depository accounts in a financial institution. During the six months ended June 30, 2023, we held deposits in this financial institution that exceeded the federally insured amount.

 

As of June 30, 2023, we had accounts receivable (net of allowance for doubtful accounts) of $294,000, inventory (net of excess and obsolete allowance) of $397,000, and prepaid expenses and other assets of $520,000 (including $10,000 in advance payments on inventory purchases). While we typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we continue to pursue larger projects.

 

As of June 30, 2023, we had total accounts payable and accrued expenses of $799,000, deferred revenue of $626,000, and the current portion of operating lease liability of $122,000. As of June 30, 2023, we had working capital of $13,862,000, compared to working capital of $14,724,000 as of December 31, 2022. The decrease in our working capital was primarily related to (i) a decrease in cash of $4,440,000, (ii) a decrease in deferred revenue of $3,713,000, (iii) a decrease in accounts payable and accrued liabilities of $409,000, and (iv) a decrease in prepaid expense of $970,000.

 

We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business. We have never declared or paid any cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future.

 

Because of the post-pandemic macro-economic and CEA industry economy that has developed during 2021 and 2022, and is continuing into 2023, we cannot predict the continuing level of working capital that we will have in the future. Additionally, we cannot predict that our future financial position will not deteriorate due to cancelled or delayed contract fulfillment, reduced sales and our ability to perform our contracts. As mentioned elsewhere, we have taken steps to conserve our cash resources by reducing staff and taking other cost-cutting measures.

 

Summary of Cash Flows

 

The following summarizes our approximate cash flows for the six months ended June 30, 2023 and June 30, 2022:

 

  

For the Six Months Ended

June 30,

 
   2023   2022 
 Net cash used in operating activities  $(4,440,000)  $(1,232,000)
 Net cash used in investing activities   -    (11,000)
 Net cash provided by financing activities   -    19,695,000 
 Net increase (decrease) in cash  $(4,440,000)  $18,452,000 

 

Operating Activities

 

We incurred a net loss for the six months ended June 30, 2023 of $1,125,000 and have an accumulated deficit of $35,404,000 as of June 30, 2023.

 

Cash used in operations for the six months ended June 30, 2023 was $4,440,000 compared to cash used in operating activities of $1,269,000 for the six months ended June 30, 2022, an increase in cash usage of $3,171,000.

 

32

 

 

The increase in cash used in operating activities during the six months ended June 30, 2023 as compared to the six months ended June 30, 2022, was primarily attributable to: (i) an increase in cash used to fund working capital of $4,712,000, (ii) a decrease in net loss of $2,059,000, and (iii) a decrease in non-cash operating charges of $517,000.

 

The decrease in our working capital was primarily related to (i) a decrease in cash of $4,440,000, (ii) a decrease in deferred revenue of $3,713,000, (iii) a decrease in prepaid expense of $970,000, (iv) a decrease in accounts payable and accrued liabilities of $409,000, and (v) an increase in accounts receivable of $291,000.

 

The decrease in non-cash operating charges was primarily due to a decrease in goodwill impairment charges of $631,000, offset by an increase in the provision for excess and obsolete inventory of $95,000.

 

Investing Activities

 

Cash used in investing activities during the six months ended June 30, 2023 was $0. Cash used in investing activities during the six months ended June 30, 2022 of $12,000 was primarily related to the purchase of property and equipment.

 

Financing Activities

 

There were no cash flows from financing activities during the six months ended June 30, 2023.

 

Cash flows from financing activities during the six months ended June 30, 2022, was the result of cash proceeds from the sale of common stock and warrants (net of issuance costs) of $21,711,000, offset by a cash payment of $2,016,000 for the redemption of series B preferred stock, including related dividends.

 

Common Stock Equity Offering

 

On February 15, 2022, the Company completed a public offering of shares of common stock and warrants. The Company received net proceeds of approximately $21,711,000 for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00, expiring February 10, 2027. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.16, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

The net proceeds from the offering will be used for the Company’s operations, to pursue select acquisitions or strategic alternatives, and for general corporate and working capital purposes. In connection with the offering, we received approval to list our common stock on the Nasdaq Capital Market under the symbol “CEAD” and our warrants under the symbol “CEADW”. Effective February 10, 2022, trading of both shares of the Company’s common stock and certain of the Company’s warrants commenced on the Nasdaq. See Item 5 below for discussion of the notice received from Nasdaq concerning a potential delisting.

 

Inflation

 

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases in the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

33

 

 

Contractual Payment Obligations

 

As of June 30, 2023, our contractual payment obligations consisted of a building lease. Refer to Note 2Leases of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of our building lease.

 

Commitments and Contingencies

 

Refer to Note 6 – Commitments and Contingencies of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of commitments and contingencies.

 

Off-Balance Sheet Arrangements

 

We are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of March 31, 2023, we had no off-balance sheet arrangements. During the three months ended March 31, 2023, we did not engage in any off-balance sheet financing activities other than those included in the “Contractual Payment Obligations” discussed above and those reflected in Note 6 of our condensed consolidated financial statements.

 

Recent Developments

 

Refer to Note 12 - Subsequent Events of the notes to condensed consolidated financial statements, included as part of this Quarterly Report for certain significant events occurring since June 30, 2023.

 

Critical Accounting Estimates

 

This discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies are particularly important to the understanding of our financial position and results of operations and require the application of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate. Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that as a result of material weakness in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC, our disclosure controls and procedures were not effective as of June 30, 2023.

 

34

 

 

We did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements, (ii) there is inadequate segregation of duties due to our limited number of accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on, for our financial reporting.

 

We intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and our financial resources, remediating the several identified weaknesses has not been possible and may not be economically feasible now or in the future.

 

Changes in Internal Control over Financial Reporting

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended June 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not currently a party to any material legal proceedings, nor are we aware of any pending or threatened litigation that would have a material adverse effect on our business, operating results, cash flows, or financial condition should such litigation be resolved unfavorably. We have and will continue to have commercial disputes arising in the ordinary course of our business.

 

Item 1A. Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under the caption “Item 1A—Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 that could materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not known to us or that we currently consider to be immaterial to our operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

35

 

 

Item 5. Other Information

 

Nasdaq Notice Regarding Minimum Bid Price

 

On April 10, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until October 9, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

In order to regain compliance with Nasdaq’s minimum bid price requirement, the Company’s common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the Compliance Period. In the event the Company does not regain compliance by the end of the Compliance Period, the Company may be eligible for additional time to regain compliance. To qualify for the additional time, the Company will be required to meet the continued listing requirement for the market value of its publicly held shares and all the other listing standards for The Nasdaq Capital Market and will need to provide written plan to cure the deficiency during the second compliance period. The Company may be granted an additional 180 calendar days to regain compliance if the plan is accepted by Nasdaq. However, if it appears to Nasdaq that the Company will be unable to cure the deficiency, or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide notice that the Company’s common stock will be subject to delisting.

 

The letter has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market, subject to the Company’s compliance with the other listing requirements of The Nasdaq Capital Market.

 

Initiation of Strategic Alternatives Review

 

On May 24, 2023, the Company’s Board of Directors hired Roth Capital Partners to assist in its review of strategic alternatives. While the Company is hopeful that this process increases the slate of opportunities available to create shareholder value, there can be no assurance regarding the results or outcome of this review.

 

Item 6. Exhibits

 

The documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

 

36

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CEA INDUSTRIES INC.
  (the “Registrant”)
     
Dated: August 14, 2023 By: /s/ Anthony K. McDonald
    Anthony K. McDonald
    Chief Executive Officer and President
    (Principal Executive Officer)
     
Dated: August 14, 2023 By: /s/ Ian K. Patel
    Ian K. Patel
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

37

 

 

EXHIBIT INDEX

 

Exhibit    
Number   Description of Exhibit
     
31.1 *   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2 *   Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1**   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2**   Certification of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Schema
     
101.CAL*   Inline XBRL Taxonomy Calculation Linkbase
     
101.DEF*   Inline XBRL Taxonomy Definition Linkbase
     
101.LAB*   Inline XBRL Taxonomy Label Linkbase
     
101.PRE*   Inline XBRL Taxonomy Presentation Linkbase
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.
** Furnished herewith.

 

38

 

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Anthony K. McDonald, the Chief Executive Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended June 30, 2023;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated August 14, 2023.

 

By: /s/ Anthony K. McDonald  
 

Anthony K. McDonald

 
  Chief Executive Officer  

 

 

 

  

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Ian K. Patel, the Principal Financial and Accounting Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended June 30, 2023;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated August 14, 2023.

 

By: /s/ Ian K. Patel  
 

Ian K. Patel

 
  Chief Financial Officer  

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Anthony K. McDonald
  Name: Anthony K. McDonald,
    Chief Executive Officer
  Date: August 14, 2023

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Ian K. Patel, the Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Ian K. Patel
  Name: Ian K. Patel,
    Chief Financial Officer
  Date: August 14, 2023

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

EX-101.SCH 6 cead-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Equity Incentive Plans link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Equity Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule of Revenue by Source (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Inventory (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Schedule of Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Equity Incentive Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cead-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cead-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cead-20230630_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.00001 par value Warrants to purchase common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Series B Preferred Stock [Member] Title of Individual [Axis] Director And Staff [Member] Product and Service [Axis] Miscellaneous [Member] Award Date [Axis] 2023 [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Booked Sales Orders From Three Customers [Member] One Customer [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] Customer One [Member] Customer Two [Member] Customer Three [Member] Accounts Receivable [Member] Equipment and Systems Sales [Member] Engineering and Other Services [Member] Shipping and Handling [Member] 2024 [Member] Income Statement Location [Axis] Cost of Sales [Member] Advertising and Marketing Expenses [Member] Product Development Costs [Member] Selling, General and Administrative Expenses [Member] New Facility Lease [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Vehicles [Member] Property, Plant and Equipment [Member] Inventory [Member] Award Type [Axis] Non-Qualified Stock Options [Member] Plan Name [Axis] 2021 Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member] January 17, 2022 [Member] January 17, 2023 [Member] Directors [Member] 2021 Equity Plan [Member] Director [Member] Audit Committee Chairman [Member] Committee Chairman [Member] Board of Directors Chairman [Member] Warrant [Member] Underwriters [Member] 2017 Equity Incentive Plan [Member] Restricted Stock [Member] Derivative Instrument [Axis] Non Qualified Stock Option [Member] Five Employees [Member] Incentive Stock Option [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Related Party, Type [Axis] Employees And Consultants [Member] Employees, Directors and Consultants [Member] Exercise Price Range [Axis] Warrants Range [Member] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] Investment, Name [Axis] Ownership [Member] Consulting Agreement [Member] Legal Entity [Axis] Lone Star Bioscience Inc [Member] Chief Executive Officer [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable, net Inventory, net Prepaid expenses and other Total Current Assets Noncurrent Assets Property and equipment, net Intangible assets, net Deposits Operating lease right-of-use asset Total Noncurrent Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY LIABILITIES Current Liabilities Accounts payable and accrued liabilities Deferred revenue Accrued equity compensation Current portion of operating lease liability Total Current Liabilities Noncurrent Liabilities Operating lease liability, net of current portion Total Noncurrent Liabilities TOTAL LIABILITIES Commitments and Contingencies (Note 6) SHAREHOLDERS’ EQUITY Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total Shareholders’ Equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Preferred stock, par or stated value per share Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par or stated value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue, net Cost of revenue Gross profit Operating expenses: Advertising and marketing expenses Product development costs Selling, general and administrative expenses Goodwill impairment charges Total operating expenses Operating loss Other income (expense): Other income (expense), net Interest income (expense), net Total other income (expense) Loss before provision for income taxes Income taxes Net loss Convertible preferred series B stock dividends Deemed dividend on convertible preferred series B stock on down round Net loss available to common shareholders Earnings Per Share, Basic Earnings Per Share, Diluted Weighted average number of common shares outstanding, basic Weighted average number of common shares outstanding, diluted Beginning balance, value Balance, shares Fair value of vested stock options granted to employees Net loss Common shares issued in settlement of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors, shares Fair value of restricted stock units issued to directors Cashless exercise of prefunded warrants Cashless exercise of prefunded warrants, shares Fair value of vested stock options granted to directors Issuance of common shares to round up partial shares following reverse split Issuance of common shares to round up partial shares following reverse split, shares Common shares and warrants issued for cash Common shares and warrants issued for cash, shares Common shares and warrants issued on conversion of series B preferred stock Common shares issued and warrants on conversion of series B preferred stock, shares Dividends on series B preferred stock Ending balance, value Balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities: Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation and intangible asset amortization expense Share-based compensation Provision for doubtful accounts Provision for excess and obsolete inventory Loss on disposal of assets Amortization of operating lease ROU asset Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other Accounts payable and accrued liabilities Deferred revenue Operating lease liability, net Accrued equity compensation Net cash provided by (used in) operating activities Cash Flows From Investing Activities Purchases of property and equipment Proceeds from the sale of property and equipment Net cash provided by (used in) investing activities Cash Flows From Financing Activities Payment of dividends on series B preferred stock Redemption of series B preferred stock Net cash proceeds on sale of common stock and warrants, net of expenses Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and  cash equivalents, end of period Supplemental cash flow information: Interest paid Income taxes paid Non-cash investing and financing activities: Unpaid purchases of equipment and other assets Conversion of series B preferred stock Deemed dividend on series B preferred stock arising on down round Cashless exercise of prefunded warrants Options issued for accrued equity compensation liability Accounting Policies [Abstract] Nature of Operations and Significant Accounting Policies Leases Leases Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Equity Share-Based Payment Arrangement [Abstract] Equity Incentive Plans Warrants Warrants Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Description of Business Impact of the COVID-19 Pandemic on Our Business Impact of Ukrainian Conflict Inflation Financial Statement Presentation Interim Financial Statements Principles of Consolidation Use of Estimates Cash, Cash Equivalents, and Restricted Cash Income (Loss) Per Common Share Goodwill Temporary Equity Revenue Recognition Product Warranty Accounting for Share-Based Compensation Concentrations Recently Issued Accounting Pronouncements Schedule of Revenue by Source Schedule of Remaining Performance Obligations Expected to be Recognized Schedule of Share-based Compensation Costs Schedule of Lease Cost Schedule of Future Annual Minimum Lease Payments Schedule of Inventory Schedule of Property and Equipment Schedule of Accounts Payable and Accrued Liabilities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Stock Option Activity Summary of Non-vested Non-qualified Stock Option Activity Schedule of Restricted Stock Units Activity Schedule of Outstanding Warrants to Purchase Common Stock Schedule of Warrants Outstanding Schedule of Product Information [Table] Product Information [Line Items] Total revenue Remaining performance obligations related to engineering only paid contracts Remaining performance obligations related to partial equipment paid contracts Total remaining performance obligations Total share-based compensation expense included in consolidated statement of operations Federal insured amount Cash balance, amount Cash equivalent balance, amount Potentially dilutive equity instruments that are convertible into common stock Goodwill and intangible asset impairment Miscellaneous revenue Contract with customer liability current Revenue recognized Revenue remaining performance obligation Product warranty description Accrued warranty reserve amount Stock price volatility Expected Term Risk-free interest rate Accrued Incentive Concentration risk percentage Schedule Of Lease Cost Operating lease liability, current Operating lease liability, long-term Remaining lease term Discount rate Operating cash outflow from operating lease Schedule Of Future Annual Minimum Lease Payments 2023 (excluding the six months ended June 30, 2023) 2024 2025 2026 Thereafter Total minimum lease payments Less imputed interest Present value of minimum lease payments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Area of land Operating lease term description Lease rental expense Increase in rent percent Security deposit Lease renew term Operating lease liability Finished goods Work in progress Raw materials Allowance for excess & obsolete inventory Inventory, net Overhead expenses Prepaid inventory expenses Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Accumulated depreciation Property and equipment, net Depreciation expenses Accounts payable Sales commissions payable Accrued payroll liabilities Product warranty accrual Other accrued expenses Total Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Common stock par value Number of stock options issued Exercise price Number of stock options issued Shares, vested Number of shares vested in period Management fee expense Share based compensation arrangement payment Vesting rights description Reverse stock split Reverse stock split Net proceeds from sale of common stock Number of shares sold Warrant term Exercise price Stock issued during period, shares, issued for services Warrants maturity date Number of shares issued Prefunded conversion warrants Number of Options, Outstanding Beginning Weighted Average Exercise Price, Outstanding Beginning Weighted Average Remaining Contractual Term, Beginning Aggregate Intrinsic Value, Outstanding Beginning Number of Options, Granted Weighted Average Exercise Price, Granted Weighted Average Remaining Contractual Term, Granted Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Forfeited/Cancelled Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Remaining Contractual Term, Forfeited Number of Options, Expired Weighted Average Exercise Price, Expired Number of Options, Outstanding Ending Weighted Average Exercise Price, Outstanding Ending Weighted Average Remaining Contractual Term, Outstanding Ending Aggregate Intrinsic Value, Outstanding Ending Number of Options, Exercisable Ending Weighted Average Exercise Price, Exercisable Ending Weighted Average Remaining Contractual Term, Exercisable Ending Aggregate Intrinsic Value, Exercisable Ending Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Beginning Grant Date Fair Value Nonvested, Beginning Number of Options Nonvested, Granted Weighted Average Grant-Date Fair Value, Nonvested, Granted Grant Date Fair Value Nonvested, Granted Number of Options Nonvested, Vested Weighted Average Grant-Date Fair Value, Nonvested, Vested Grant Date Fair Value Nonvested, Vested Number of Options Nonvested, Forfeited Weighted Average Grant-Date Fair Value, Nonvested, Forfeited Grant Date Fair Value Nonvested, Forfeited Number of Options Nonvested, Expired Weighted Average Grant-Date Fair Value, Nonvested, Expired Grant Date Fair Value Nonvested, Expired Number of Options Nonvested, Ending Weighted Average Grant-Date Fair Value, Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Ending Grant Date Fair Value Nonvested, Ending Number of Units Outstanding, beginning Weighted Average Grant-Date Fair Value Outstanding, Beginning Aggregate Intrinsic Value Outstanding, Beginning Number of Units, Granted Weighted Average Grant-Date Fair Value, Granted Aggregate Intrinsic Value Outstanding, Granted Number of Units, Vested and settled with share issuance Weighted Average Grant-Date Fair Value, Vested and settled with share issuance Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance Number of Units, Forfeited/canceled Weighted Average Grant-Date Fair Value, Forfeited/Canceled Aggregate Intrinsic Value Outstanding, Forfeited/canceled Number of Units Outstanding, ending Weighted Average Grant-Date Fair Value Outstanding,ending Aggregate Intrinsic Value Outstanding, ending Number of options to purchase shares Number of shares authorized Number of shares issued Number of option remain outstanding Shares available for future equity awards Number of shares grant in period Shares issued during the period Number of share awards granted Exercise price per share Additional expense Number of shares authorized Unrecognized compensation expense Weighted Average Remaining Contractual Term Share based compensation Number of options to purchase shares Number of shares granted Schedule Of Outstanding Warrants To Purchase Common Stock Warrants Outstanding, Beginning Balance Warrants Exercisable, Beginning Balance Weighted Average Exercise Price, Beginning Balance Weighted Average Life of Outstanding Warrants in Months, Beginning Balance Aggregate Intrinsic Value, Beginning Balance Warrants, Granted Warrants, Granted Weighted Average Exercise Price, Granted Weighted Average Life of Outstanding Warrants in Months, Granted Aggregate Intrinsic Value, Granted Warrants, Exercised Warrants, Exercised Weighted Average Exercise Price, Exercised Weighted Average Remaining Life, Exercised Aggregate Intrinsic Value, Exercised Warrants, Expired Warrants, Expired Weighted Average Exercise Price, Expired Weighted Average Life of Outstanding Warrants in Months, Granted Aggregate Intrinsic Value, Expired Warrants Outstanding, Ending Balance Warrants Exercisable, Ending Balance Weighted Average Exercise Price, Ending Balance Weighted Average Life of Outstanding Warrants in Months, Ending Balance Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Warrants Outstanding Warrants Exercisable Weighted Average Life of Outstanding Warrants in Months Operating loss carryforward Net operating loss carry forward expected to expire amount Net operating loss expiration term NOLs usage against taxable income, percentage Percentage of ownership change NOLs carryforwards term Payments for commissions Proceeds from deposits Proceeds from sales Cash payments Revenue Warrant to purchase of common stock. Common Stock, $0.00001 par value. Convertible preferred stock converted to securities. Deemed dividend on series B preferred stock on down round. Fair value of vested stock options granted to employees Common shares issued in settlement of restricted stock units issued to directors. Fair value of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors Cashless exercise of prefunded warrants, value. Stock issued during period shares cashless exercise of prefunded warrants. Adjustments to additional paid in capital fair value of vested stock options granted to directors. Issuance of common shares to round up partial shares following reverse split Common shares and warrants issued value for cash. Dividends on series B preferred stock Common shares and warrants issued shares for cash. Redemption of series B preferred stock Cash proceeds from sale of common stock and warrants net of issuance costs. Conversion of series B preferred stock. Deemed dividend on series B preferred stock arising on down round. Options issued for accrued equity compensation liability. Cashless exercise or prepaid warrants. Unpaid purchases of equipment and other assets. Description of Business [Policy Text Block] Impact of Covid-19 Pandemic On Our Business [Policy Text Block] Impact of Ukrainian Conflict [Policy Text Block] Inflation [Policy Text Block] Interim Financial Statements [Policy Text Block] Director And Staff [Member] Temporary Equity [Policy Text Block] Miscellaneous [Member] 2023 [Member] Booked Sales Orders From Three Customers [Member] One Customer [Member] 2024 [Member] Remaining performance obligations related to engineering only paid contracts. Remaining performance obligations related to partial equipment paid contracts. Customer One [Member] Customer Two [Member] Customer Three [Member] New Facility Lease [Member] Increase in rent percent. Prepaid inventory expenses Inventory [Member] Non-qualified Stock Options [Member] 2021 Equity Incentive Plan [Member] January 17, 2022 [Member] January 17, 2023 [Member] Directors [Member] 2021 Equity Plan [Member] Share based compensation arrangement by share based payment award value issued period. Audit Committee Chairman [Member] Committee Chairman [Member] Underwriters [Member] 2017 Equity Incentive Plan [Member] Non Qualified Stock Option [Member] Five Employees [Member] Employee stock ownership plan additional expense. Share-based compensation arrangement by share-based payment award, number of shares authorized. Incentive Stock Option [Member] Employees And Consultants [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Weighted average remaining contractual term, granted. Weighted Average Remaining Contractual Term,Forfeited. Weighted Average Remaining Contractual Term, Ending. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted. Number of Options, Expired. Number of Options, price per share. Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested. Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited. Share based compensation arrangement by sharebased payment award options nonvested grant date fair value expired. Employees, Directors and Consultants [Member] Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options. Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options. Warrants Disclosure [Text Block] Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block] Class of Warrant or Right Exercised Number of equity instruments other than options exercisable, including both vested and non-vested instruments. Net number of non-option equity instruments granted to participants. Number of non-option equity instruments exercised by participants. Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Warrants weighted average exercise price granted. Weighted average exercise price of warrants exercised. Weighted average exercise price of warrants expired. Weighted average life of outstanding warrants in months, beginning balance. Warrants weighted average remaining contractual terms. Weighted Average Remaining Life, Exercised Weighted average life of outstanding warrants in months, ending balance. Sharebased compensation arrangement by sharebased payment award non options expired weighted average remaining contractual terms. Aggregate intrinsic value of outstanding warrants. Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options. Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options. Warrants Range [Member] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] Net operating loss carry forward expected to expire amount. Net operating loss expiration term. Nols usage against taxable income percentage. Ownership [Member]. Nols carryforwards term description. Proceeds fom deposit. Consulting Agreement [Member] Lone Star Bioscience Inc [Member] Proceeds fom sales. Increase decrease in accrued equity compensation. Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Equipment and Systems Sales [Member] Engineering and Other Services [Member] Advertising and Marketing Expenses [Member] Product Development Costs [Member] Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) ConvertiblePreferredStockConvertedToSecurities Deemed dividend on series B preferred stock on down round Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability IncreaseDecreaseInAccruedEquityCompensation Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Preferred Stock and Preference Stock Redemption of series B preferred stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations CashlessExerciseOrPrepaidWarrants Lessee, Operating Leases [Text Block] Outstanding Warrants Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Inventory Valuation Reserves Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Stock Issued During Period, Shares, Stock Splits Class of Warrant or Right, Exercise Price of Warrants or Rights Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Aggregated Intrinsic Value, Nonvested Beginning Aggregated Intrinsic Value, Nonvested Beginning [Default Label] Grant Date Fair Value Nonvested, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Grant Date Fair Value Nonvested, Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Number of shares authorized [Default Label] Aggregate intrinsic value of outstanding warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised Weighted Average Exercise Price, Exercised [Default Label] ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations Weighted Average Exercise Price, Expired [Default Label] SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms EX-101.PRE 10 cead-20230630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 14, 2023
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41266  
Entity Registrant Name CEA INDUSTRIES INC.  
Entity Central Index Key 0001482541  
Entity Tax Identification Number 27-3911608  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 385 South Pierce Avenue  
Entity Address, Address Line Two Suite C  
Entity Address, City or Town Louisville  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80027  
City Area Code (303)  
Local Phone Number 993-5271  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   8,076,372
Common Stock, $0.00001 par value    
Title of 12(b) Security Common Stock, $0.00001 par value  
Trading Symbol CEAD  
Security Exchange Name NASDAQ  
Warrants to purchase common stock    
Title of 12(b) Security Warrants to purchase common stock  
Trading Symbol CEADW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 14,197,485 $ 18,637,114
Accounts receivable, net 293,767 2,649
Inventory, net 397,155 348,411
Prepaid expenses and other 520,256 1,489,921
Total Current Assets 15,408,663 20,478,095
Noncurrent Assets    
Property and equipment, net 53,225 68,513
Intangible assets, net 1,830 1,830
Deposits 14,747 14,747
Operating lease right-of-use asset 409,981 462,874
Total Noncurrent Assets 479,783 547,964
TOTAL ASSETS 15,888,446 21,026,059
Current Liabilities    
Accounts payable and accrued liabilities 798,624 1,207,258
Deferred revenue 625,911 4,338,570
Accrued equity compensation 89,970
Current portion of operating lease liability 122,272 118,235
Total Current Liabilities 1,546,807 5,754,033
Noncurrent Liabilities    
Operating lease liability, net of current portion 319,247 376,851
Total Noncurrent Liabilities 319,247 376,851
TOTAL LIABILITIES 1,866,054 6,130,884
Commitments and Contingencies (Note 6)
SHAREHOLDERS’ EQUITY    
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively 81 80
Additional paid in capital 49,426,065 49,173,836
Accumulated deficit (35,403,754) (34,278,741)
Total Shareholders’ Equity 14,022,392 14,895,175
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 15,888,446 $ 21,026,059
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par or stated value per share $ 0.00001 $ 0.00001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par or stated value per share $ 0.00001 $ 0.00001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 8,076,372 7,953,974
Common stock, shares outstanding 8,076,372 7,953,974
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue, net $ 1,063,714 $ 3,014,885 $ 5,746,287 $ 4,759,312
Cost of revenue 985,021 2,708,646 4,814,318 4,362,565
Gross profit 78,693 306,239 931,969 396,747
Operating expenses:        
Advertising and marketing expenses 33,091 309,690 235,414 560,705
Product development costs 74 56,577 76,487 195,495
Selling, general and administrative expenses 750,156 1,080,094 1,770,858 2,391,871
Goodwill impairment charges 631,064 631,064
Total operating expenses 783,321 2,077,425 2,082,759 3,779,135
Operating loss (704,628) (1,771,186) (1,150,790) (3,382,388)
Other income (expense):        
Other income (expense), net 2,074 7,778 185,000
Interest income (expense), net 8,979 10,600 17,999 13,860
Total other income (expense) 11,053 10,600 25,777 198,860
Loss before provision for income taxes (693,575) (1,760,586) (1,125,013) (3,183,528)
Income taxes
Net loss (693,575) (1,760,586) (1,125,013) (3,183,528)
Convertible preferred series B stock dividends (35,984)
Deemed dividend on convertible preferred series B stock on down round (439,999)
Net loss available to common shareholders $ (693,575) $ (1,760,586) $ (1,125,013) $ (3,659,511)
Earnings Per Share, Basic $ (0.09) $ (0.23) $ (0.14) $ (0.59)
Earnings Per Share, Diluted $ (0.09) $ (0.23) $ (0.14) $ (0.59)
Weighted average number of common shares outstanding, basic 8,076,372 7,801,211 8,074,064 6,220,600
Weighted average number of common shares outstanding, diluted 8,076,372 7,801,211 8,074,064 6,220,600
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 16 $ 25,211,017 $ (28,781,566) $ (3,570,533)
Balance, shares at Dec. 31, 2021 1,600,835      
Fair value of vested stock options granted to employees 159,573 159,573
Net loss (3,183,528) (3,183,528)
Common shares issued in settlement of restricted stock units issued to directors 24,994 24,994
Common shares issued in settlement of restricted stock units issued to directors, shares 3,367      
Fair value of restricted stock units issued to directors 11,173 11,173
Cashless exercise of prefunded warrants $ 2 (2)
Cashless exercise of prefunded warrants, shares 169,530      
Fair value of vested stock options granted to directors 29,656 29,656
Issuance of common shares to round up partial shares following reverse split  
Issuance of common shares to round up partial shares following reverse split, shares 6,798      
Common shares and warrants issued for cash $ 58 21,711,073 21,711,131
Common shares and warrants issued for cash, shares 5,811,138      
Common shares and warrants issued on conversion of series B preferred stock $ 4 1,979,996 1,980,000
Common shares issued and warrants on conversion of series B preferred stock, shares 362,306      
Dividends on series B preferred stock (35,984) (35,984)
Ending balance, value at Jun. 30, 2022 $ 80 49,091,496 (31,965,094) 17,126,482
Balance, shares at Jun. 30, 2022 7,953,974      
Beginning balance, value at Mar. 31, 2022 $ 78 48,958,618 (30,204,508) 18,754,188
Balance, shares at Mar. 31, 2022 7,784,444      
Fair value of vested stock options granted to employees 126,635 126,635
Net loss (1,760,586) (1,760,586)
Fair value of restricted stock units issued to directors 6,245 6,245
Cashless exercise of prefunded warrants $ 2 (2)
Cashless exercise of prefunded warrants, shares 169,530      
Ending balance, value at Jun. 30, 2022 $ 80 49,091,496 (31,965,094) 17,126,482
Balance, shares at Jun. 30, 2022 7,953,974      
Beginning balance, value at Dec. 31, 2022 $ 80 49,173,836 (34,278,741) 14,895,175
Balance, shares at Dec. 31, 2022 7,953,974      
Fair value of vested stock options granted to employees 150,914 150,914
Net loss (1,125,013) (1,125,013)
Common shares issued in settlement of restricted stock units issued to directors $ 1 (1)
Common shares issued in settlement of restricted stock units issued to directors, shares 122,398      
Fair value of restricted stock units issued to directors 101,316 101,316
Ending balance, value at Jun. 30, 2023 $ 81 49,426,065 (35,403,754) 14,022,392
Balance, shares at Jun. 30, 2023 8,076,372      
Beginning balance, value at Mar. 31, 2023 $ 81 49,410,899 (34,710,179) 14,700,801
Balance, shares at Mar. 31, 2023 8,076,372      
Fair value of vested stock options granted to employees 15,166 15,166
Net loss (693,575) (693,575)
Ending balance, value at Jun. 30, 2023 $ 81 $ 49,426,065 $ (35,403,754) $ 14,022,392
Balance, shares at Jun. 30, 2023 8,076,372      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows From Operating Activities:    
Net loss $ (1,125,013) $ (3,183,528)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and intangible asset amortization expense 14,988 16,697
Share-based compensation 162,260 225,396
Provision for doubtful accounts 2,096 (9,182)
Provision for excess and obsolete inventory 60,574 (34,417)
Loss on disposal of assets 100 4,060
Amortization of operating lease ROU asset 52,893 51,061
Goodwill impairment charges 631,064
Changes in operating assets and liabilities:    
Accounts receivable (293,214) 48,153
Inventory (109,318) 10,986
Prepaid expenses and other 969,665 (1,692,816)
Accounts payable and accrued liabilities (408,634) (317,453)
Deferred revenue (3,712,659) 3,095,431
Operating lease liability, net (53,567) (39,870)
Accrued equity compensation (37,251)
Net cash provided by (used in) operating activities (4,439,829) (1,231,669)
Cash Flows From Investing Activities    
Purchases of property and equipment (13,948)
Proceeds from the sale of property and equipment 200 2,250
Net cash provided by (used in) investing activities 200 (11,698)
Cash Flows From Financing Activities    
Payment of dividends on series B preferred stock (35,984)
Redemption of series B preferred stock (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses 21,711,131
Net cash provided by financing activities 19,695,147
Net change in cash and cash equivalents (4,439,629) 18,451,781
Cash and cash equivalents, beginning of period 18,637,114 2,159,608
Cash and  cash equivalents, end of period 14,197,485 20,611,388
Supplemental cash flow information:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Unpaid purchases of equipment and other assets 16,400
Conversion of series B preferred stock 1,980,000
Deemed dividend on series B preferred stock arising on down round 439,999
Cashless exercise of prefunded warrants   2
Options issued for accrued equity compensation liability $ 89,970 $ 83,625
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations and Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Nature of Operations and Significant Accounting Policies

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of June 30, 2023, the balance in the Company’s accounts was approximately $14,197,000, consequently approximately $13,947,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of June 30, 2023, and June 30, 2022, there were respectively, 8,009,889 and 7,882,061, potentially dilutive equity instruments outstanding in respect of warrants options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both June 30, 2023 and June 30, 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 386,117 and 252,289 potentially dilutive equity instruments outstanding as of June 30, 2023 and June 30, 2022, respectively, related to options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

Revenue Recognition

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $899,748   $2,791,141   $5,296,574   $4,433,713 
Engineering and other services   103,232    192,076    227,643    278,125 
Shipping and handling   4,775    31,668    17,335    47,474 
Miscellaneous   55,959    -    204,735    - 
Total revenue  $1,063,714   $3,014,885   $5,746,287   $4,759,312 

 

Miscellaneous revenue of $55,959 and $204,735 recognized during the three and six months ended June 30, 2023, respectively, represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of June 30, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of June 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $625,911 and $4,338,570, respectively.

 

For the three and six months ended June 30, 2023, the Company recognized revenue of $45,716 and $3,898,622, respectively, related to the deferred revenue at January 1, 2023 For the three and six months ended June 30, 2022, the Company recognized revenue of $1,030,830 and $2,193,204, respectively, related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of June 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $1,066,000. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer and smaller new contracts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at June 30, 2023, includes booked sales orders of $250,000 from three customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $279,000 (26% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   816,000    250,000    1,066,000 
Total remaining performance obligations  $816,000   $250,000   $1,066,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of June 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $193,498 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the six months ended June 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and June 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $5,104   $4,898   $5,895 
Advertising and marketing expenses   -    4,080    1,113    6,842 
Product development costs   -    4,961    3,570    4,961 
Selling, general and administrative expenses   15,166    81,482    152,679    170,446 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $95,627   $162,260   $188,144 

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Included in the expense for the three and six months ended June 30, 2022, is an accrual for $46,374 and $46,374, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.

 

Concentrations

 

Two customers accounted for 64%, and 10% of the Company’s revenue for the three months ended June 30, 2023. Three customers accounted for 44%, 23% and 14% of the Company’s revenue for the six months ended June 30, 2023. Two customers accounted for 53% and 12% of the Company’s revenue for the three months ended June 30, 2022 and one customer accounted for 47% of the Company’s revenue for the six months ended June 30, 2022.

 

Three customers accounted for 69%, 17%, and 12% of the Company’s accounts receivable as of June 30, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Leases
6 Months Ended
Jun. 30, 2023
Leases  
Leases

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

June 30, 2023

 
Operating lease right-of-use asset  $409,981 
Operating lease liability, current  $122,272 
Operating lease liability, long-term  $319,247 
      
Remaining lease term   3.6 years 
Discount rate   3.63%

 

   For the Six Months Ended June 30, 2023 
Operating cash outflow from operating lease  $62,138 

 

Future annual minimum lease payments on the New Facility Lease as of June 30, 2023 are as follows:

 

As of June 30, 2023    
     
Years ended December 31,    
2023 (excluding the six months ended June 30, 2023)  $62,759 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   472,032 
Less imputed interest   (30,513)
Present value of minimum lease payments  $441,519 

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

 

Inventory consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Finished goods  $398,455   $270,555 
Work in progress   -    155 
Raw materials   130,180    148,608 
Allowance for excess & obsolete inventory   (131,480)   (70,907)
Inventory, net  $397,155   $348,411 

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Overhead expenses of $15,055 and $12,770 were included in the inventory balance as of June 30, 2023, and December 31, 2022, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $10,000 and $1,176,000 in advance payments for inventory for the periods ended June 30, 2023, and December 31, 2022, respectively.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (237,769)   (224,876)
Property and equipment, net  $53,225   $68,513 

 

Depreciation expense was $14,988 for the six months ended June 30, 2023. For the six months ended June 30, 2023, $1,749 was allocated to cost of sales, $437 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts Payable and Accrued Liabilities
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

  

   June 30,   December 31, 
   2023   2022 
Accounts payable  $280,763   $311,162 
Sales commissions payable   2,061    25,951 
Accrued payroll liabilities   231,182    465,094 
Product warranty accrual   193,498    180,457 
Other accrued expenses   91,120    224,594 
Total  $798,624   $1,207,258 

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 – Commitments and Contingencies

 

Litigation

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders’ Equity
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Stockholders’ Equity

Note 7 – Stockholders’ Equity

 

As of June 30, 2023, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of June 30, 2023, 8,076,372 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock vested on January 17, 2023. 1,684 shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Revised Compensation Plan

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The Plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.

 

The plan is divided into two phases: from the Effective Date of the Plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).

 

Pre-uplist phase: The Company paid its independent directors an annual cash fee of $15,000, payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

The Company pays the Audit Committee Chairman an additional annual fee of $10,000, payable quarterly in advance, for services as the Audit Committee Chairman.

 

The Company pays the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services as a Committee Chairman.

 

There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.

 

Post-uplist phase: The Company will pay its independent directors an annual cash fee of $25,000, payable quarterly in advance on the first business day of each quarter. All other terms remain the same.

 

Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.

 

The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.

 

Employee directors do not receive separate fees for their services as directors.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

An additional 6,798 shares of common stock were issued to round up partial shares following the reverse split.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,224 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Warrant Exercise

 

On June 21, 2022, the Company issued 169,530 shares of its common stock in connection with the cashless exercise of 170,382 prefunded conversion warrants.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Incentive Plans
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

During the six months ended June 30, 2023, no shares or options were issued, or cancelled under the 2017 Plan.

 

As of June 30, 2023, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 147,132 options remain outstanding, and 22,509 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

During the six months ended June 30, 2023, the Company issued 122,398 shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.

 

During the six months ended June 30, 2023, 138,489 non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $0.8955. An expense of $89,970 in respect of this issuance had been accrued in 2022. An additional expense of $32,376 was recognized in 2023 upon management and board finalization and approval of the awards.

 

As of June 30, 2023, of the 666,667 shares authorized under the 2021 Equity Plan, 132,568 shares have been issued in settlement of restricted stock units, awards relating to 198,170 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 295,113 shares remain available for future equity awards.

 

There was $30,753 in unrecognized compensation expense for unvested non-qualified stock options, and incentive stock options at June 30, 2023 which will be recognized over approximately 2 years.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the six months ended June 30, 2023, are presented in the table below:

  

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $- 
Granted   138,489   $0.90    6.6   $- 
Exercised   -   $-    -   $- 
Forfeited   (1,567)  $4.15    8.9   $- 
Expired   -   $-    -   $- 
Outstanding, June 30, 2023   328,995   $5.58    6.5   $- 
Exercisable, June 30, 2023   303,905   $5.61    6.4   $      - 

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the six months ended June 30, 2023, are presented in the table below:

 

  Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2022   28,756   $4.73   $-   $135,932 
Granted   138,489   $0.88   $-   $121,870 
Vested   (141,822)  $0.92   $-   $(131,094)
Forfeited   (333)  $6.67   $-   $(2,222)
Expired   -   $-   $-   $- 
Nonvested, June 30, 2023   25,090   $4.98   $       -   $124,486 

 

For the six months ended June 30, 2023 and June 30, 2022, the Company recorded $60,944 and $75,947 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the six months ended June 30, 2023, are presented in the table below:

  

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $- 
Granted   -    -    -   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, June 30, 2023   57,122   $9.44    5.5   $- 
Exercisable, June 30, 2023   57,122   $9.44    5.5   $      - 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the six months ended June 30, 2023.

 

During the six months ended June 30, 2023 and June 30, 2022, the Company incurred $0 and $29,656 respectively, as compensation expense related to 0 and 6,250 fully vested options issued to directors, respectively.

 

Restricted Stock Units

 

Effective January 3, 2023, the Company issued a total of 119,032 restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.

 

Effective January 17, 2023, the Company settled 3,366 RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock

 

During the six months ended June 30, 2023 and June 30, 2022, the Company recorded $101,316 and $36,168, respectively, as compensation expense related to vested RSUs issued to directors.

 

  Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
            
Outstanding, December 31, 2022   3,366   $7.42   $- 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, June 30, 2023   -   $-   $       - 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Warrants
6 Months Ended
Jun. 30, 2023
Warrants  
Warrants

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June 30, 2023:

  

           Weighted   Weighted    
   Warrants  

Average

Exercise

  

Average

Remaining Life

  

Aggregate

Intrinsic

 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49    - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at June 30, 2023   7,623,772    7,623,772   $5.14    43           - 

 

The following table summarizes information about warrants outstanding at June 30, 2023:

  

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    15 
                  
$10.40    34,737    34,737    16 
                  
$5.00    7,105,496    7,105,496    44 
                  
$5.16    290,557    290,557    44 
                  
      7,623,772    7,623,772    43 

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 10 – Income Taxes

 

As of June 30, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $27,074,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of June 30, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 11 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the six months ended June 30, 2023 and June 30, 2022, the Company paid $18,273 and $9,884, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March 2023 of $3,577 increasing the total of the second sales order to $14,477. During the six months ended June 30, 2023, the Company received $14,035 in cash payments for these contracts. Revenue of $16,977 was recorded in the six months ended June 30, 2023 in respect of these agreements.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date of issuance of these financial statements issued and determined no material subsequent events occurred after June 30, 2023 for which disclosure was required.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations and Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Description of Business

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

Inflation

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

Principles of Consolidation

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

Cash, Cash Equivalents, and Restricted Cash

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of June 30, 2023, the balance in the Company’s accounts was approximately $14,197,000, consequently approximately $13,947,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of June 30, 2023, and June 30, 2022, there were respectively, 8,009,889 and 7,882,061, potentially dilutive equity instruments outstanding in respect of warrants options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both June 30, 2023 and June 30, 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 386,117 and 252,289 potentially dilutive equity instruments outstanding as of June 30, 2023 and June 30, 2022, respectively, related to options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Goodwill

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

Temporary Equity

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

Revenue Recognition

Revenue Recognition

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $899,748   $2,791,141   $5,296,574   $4,433,713 
Engineering and other services   103,232    192,076    227,643    278,125 
Shipping and handling   4,775    31,668    17,335    47,474 
Miscellaneous   55,959    -    204,735    - 
Total revenue  $1,063,714   $3,014,885   $5,746,287   $4,759,312 

 

Miscellaneous revenue of $55,959 and $204,735 recognized during the three and six months ended June 30, 2023, respectively, represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of June 30, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of June 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $625,911 and $4,338,570, respectively.

 

For the three and six months ended June 30, 2023, the Company recognized revenue of $45,716 and $3,898,622, respectively, related to the deferred revenue at January 1, 2023 For the three and six months ended June 30, 2022, the Company recognized revenue of $1,030,830 and $2,193,204, respectively, related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of June 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $1,066,000. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer and smaller new contracts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at June 30, 2023, includes booked sales orders of $250,000 from three customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $279,000 (26% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   816,000    250,000    1,066,000 
Total remaining performance obligations  $816,000   $250,000   $1,066,000 

 

Product Warranty

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of June 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $193,498 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

Accounting for Share-Based Compensation

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the six months ended June 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and June 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $5,104   $4,898   $5,895 
Advertising and marketing expenses   -    4,080    1,113    6,842 
Product development costs   -    4,961    3,570    4,961 
Selling, general and administrative expenses   15,166    81,482    152,679    170,446 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $95,627   $162,260   $188,144 

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

Included in the expense for the three and six months ended June 30, 2022, is an accrual for $46,374 and $46,374, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.

 

Concentrations

Concentrations

 

Two customers accounted for 64%, and 10% of the Company’s revenue for the three months ended June 30, 2023. Three customers accounted for 44%, 23% and 14% of the Company’s revenue for the six months ended June 30, 2023. Two customers accounted for 53% and 12% of the Company’s revenue for the three months ended June 30, 2022 and one customer accounted for 47% of the Company’s revenue for the six months ended June 30, 2022.

 

Three customers accounted for 69%, 17%, and 12% of the Company’s accounts receivable as of June 30, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

 

CEA Industries Inc.
Notes to Condensed Consolidated Financial Statements
June 30, 2023
(in US Dollars except share numbers)
(Unaudited)

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations and Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Revenue by Source

The following table sets forth the Company’s revenue by source:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Equipment and systems sales  $899,748   $2,791,141   $5,296,574   $4,433,713 
Engineering and other services   103,232    192,076    227,643    278,125 
Shipping and handling   4,775    31,668    17,335    47,474 
Miscellaneous   55,959    -    204,735    - 
Total revenue  $1,063,714   $3,014,885   $5,746,287   $4,759,312 
Schedule of Remaining Performance Obligations Expected to be Recognized

The remaining performance obligations expected to be recognized through 2024 are as follows:

  

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   816,000    250,000    1,066,000 
Total remaining performance obligations  $816,000   $250,000   $1,066,000 
Schedule of Share-based Compensation Costs

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and June 30, 2022:

 

   2023   2022   2023   2022 
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2023   2022   2023   2022 
Share-based compensation expense included in:                    
Cost of revenue  $-   $5,104   $4,898   $5,895 
Advertising and marketing expenses   -    4,080    1,113    6,842 
Product development costs   -    4,961    3,570    4,961 
Selling, general and administrative expenses   15,166    81,482    152,679    170,446 
Total share-based compensation expense included in consolidated statement of operations  $15,166   $95,627   $162,260   $188,144 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Leases (Tables)
6 Months Ended
Jun. 30, 2023
Leases  
Schedule of Lease Cost

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

June 30, 2023

 
Operating lease right-of-use asset  $409,981 
Operating lease liability, current  $122,272 
Operating lease liability, long-term  $319,247 
      
Remaining lease term   3.6 years 
Discount rate   3.63%

 

   For the Six Months Ended June 30, 2023 
Operating cash outflow from operating lease  $62,138 
Schedule of Future Annual Minimum Lease Payments

Future annual minimum lease payments on the New Facility Lease as of June 30, 2023 are as follows:

 

As of June 30, 2023    
     
Years ended December 31,    
2023 (excluding the six months ended June 30, 2023)  $62,759 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   472,032 
Less imputed interest   (30,513)
Present value of minimum lease payments  $441,519 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory (Tables)
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Finished goods  $398,455   $270,555 
Work in progress   -    155 
Raw materials   130,180    148,608 
Allowance for excess & obsolete inventory   (131,480)   (70,907)
Inventory, net  $397,155   $348,411 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment (Tables)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (237,769)   (224,876)
Property and equipment, net  $53,225   $68,513 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Accounts Payable and Accrued Liabilities (Tables)
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
Schedule of Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

  

   June 30,   December 31, 
   2023   2022 
Accounts payable  $280,763   $311,162 
Sales commissions payable   2,061    25,951 
Accrued payroll liabilities   231,182    465,094 
Product warranty accrual   193,498    180,457 
Other accrued expenses   91,120    224,594 
Total  $798,624   $1,207,258 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Incentive Plans (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the six months ended June 30, 2023, are presented in the table below:

  

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $- 
Granted   138,489   $0.90    6.6   $- 
Exercised   -   $-    -   $- 
Forfeited   (1,567)  $4.15    8.9   $- 
Expired   -   $-    -   $- 
Outstanding, June 30, 2023   328,995   $5.58    6.5   $- 
Exercisable, June 30, 2023   303,905   $5.61    6.4   $      - 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the six months ended June 30, 2023, are presented in the table below:

 

  Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2022   28,756   $4.73   $-   $135,932 
Granted   138,489   $0.88   $-   $121,870 
Vested   (141,822)  $0.92   $-   $(131,094)
Forfeited   (333)  $6.67   $-   $(2,222)
Expired   -   $-   $-   $- 
Nonvested, June 30, 2023   25,090   $4.98   $       -   $124,486 
Schedule of Restricted Stock Units Activity

 

  Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
            
Outstanding, December 31, 2022   3,366   $7.42   $- 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, June 30, 2023   -   $-   $       - 
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the six months ended June 30, 2023, are presented in the table below:

  

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $- 
Granted   -    -    -   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, June 30, 2023   57,122   $9.44    5.5   $- 
Exercisable, June 30, 2023   57,122   $9.44    5.5   $      - 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Warrants (Tables)
6 Months Ended
Jun. 30, 2023
Warrants  
Schedule of Outstanding Warrants to Purchase Common Stock

The following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June 30, 2023:

  

           Weighted   Weighted    
   Warrants  

Average

Exercise

  

Average

Remaining Life

  

Aggregate

Intrinsic

 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49    - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at June 30, 2023   7,623,772    7,623,772   $5.14    43           - 
Schedule of Warrants Outstanding

The following table summarizes information about warrants outstanding at June 30, 2023:

  

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    15 
                  
$10.40    34,737    34,737    16 
                  
$5.00    7,105,496    7,105,496    44 
                  
$5.16    290,557    290,557    44 
                  
      7,623,772    7,623,772    43 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Revenue by Source (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Product Information [Line Items]        
Total revenue $ 1,063,714 $ 3,014,885 $ 5,746,287 $ 4,759,312
Equipment and Systems Sales [Member]        
Product Information [Line Items]        
Total revenue 899,748 2,791,141 5,296,574 4,433,713
Engineering and Other Services [Member]        
Product Information [Line Items]        
Total revenue 103,232 192,076 227,643 278,125
Shipping and Handling [Member]        
Product Information [Line Items]        
Total revenue 4,775 31,668 17,335 47,474
Miscellaneous [Member]        
Product Information [Line Items]        
Total revenue $ 55,959 $ 204,735
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Remaining Performance Obligations Expected to be Recognized (Details)
Jun. 30, 2023
USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 1,066,000
Total remaining performance obligations 1,066,000
2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 816,000
Total remaining performance obligations 816,000
2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 250,000
Total remaining performance obligations $ 250,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Share-based Compensation Costs (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Total share-based compensation expense included in consolidated statement of operations $ 15,166 $ 95,627 $ 162,260 $ 188,144
Cost of Sales [Member]        
Total share-based compensation expense included in consolidated statement of operations 5,104 4,898 5,895
Advertising and Marketing Expenses [Member]        
Total share-based compensation expense included in consolidated statement of operations 4,080 1,113 6,842
Product Development Costs [Member]        
Total share-based compensation expense included in consolidated statement of operations 4,961 3,570 4,961
Selling, General and Administrative Expenses [Member]        
Total share-based compensation expense included in consolidated statement of operations $ 15,166 $ 81,482 $ 152,679 $ 170,446
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Product Information [Line Items]          
Federal insured amount $ 250,000   $ 250,000    
Cash balance, amount 14,197,000   14,197,000    
Cash equivalent balance, amount 13,947,000   $ 13,947,000    
Potentially dilutive equity instruments that are convertible into common stock     8,009,889 7,882,061  
Goodwill and intangible asset impairment $ 631,064 $ 631,064  
Miscellaneous revenue 1,063,714 3,014,885 5,746,287 4,759,312  
Contract with customer liability current 625,911   625,911   $ 4,338,570
Revenue recognized 45,716 $ 1,030,830 3,898,622 $ 2,193,204  
Revenue remaining performance obligation 1,066,000   $ 1,066,000    
Product warranty description     The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.    
Accrued warranty reserve amount 193,498   $ 193,498   $ 180,457
Stock price volatility     152.23%    
Expected Term     10 years    
Risk-free interest rate     3.48%    
Accrued Incentive $ 46,374   $ 46,374    
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]          
Product Information [Line Items]          
Concentration risk percentage 64.00% 53.00% 44.00% 47.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]          
Product Information [Line Items]          
Concentration risk percentage 10.00% 12.00% 23.00%    
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]          
Product Information [Line Items]          
Concentration risk percentage     14.00%    
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]          
Product Information [Line Items]          
Concentration risk percentage     69.00%   57.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]          
Product Information [Line Items]          
Concentration risk percentage     17.00%   43.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]          
Product Information [Line Items]          
Concentration risk percentage     12.00%    
2023 [Member]          
Product Information [Line Items]          
Revenue remaining performance obligation $ 816,000   $ 816,000    
2023 [Member] | Booked Sales Orders From Three Customers [Member]          
Product Information [Line Items]          
Revenue remaining performance obligation 250,000   250,000    
Miscellaneous [Member]          
Product Information [Line Items]          
Miscellaneous revenue 55,959 $ 204,735  
Director And Staff [Member]          
Product Information [Line Items]          
Potentially dilutive equity instruments that are convertible into common stock     386,117 252,289  
One Customer [Member]          
Product Information [Line Items]          
Revenue remaining performance obligation $ 279,000   $ 279,000    
Series B Preferred Stock [Member]          
Product Information [Line Items]          
Potentially dilutive equity instruments that are convertible into common stock     7,623,772 7,623,772  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Lease Cost (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Leases    
Operating lease right-of-use asset $ 409,981 $ 462,874
Operating lease liability, current 122,272 118,235
Operating lease liability, long-term $ 319,247 $ 376,851
Remaining lease term 3 years 7 months 6 days  
Discount rate 3.63%  
Operating cash outflow from operating lease $ 62,138  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Future Annual Minimum Lease Payments (Details)
Jun. 30, 2023
USD ($)
Leases  
2023 (excluding the six months ended June 30, 2023) $ 62,759
2024 128,643
2025 132,503
2026 136,473
Thereafter 11,654
Total minimum lease payments 472,032
Less imputed interest (30,513)
Present value of minimum lease payments $ 441,519
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Leases (Details Narrative)
Jul. 28, 2021
USD ($)
ft²
Jun. 30, 2023
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Lease renew term 5 years  
Operating lease liability   $ 441,519
New Facility Lease [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Area of land | ft² 11,491  
Operating lease term description The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027  
Lease rental expense $ 10,055  
Increase in rent percent 3.00%  
Security deposit $ 14,747  
Operating lease liability $ 582,838  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Inventory (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods $ 398,455 $ 270,555
Work in progress 155
Raw materials 130,180 148,608
Allowance for excess & obsolete inventory (131,480) (70,907)
Inventory, net $ 397,155 $ 348,411
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Overhead expenses $ 15,055 $ 12,770
Prepaid inventory expenses $ 10,000 $ 1,176,000
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Property and Equipment (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 290,994 $ 293,389
Accumulated depreciation (237,769) (224,876)
Property and equipment, net 53,225 68,513
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 275,994 278,389
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 15,000 $ 15,000
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment (Details Narrative)
6 Months Ended
Jun. 30, 2023
USD ($)
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 14,988
Property, Plant and Equipment [Member] | Cost of Sales [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses 1,749
Property, Plant and Equipment [Member] | Inventory [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 437
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accounts payable $ 280,763 $ 311,162
Sales commissions payable 2,061 25,951
Accrued payroll liabilities 231,182 465,094
Product warranty accrual 193,498 180,457
Other accrued expenses 91,120 224,594
Total $ 798,624 $ 1,207,258
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders’ Equity (Details Narrative) - USD ($)
6 Months Ended
Jan. 03, 2023
Jun. 21, 2022
Feb. 15, 2022
Jan. 17, 2022
Jan. 03, 2022
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 30, 2021
Mar. 22, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Common stock, shares authorized           200,000,000 200,000,000      
Preferred stock, shares authorized           25,000,000 25,000,000      
Common stock par value           $ 0.00001 $ 0.00001      
Common stock, shares issued           8,076,372 7,953,974      
Common stock, shares outstanding           8,076,372 7,953,974 1,600,835 240,125,224  
Reverse stock split       one-for-one hundred and fifty            
Reverse stock split       6,798            
Net proceeds from sale of common stock     $ 22,000,000              
Exercise price           $ 5.14 $ 5.14      
Number of shares issued   169,530                
Prefunded conversion warrants   170,382                
Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares sold     5,811,138              
Warrant [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares sold     6,572,808              
Warrant term     5 years              
Exercise price     $ 5.00              
Director [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Management fee expense       $ 15,000   $ 25,000        
Audit Committee Chairman [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Management fee expense       10,000            
Committee Chairman [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Management fee expense       $ 5,000            
Board of Directors Chairman [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Common stock, shares authorized           200,000,000        
Preferred stock, shares authorized           25,000,000        
Underwriters [Member] | Warrant [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Exercise price     $ 5.1625              
Stock issued during period, shares, issued for services     290,557              
Warrants maturity date     Feb. 10, 2027              
2021 Equity Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Exercise price         $ 4.80          
2021 Equity Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued                   666,667
Number of shares issued           122,398        
Non-Qualified Stock Options [Member] | 2021 Equity Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued         3,125          
Restricted Stock Units (RSUs) [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Vesting rights description       Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.            
Restricted Stock Units (RSUs) [Member] | Director [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Share based compensation arrangement payment       $ 25,000            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued 29,758     3,367            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member] | January 17, 2022 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued       1,684            
Shares, vested       1,684            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member] | January 17, 2023 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued       1,683            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Plan [Member] | Directors [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares vested in period 119,032                  
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Stock Option Activity (Details) - 2017 Equity Plan and 2021 Equity Plan [Member]
6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Employees And Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Granted 138,489
Employees And Consultants [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 192,073
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 8.94
Weighted Average Remaining Contractual Term, Beginning 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted 138,489
Weighted Average Exercise Price, Granted | $ / shares $ 0.90
Weighted Average Remaining Contractual Term, Granted 6 years 7 months 6 days
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled (1,567)
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares $ 4.15
Weighted Average Remaining Contractual Term, Forfeited 8 years 10 months 24 days
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 328,995
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 5.58
Weighted Average Remaining Contractual Term, Outstanding Ending 6 years 6 months
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 303,905
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 5.61
Weighted Average Remaining Contractual Term, Exercisable Ending 6 years 4 months 24 days
Aggregate Intrinsic Value, Exercisable Ending | $
Directors [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 57,122
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Beginning 6 years
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted
Weighted Average Exercise Price, Granted | $ / shares
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 57,122
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Outstanding Ending 5 years 6 months
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 57,122
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Exercisable Ending 5 years 6 months
Aggregate Intrinsic Value, Exercisable Ending | $
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Non-vested Non-qualified Stock Option Activity (Details) - Employees And Consultants [Member] - 2017 Equity Plan and 2021 Equity Plan [Member]
6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Nonvested, Beginning | shares 28,756
Weighted Average Grant-Date Fair Value, Nonvested, Beginning | $ / shares $ 4.73
Aggregated Intrinsic Value, Nonvested Beginning
Grant Date Fair Value Nonvested, Beginning $ 135,932
Number of Options Nonvested, Granted | shares 138,489
Weighted Average Grant-Date Fair Value, Nonvested, Granted | $ / shares $ 0.88
Grant Date Fair Value Nonvested, Granted $ 121,870
Number of Options Nonvested, Vested $ (141,822)
Weighted Average Grant-Date Fair Value, Nonvested, Vested | $ / shares $ 0.92
Grant Date Fair Value Nonvested, Vested $ (131,094)
Number of Options Nonvested, Forfeited | shares (333)
Weighted Average Grant-Date Fair Value, Nonvested, Forfeited | $ / shares $ 6.67
Grant Date Fair Value Nonvested, Forfeited $ (2,222)
Number of Options Nonvested, Expired | shares
Weighted Average Grant-Date Fair Value, Nonvested, Expired | $ / shares
Grant Date Fair Value Nonvested, Expired
Number of Options Nonvested, Ending | shares 25,090
Weighted Average Grant-Date Fair Value, Nonvested, Beginning | $ / shares $ 4.98
Aggregated Intrinsic Value, Nonvested Ending
Grant Date Fair Value Nonvested, Ending $ 124,486
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Restricted Stock Units Activity (Details)
6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Aggregate Intrinsic Value Outstanding, Granted
Aggregate Intrinsic Value Outstanding, ending
2017 Equity Incentive Plan [Member] | Employees, Directors and Consultants [Member] | Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Units Outstanding, beginning | shares 3,366
Weighted Average Grant-Date Fair Value Outstanding, Beginning | $ / shares $ 7.42
Aggregate Intrinsic Value Outstanding, Beginning
Number of Units, Granted | shares 119,032
Weighted Average Grant-Date Fair Value, Granted | $ / shares $ 0.84
Aggregate Intrinsic Value Outstanding, Granted
Number of Units, Vested and settled with share issuance | shares (122,398)
Weighted Average Grant-Date Fair Value, Vested and settled with share issuance | $ / shares $ 1.02
Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance
Number of Units, Forfeited/canceled | shares
Weighted Average Grant-Date Fair Value, Forfeited/Canceled | $ / shares
Aggregate Intrinsic Value Outstanding, Forfeited/canceled
Number of Units Outstanding, ending | shares
Weighted Average Grant-Date Fair Value Outstanding,ending | $ / shares
Aggregate Intrinsic Value Outstanding, ending
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Incentive Plans (Details Narrative) - USD ($)
6 Months Ended
Jan. 17, 2023
Jan. 03, 2023
Jun. 21, 2022
Jan. 03, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Jan. 17, 2022
Mar. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Shares issued during the period     169,530            
Accrued equity compensation           $ 89,970    
Additional expense         32,376        
Share based compensation         162,260 $ 225,396      
Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 101,316 36,168      
2017 Equity Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of options to purchase shares         333,333        
Number of shares authorized         333,333        
2017 Equity Incentive Plan [Member] | Director [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 0 $ 29,656      
Number of options to purchase shares         0 6,250      
2017 Equity Incentive Plan [Member] | Non Qualified Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         147,132        
Shares available for future equity awards         22,509        
2017 Equity Incentive Plan [Member] | Restricted Stock [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued         163,692        
2017 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares vested in period         122,398        
Number of shares granted         119,032        
2021 Equity Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Shares available for future equity awards         295,113        
Number of shares grant in period                 666,667
Shares issued during the period         122,398        
Number of shares authorized         666,667        
Unrecognized compensation expense         $ 30,753        
Weighted Average Remaining Contractual Term         2 years        
2021 Equity Plan [Member] | Non Qualified Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         198,170        
2021 Equity Plan [Member] | Incentive Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         40,816        
2021 Equity Plan [Member] | Restricted Stock [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued         132,568        
2021 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member] | Directors [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares vested in period   119,032              
Number of shares granted 3,366                
2021 Equity Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Exercise price per share       $ 4.80          
2021 Equity Incentive Plan [Member] | Five Employees [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of share awards granted         138,489        
Exercise price per share         $ 0.8955        
2021 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued       3,125          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares grant in period   29,758           3,367  
2017 Equity Plan and 2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Employees And Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 60,944 $ 75,947      
2017 Equity Plan and 2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         57,122   57,122    
Number of share awards granted                
Exercise price per share                
Weighted Average Remaining Contractual Term         6 years        
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Outstanding Warrants to Purchase Common Stock (Details)
6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Warrants  
Warrants Outstanding, Beginning Balance 7,623,772
Warrants Exercisable, Beginning Balance 7,623,772
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Beginning Balance 49 months
Aggregate Intrinsic Value, Beginning Balance | $
Warrants, Granted
Warrants, Granted
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Granted
Aggregate Intrinsic Value, Granted | $
Warrants, Exercised
Warrants, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Life, Exercised
Aggregate Intrinsic Value, Exercised | $
Warrants, Expired
Warrants, Expired
Weighted Average Exercise Price, Expired | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Granted
Aggregate Intrinsic Value, Expired | $
Warrants Outstanding, Ending Balance 7,623,772
Warrants Exercisable, Ending Balance 7,623,772
Weighted Average Exercise Price, Ending Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Ending Balance 43 months
Aggregate Intrinsic Value Outstanding, ending | $
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Schedule of Warrants Outstanding (Details) - $ / shares
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.14 $ 5.14
Warrants Outstanding 7,623,772 7,623,772
Warrants Exercisable 7,623,772 7,623,772
Weighted Average Life of Outstanding Warrants in Months 43 months  
Warrants Range [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 9.45  
Warrants Outstanding 192,982  
Warrants Exercisable 192,982  
Weighted Average Life of Outstanding Warrants in Months 15 months  
Warrants Range One [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 10.40  
Warrants Outstanding 34,737  
Warrants Exercisable 34,737  
Weighted Average Life of Outstanding Warrants in Months 16 months  
Warrants Range Two [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.00  
Warrants Outstanding 7,105,496  
Warrants Exercisable 7,105,496  
Weighted Average Life of Outstanding Warrants in Months 44 months  
Warrants Range Three [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.16  
Warrants Outstanding 290,557  
Warrants Exercisable 290,557  
Weighted Average Life of Outstanding Warrants in Months 44 months  
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes (Details Narrative)
6 Months Ended
Jun. 30, 2023
USD ($)
Operating loss carryforward $ 27,074,000
Net operating loss carry forward expected to expire amount $ 11,196,000
Net operating loss expiration term 2034 through 2037
NOLs usage against taxable income, percentage 80.00%
NOLs carryforwards term three-year period
Ownership [Member]  
Percentage of ownership change 50.00%
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 20, 2022
Oct. 13, 2022
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Payments for commissions       $ 18,273 $ 9,884  
Cash payments       14,035    
Revenue       $ 16,977    
Consulting Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Proceeds from deposits $ 10,900          
Consulting Agreement [Member] | Lone Star Bioscience Inc [Member] | Chief Executive Officer [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Proceeds from deposits   $ 2,500 $ 3,577     $ 1,250
Proceeds from sales     $ 14,477      
XML 58 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001482541 2023-01-01 2023-06-30 0001482541 CEAD:CommonStock0.00001ParValueMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-06-30 0001482541 2023-08-14 0001482541 2023-06-30 0001482541 2022-12-31 0001482541 2023-04-01 2023-06-30 0001482541 2022-04-01 2022-06-30 0001482541 2022-01-01 2022-06-30 0001482541 us-gaap:CommonStockMember 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-03-31 0001482541 2023-03-31 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 us-gaap:CommonStockMember 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-03-31 0001482541 2022-03-31 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 2021-12-31 0001482541 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001482541 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001482541 us-gaap:CommonStockMember 2023-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001482541 us-gaap:RetainedEarningsMember 2023-06-30 0001482541 us-gaap:CommonStockMember 2022-06-30 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001482541 us-gaap:RetainedEarningsMember 2022-06-30 0001482541 2022-06-30 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-06-30 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-06-30 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-06-30 0001482541 CEAD:DirectorAndStaffMember 2022-01-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2023-04-01 2023-06-30 0001482541 CEAD:MiscellaneousMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember CEAD:BookedSalesOrdersFromThreeCustomersMember 2023-06-30 0001482541 CEAD:OneCustomerMember 2023-06-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001482541 CEAD:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-04-01 2023-06-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-04-01 2022-06-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-06-30 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-04-01 2023-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-04-01 2022-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-06-30 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-04-01 2023-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-04-01 2022-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-06-30 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2022-04-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2022-01-01 2022-06-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2023-06-30 0001482541 CEAD:TwoThousandAndTwentyFourMember 2023-06-30 0001482541 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001482541 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-04-01 2023-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-04-01 2022-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-06-30 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-04-01 2023-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-04-01 2022-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-06-30 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-07-28 0001482541 2022-01-01 2022-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001482541 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001482541 us-gaap:VehiclesMember 2023-06-30 0001482541 us-gaap:VehiclesMember 2022-12-31 0001482541 us-gaap:CostOfSalesMember us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-06-30 0001482541 CEAD:InventoryMember us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyThreeMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-02 2023-01-03 0001482541 srt:DirectorMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:AuditCommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 CEAD:CommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember 2023-01-01 2023-06-30 0001482541 2022-01-12 2022-01-17 0001482541 2021-12-30 0001482541 srt:BoardOfDirectorsChairmanMember 2023-06-30 0001482541 2022-02-14 2022-02-15 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-15 0001482541 2022-06-20 2022-06-21 0001482541 2022-06-21 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-06-30 0001482541 us-gaap:RestrictedStockMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:FiveEmployeesMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-01 2023-06-30 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-06-30 0001482541 us-gaap:RestrictedStockMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:IncentiveStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-06-30 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-06-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-06-30 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-06-30 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-16 2023-01-17 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001482541 CEAD:DirectorsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-06-30 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-06-30 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-06-30 0001482541 CEAD:WarrantsRangeMember 2023-06-30 0001482541 CEAD:WarrantsRangeMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsRangeOneMember 2023-06-30 0001482541 CEAD:WarrantsRangeOneMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-06-30 0001482541 CEAD:WarrantsRangeTwoMember 2023-01-01 2023-06-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-06-30 0001482541 CEAD:WarrantsRangeThreeMember 2023-01-01 2023-06-30 0001482541 CEAD:OwnershipMember 2023-06-30 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-10-12 2022-10-13 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-01-01 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-19 2022-12-20 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2023-01-01 2023-03-31 iso4217:USD shares iso4217:USD shares pure utr:sqft CEAD:integer CEAD:Segment 0001482541 false --12-31 Q2 Yes Yes 10-Q true 2023-06-30 2023 false 001-41266 CEA INDUSTRIES INC. NV 27-3911608 385 South Pierce Avenue Suite C Louisville CO 80027 80027 (303) 993-5271 Common Stock, $0.00001 par value CEAD NASDAQ Warrants to purchase common stock CEADW NASDAQ Non-accelerated Filer true false false 8076372 14197485 18637114 293767 2649 397155 348411 520256 1489921 15408663 20478095 53225 68513 1830 1830 14747 14747 409981 462874 479783 547964 15888446 21026059 798624 1207258 625911 4338570 89970 122272 118235 1546807 5754033 319247 376851 319247 376851 1866054 6130884 0.00001 0.00001 25000000 25000000 0 0 0 0 0.00001 0.00001 200000000 200000000 8076372 8076372 7953974 7953974 81 80 49426065 49173836 -35403754 -34278741 14022392 14895175 15888446 21026059 1063714 3014885 5746287 4759312 985021 2708646 4814318 4362565 78693 306239 931969 396747 33091 309690 235414 560705 74 56577 76487 195495 750156 1080094 1770858 2391871 631064 631064 783321 2077425 2082759 3779135 -704628 -1771186 -1150790 -3382388 2074 7778 185000 8979 10600 17999 13860 11053 10600 25777 198860 -693575 -1760586 -1125013 -3183528 -693575 -1760586 -1125013 -3183528 35984 439999 -693575 -1760586 -1125013 -3659511 -0.09 -0.09 -0.23 -0.23 -0.14 -0.14 -0.59 -0.59 8076372 8076372 7801211 7801211 8074064 8074064 6220600 6220600 8076372 81 49410899 -34710179 14700801 15166 15166 -693575 -693575 8076372 81 49426065 -35403754 14022392 7953974 80 49173836 -34278741 14895175 150914 150914 122398 1 -1 101316 101316 -1125013 -1125013 8076372 81 49426065 -35403754 14022392 7784444 78 48958618 -30204508 18754188 126635 126635 6245 6245 169530 2 -2 -1760586 -1760586 7953974 80 49091496 -31965094 17126482 1600835 16 25211017 -28781566 -3570533 159573 159573 29656 29656 3367 24994 24994 11173 11173 6798 5811138 58 21711073 21711131 362306 4 1979996 1980000 -35984 -35984 169530 2 -2 -3183528 -3183528 7953974 80 49091496 -31965094 17126482 -1125013 -3183528 14988 16697 162260 225396 2096 -9182 60574 -34417 -100 -4060 52893 51061 631064 293214 -48153 109318 -10986 -969665 1692816 -408634 -317453 -3712659 3095431 -53567 -39870 -37251 -4439829 -1231669 13948 200 2250 200 -11698 35984 1980000 21711131 19695147 -4439629 18451781 18637114 2159608 14197485 20611388 16400 1980000 439999 2 89970 83625 <p id="xdx_800_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zA3t6iAQZqv8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_827_zFXYUN2uS6I3">Nature of Operations and Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_zBSx7sGSLAR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zs3hhAEdUM29">Description of Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zX0y0eCrkza2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zdPx08t8m946">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--ImpactofUkrainianConflictPolicyTextBlock_zNXjyjZbAVkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zXEmUtjN2lIl">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.</span></p> <p id="xdx_85F_zJ1KQSgxO211" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--InflationPolicyTextBlock_zL9G7WBodmw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z5UOQvru6RL6">Inflation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1GF30i6xKmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zjkEZI7K6OAd">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--InterimFinancialStatementsPolicyTextBlock_zVA2A5Rx4uck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zrSUdNDzATWe">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zsOFWJBAY6Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_ztZkr9tmLua1">Principles of Consolidation </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_z4t2ovlzwIPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z6U2yuPbqvH1">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p id="xdx_856_zE0abDtvexgh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zgv5C9zdVKa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zqce8ZLmfU7f">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20230630_zXskXxbrGqIf" title="Federal insured amount">250,000</span>. As of June 30, 2023, the balance in the Company’s accounts was approximately $<span id="xdx_909_eus-gaap--Cash_iI_c20230630_z0zADSVpChzk" title="Cash balance, amount">14,197,000</span>, consequently approximately $<span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20230630_z6Qdvk5JeWi6" title="Cash equivalent balance, amount">13,947,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zHzyXbG2emh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zgBXl2JB0Gug">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of June 30, 2023, and June 30, 2022, there were respectively,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230630_zYPLBaNCLlK1" title="Potentially dilutive equity instruments that are convertible into common stock">8,009,889</span> and <span id="xdx_90F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220630_znMfZ6Ab96m1" title="Potentially dilutive equity instruments that are convertible into common stock">7,882,061</span>, potentially dilutive equity instruments outstanding in respect of warrants options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, <span id="xdx_90D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zTe4pw9g9Bvk" title="Potentially dilutive equity instruments that are convertible into common stock"><span id="xdx_90D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVwJ9KLG0Vt2" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772</span></span> related to warrants outstanding at both June 30, 2023 and June 30, 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining <span id="xdx_907_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_z2lMaF4f2Yu1" title="Potentially dilutive equity instruments that are convertible into common stock">386,117</span> and <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220630__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zOmFiUf38yx4" title="Potentially dilutive equity instruments that are convertible into common stock">252,289</span> potentially dilutive equity instruments outstanding as of June 30, 2023 and June 30, 2022, respectively, related to options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z0aYdyZW2dm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zQapLv9IWgK5">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $<span id="xdx_90B_eus-gaap--GoodwillAndIntangibleAssetImpairment_c20220101__20220630_zhUiutSqTIt4" title="Goodwill and intangible asset impairment">631,064</span> at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.</span></p> <p id="xdx_85A_zFiMmJAIMfW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--TemporaryEquityPolicyTextBlock_zi7RNBZYVnO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zsCMlYwItwti">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z2YeT5m4RAil" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zBeFLVR9pZf2">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zVOd3ZvJBYY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyvKfqDUNtqd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20230401__20230630_zsiCzQwgwvT7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20220401__20220630_zvqmyfaNZ2E" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20230101__20230630_zwcpM9dxy9j9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220101__20220630_zxB2nukCuACd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zhGIYdGXlSW7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment and systems sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">899,748</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,791,141</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,296,574</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,433,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyblISKp91wk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engineering and other services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,232</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,076</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,125</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z0hH4hvmraVa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,668</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,474</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousMember_zJCPtcEngLLl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">204,735</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0662">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbCbmDbaU3ug" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,063,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,014,885</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,746,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,759,312</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zWTqNVdZEBp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous revenue of $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--ProductOrServiceAxis__custom--MiscellaneousMember_zh3Wr5aoiTU7" title="Miscellaneous revenue">55,959</span> and $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--ProductOrServiceAxis__custom--MiscellaneousMember_zojZ8Oorehti" title="Miscellaneous revenue">204,735</span> recognized during the three and six months ended June 30, 2023, respectively, represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of June 30, 2023 and December 31, 2022, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of June 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $<span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230630_z6AQLnioYvcg" title="Contract with customer liability current">625,911</span> and $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20221231_zg4tDIWUl895" title="Contract with customer liability current">4,338,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three and six months ended June 30, 2023, the Company recognized revenue of $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230401__20230630_zJ62Ls8D5Yif" title="Revenue recognized">45,716</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230630_zYd6TeHOWKS7" title="Revenue recognized">3,898,622</span>, respectively, related to the deferred revenue at January 1, 2023 For the three and six months ended June 30, 2022, the Company recognized revenue of $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220401__20220630_zBovHEj7qj71">1,030,830</span> and $<span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220630_zMHSyrWmeZLk">2,193,204</span>, respectively, related to the deferred revenue at January 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_901_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230630_zKYF2lCX8ZMa" title="Revenue remaining performance obligation">1,066,000</span>. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer and smaller new contracts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at June 30, 2023, includes booked sales orders of $<span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember__us-gaap--TypeOfArrangementAxis__custom--BookedSalesOrdersFromThreeCustomersMember_zfef396uuip4">250,000</span> from three customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230630__srt--TitleOfIndividualAxis__custom--OneCustomerMember_z9U96G6JiCb4">279,000</span> (26% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zEs4F9eGsGBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zCFODIL6uSPe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zUaSI1s6StKc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_z3WuzdtFoSM5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_zJ1ix3emhqw3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zc1cTMQGNzEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0689">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0690">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zydnNBsM95Wf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">816,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zSwZlTjta9g9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total remaining performance obligations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">816,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zN396rFWuGme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_zOoLmrFqYIrk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zn33bkpSrek9">Product Warranty</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20230101__20230630_zfU5YABmrxa" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.</span> The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of June 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $<span id="xdx_90E_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20230630_zHOHDkpq5786" title="Accrued warranty reserve amount">193,498</span> and $<span id="xdx_90C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20221231_zk6VZczrRMdg" title="Accrued warranty reserve amount">180,457</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p id="xdx_859_zFNJYzRj7NWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z1I3G38ATLC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zvbKajSkOfI8">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the six months ended June 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230630_zdZhZEagCJf7" title="Stock price volatility">152.23</span>%; expected term in years of <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230630_z4NA7SGQGao8" title="Expected Term">10</span> and risk-free interest rate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230630_zaZ7BKcAHa6b" title="Risk-free interest rate">3.48</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zWizS4zoJQF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and June 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zuG5TWAB2UB5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20230401__20230630_zrj8TGGLhwdf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220401__20220630_zUOKUr2a8wnc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20230101__20230630_zagb3JrxkMn7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220101__20220630_zKNFaxdwM79k" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended <br/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation expense included in:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zqlqXjsKKx01" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,898</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,895</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztr1LT8OQfV3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising and marketing expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,080</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,842</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_z1dvmejWL2K2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product development costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,570</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zg8sBr9Qy0h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling, general and administrative expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,482</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152,679</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,446</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zMPYdxHAmY0g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,627</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,260</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,144</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zCOUTncBJujl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the expense for the three and six months ended June 30, 2022, is an accrual for $<span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20230401__20230630_zRu4P8FrCA64" title="Accrued Incentive">46,374</span> and $<span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20230101__20230630_zEnZBBRlXGo6" title="Accrued Incentive">46,374</span>, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_znQy6hOzggbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zkYV0VJz9d2b">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zVKQOsMSxSYd" title="Concentration risk percentage">64</span>%, and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zFKnjzBPR4kj" title="Concentration risk percentage">10</span>% of the Company’s revenue for the three months ended June 30, 2023. Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zptW3wL5cKc7" title="Concentration risk percentage">44</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zcX0udDdgt9l" title="Concentration risk percentage">23</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zpuJqXuL4vt4" title="Concentration risk percentage">14</span>% of the Company’s revenue for the six months ended June 30, 2023. Two customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z2yc1ROx0pM3" title="Concentration risk percentage">53</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zT0CoumXNSP4" title="Concentration risk percentage">12</span>% of the Company’s revenue for the three months ended June 30, 2022 and one customer accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zbEoPjA0ENje" title="Concentration risk percentage">47</span>% of the Company’s revenue for the six months ended June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zgW086ZbEovj" title="Concentration risk percentage">69</span>%, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkZIm1qdThde" title="Concentration risk percentage">17</span>%, and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zAY6kC9URcVd" title="Concentration risk percentage">12</span>% of the Company’s accounts receivable as of June 30, 2023. Two customers accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHgKGRc18FO5" title="Concentration risk percentage">57</span>% and<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhYDcCqOlLIg" title="Concentration risk percentage"> 43</span>% of the Company’s accounts receivable as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zQTNnY1LROoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zNX8DWj7elth">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “<i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</i>, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_85B_zHcWAuLoFR4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_zBSx7sGSLAR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zs3hhAEdUM29">Description of Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the faster-evolving sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zX0y0eCrkza2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zdPx08t8m946">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--ImpactofUkrainianConflictPolicyTextBlock_zNXjyjZbAVkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zXEmUtjN2lIl">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.</span></p> <p id="xdx_842_ecustom--InflationPolicyTextBlock_zL9G7WBodmw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z5UOQvru6RL6">Inflation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1GF30i6xKmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zjkEZI7K6OAd">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--InterimFinancialStatementsPolicyTextBlock_zVA2A5Rx4uck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zrSUdNDzATWe">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zsOFWJBAY6Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_ztZkr9tmLua1">Principles of Consolidation </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_z4t2ovlzwIPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z6U2yuPbqvH1">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zgv5C9zdVKa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zqce8ZLmfU7f">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20230630_zXskXxbrGqIf" title="Federal insured amount">250,000</span>. As of June 30, 2023, the balance in the Company’s accounts was approximately $<span id="xdx_909_eus-gaap--Cash_iI_c20230630_z0zADSVpChzk" title="Cash balance, amount">14,197,000</span>, consequently approximately $<span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20230630_z6Qdvk5JeWi6" title="Cash equivalent balance, amount">13,947,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 250000 14197000 13947000 <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zHzyXbG2emh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zgBXl2JB0Gug">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of June 30, 2023, and June 30, 2022, there were respectively,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230630_zYPLBaNCLlK1" title="Potentially dilutive equity instruments that are convertible into common stock">8,009,889</span> and <span id="xdx_90F_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220630_znMfZ6Ab96m1" title="Potentially dilutive equity instruments that are convertible into common stock">7,882,061</span>, potentially dilutive equity instruments outstanding in respect of warrants options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, <span id="xdx_90D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zTe4pw9g9Bvk" title="Potentially dilutive equity instruments that are convertible into common stock"><span id="xdx_90D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVwJ9KLG0Vt2" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772</span></span> related to warrants outstanding at both June 30, 2023 and June 30, 2022 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining <span id="xdx_907_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_z2lMaF4f2Yu1" title="Potentially dilutive equity instruments that are convertible into common stock">386,117</span> and <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220630__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zOmFiUf38yx4" title="Potentially dilutive equity instruments that are convertible into common stock">252,289</span> potentially dilutive equity instruments outstanding as of June 30, 2023 and June 30, 2022, respectively, related to options to purchase shares of the Company’s common stock and restricted stock units that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8009889 7882061 7623772 7623772 386117 252289 <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z0aYdyZW2dm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zQapLv9IWgK5">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $<span id="xdx_90B_eus-gaap--GoodwillAndIntangibleAssetImpairment_c20220101__20220630_zhUiutSqTIt4" title="Goodwill and intangible asset impairment">631,064</span> at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.</span></p> 631064 <p id="xdx_840_ecustom--TemporaryEquityPolicyTextBlock_zi7RNBZYVnO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zsCMlYwItwti">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z2YeT5m4RAil" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zBeFLVR9pZf2">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zVOd3ZvJBYY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyvKfqDUNtqd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20230401__20230630_zsiCzQwgwvT7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20220401__20220630_zvqmyfaNZ2E" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20230101__20230630_zwcpM9dxy9j9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220101__20220630_zxB2nukCuACd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zhGIYdGXlSW7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment and systems sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">899,748</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,791,141</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,296,574</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,433,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyblISKp91wk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engineering and other services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,232</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,076</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,125</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z0hH4hvmraVa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,668</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,474</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousMember_zJCPtcEngLLl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">204,735</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0662">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbCbmDbaU3ug" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,063,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,014,885</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,746,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,759,312</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zWTqNVdZEBp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous revenue of $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--ProductOrServiceAxis__custom--MiscellaneousMember_zh3Wr5aoiTU7" title="Miscellaneous revenue">55,959</span> and $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--ProductOrServiceAxis__custom--MiscellaneousMember_zojZ8Oorehti" title="Miscellaneous revenue">204,735</span> recognized during the three and six months ended June 30, 2023, respectively, represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of June 30, 2023 and December 31, 2022, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of June 30, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $<span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230630_z6AQLnioYvcg" title="Contract with customer liability current">625,911</span> and $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20221231_zg4tDIWUl895" title="Contract with customer liability current">4,338,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three and six months ended June 30, 2023, the Company recognized revenue of $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230401__20230630_zJ62Ls8D5Yif" title="Revenue recognized">45,716</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230630_zYd6TeHOWKS7" title="Revenue recognized">3,898,622</span>, respectively, related to the deferred revenue at January 1, 2023 For the three and six months ended June 30, 2022, the Company recognized revenue of $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220401__20220630_zBovHEj7qj71">1,030,830</span> and $<span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220630_zMHSyrWmeZLk">2,193,204</span>, respectively, related to the deferred revenue at January 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_901_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230630_zKYF2lCX8ZMa" title="Revenue remaining performance obligation">1,066,000</span>. The decline in backlog was primarily the result of lower bookings. The Company has entered into fewer and smaller new contracts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at June 30, 2023, includes booked sales orders of $<span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember__us-gaap--TypeOfArrangementAxis__custom--BookedSalesOrdersFromThreeCustomersMember_zfef396uuip4">250,000</span> from three customers that the Company does not expect to be realized until 2024, if at all. Our projected revenue amount contains a booked sales order of $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230630__srt--TitleOfIndividualAxis__custom--OneCustomerMember_z9U96G6JiCb4">279,000</span> (26% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that contract fulfillment could be delayed for these reasons.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zEs4F9eGsGBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zCFODIL6uSPe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zUaSI1s6StKc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_z3WuzdtFoSM5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_zJ1ix3emhqw3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zc1cTMQGNzEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0689">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0690">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zydnNBsM95Wf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">816,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zSwZlTjta9g9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total remaining performance obligations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">816,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zN396rFWuGme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zVOd3ZvJBYY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyvKfqDUNtqd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20230401__20230630_zsiCzQwgwvT7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20220401__20220630_zvqmyfaNZ2E" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20230101__20230630_zwcpM9dxy9j9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220101__20220630_zxB2nukCuACd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zhGIYdGXlSW7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment and systems sales</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">899,748</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,791,141</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,296,574</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,433,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zyblISKp91wk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engineering and other services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,232</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,076</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,125</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z0hH4hvmraVa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,668</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,474</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousMember_zJCPtcEngLLl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">204,735</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0662">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zbCbmDbaU3ug" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,063,714</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,014,885</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,746,287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,759,312</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 899748 2791141 5296574 4433713 103232 192076 227643 278125 4775 31668 17335 47474 55959 204735 1063714 3014885 5746287 4759312 55959 204735 625911 4338570 45716 3898622 1030830 2193204 1066000 250000 279000 <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zEs4F9eGsGBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zCFODIL6uSPe" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zUaSI1s6StKc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20230630__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_z3WuzdtFoSM5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_zJ1ix3emhqw3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zc1cTMQGNzEl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0689">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0690">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zydnNBsM95Wf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">816,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zSwZlTjta9g9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total remaining performance obligations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">816,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,066,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 816000 250000 1066000 816000 250000 1066000 <p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_zOoLmrFqYIrk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zn33bkpSrek9">Product Warranty</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20230101__20230630_zfU5YABmrxa" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.</span> The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of June 30, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $<span id="xdx_90E_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20230630_zHOHDkpq5786" title="Accrued warranty reserve amount">193,498</span> and $<span id="xdx_90C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20221231_zk6VZczrRMdg" title="Accrued warranty reserve amount">180,457</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. 193498 180457 <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z1I3G38ATLC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zvbKajSkOfI8">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the six months ended June 30, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230630_zdZhZEagCJf7" title="Stock price volatility">152.23</span>%; expected term in years of <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230630_z4NA7SGQGao8" title="Expected Term">10</span> and risk-free interest rate of <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230630_zaZ7BKcAHa6b" title="Risk-free interest rate">3.48</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zWizS4zoJQF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and June 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zuG5TWAB2UB5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20230401__20230630_zrj8TGGLhwdf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220401__20220630_zUOKUr2a8wnc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20230101__20230630_zagb3JrxkMn7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220101__20220630_zKNFaxdwM79k" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended <br/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation expense included in:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zqlqXjsKKx01" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,898</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,895</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztr1LT8OQfV3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising and marketing expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,080</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,842</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_z1dvmejWL2K2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product development costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,570</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zg8sBr9Qy0h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling, general and administrative expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,482</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152,679</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,446</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zMPYdxHAmY0g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,627</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,260</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,144</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zCOUTncBJujl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the expense for the three and six months ended June 30, 2022, is an accrual for $<span id="xdx_903_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20230401__20230630_zRu4P8FrCA64" title="Accrued Incentive">46,374</span> and $<span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20230101__20230630_zEnZBBRlXGo6" title="Accrued Incentive">46,374</span>, respectively, for the 2022 Annual Employee Incentive Compensation Plan. No accrual is being recorded in 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1.5223 P10Y 0.0348 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zWizS4zoJQF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and June 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zuG5TWAB2UB5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20230401__20230630_zrj8TGGLhwdf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220401__20220630_zUOKUr2a8wnc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20230101__20230630_zagb3JrxkMn7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220101__20220630_zKNFaxdwM79k" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three Months Ended</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended <br/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation expense included in:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zqlqXjsKKx01" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,898</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,895</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztr1LT8OQfV3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising and marketing expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,080</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,842</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_z1dvmejWL2K2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product development costs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,570</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,961</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zg8sBr9Qy0h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling, general and administrative expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,482</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152,679</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,446</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zMPYdxHAmY0g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,627</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,260</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">188,144</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5104 4898 5895 4080 1113 6842 4961 3570 4961 15166 81482 152679 170446 15166 95627 162260 188144 46374 46374 <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_znQy6hOzggbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zkYV0VJz9d2b">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zVKQOsMSxSYd" title="Concentration risk percentage">64</span>%, and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zFKnjzBPR4kj" title="Concentration risk percentage">10</span>% of the Company’s revenue for the three months ended June 30, 2023. Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zptW3wL5cKc7" title="Concentration risk percentage">44</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zcX0udDdgt9l" title="Concentration risk percentage">23</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zpuJqXuL4vt4" title="Concentration risk percentage">14</span>% of the Company’s revenue for the six months ended June 30, 2023. Two customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z2yc1ROx0pM3" title="Concentration risk percentage">53</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zT0CoumXNSP4" title="Concentration risk percentage">12</span>% of the Company’s revenue for the three months ended June 30, 2022 and one customer accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zbEoPjA0ENje" title="Concentration risk percentage">47</span>% of the Company’s revenue for the six months ended June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zgW086ZbEovj" title="Concentration risk percentage">69</span>%, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkZIm1qdThde" title="Concentration risk percentage">17</span>%, and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zAY6kC9URcVd" title="Concentration risk percentage">12</span>% of the Company’s accounts receivable as of June 30, 2023. Two customers accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHgKGRc18FO5" title="Concentration risk percentage">57</span>% and<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhYDcCqOlLIg" title="Concentration risk percentage"> 43</span>% of the Company’s accounts receivable as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.64 0.10 0.44 0.23 0.14 0.53 0.12 0.47 0.69 0.17 0.12 0.57 0.43 <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zQTNnY1LROoi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zNX8DWj7elth">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “<i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</i>, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_80C_eus-gaap--LesseeOperatingLeasesTextBlock_z0mrB7QDTrtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span id="xdx_82B_ztdhp37vUnq2">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842) </i>(“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company entered into an agreement to lease <span id="xdx_906_eus-gaap--AreaOfLand_iI_uSquareFoot_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zFNd98nMDVp" title="Area of land">11,491</span> square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. <span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDescription_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zwzhTiTiIpb" title="Operating lease term description">The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027</span>. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $<span id="xdx_90A_eus-gaap--PaymentsForRent_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zbEJo2WYbpwe" title="Lease rental expense">10,055</span> and will increase by <span id="xdx_909_ecustom--IncreaseInRentPercent_pid_dp_uPure_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zcVWHOd5PtWe" title="Increase in rent percent">3</span>% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $<span id="xdx_90A_eus-gaap--SecurityDeposit_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zDTJL8hhBWV8" title="Security deposit">14,747</span>. The Company has the option to renew the New Facility Lease for an additional <span id="xdx_909_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210728_zSnSUkoUaQDh" title="Lease renew term">five years</span>. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $<span id="xdx_90B_eus-gaap--OperatingLeaseLiability_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zZ0TU6IjIpR4" title="Operating lease liability">582,838</span>. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zZjFXvM6bqT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease cost, cash flows and other information related to the New Facility Lease were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zlLvKtrcGpI7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Lease Cost</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_zrQKEyqjgrqk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_z0NMY1Sq03r2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">409,981</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zIoTMHAo9ajk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_znndkWhWGyx7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, long-term</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">319,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining lease term</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zMDu9uRWql85" title="Remaining lease term">3.6</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_zXQTYCk5DkQ6" title="Discount rate">3.63</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended June 30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating cash outflow from operating lease</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--OperatingLeasePayments_c20230101__20230630_zQHvYb53uay" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Operating cash outflow from operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,138</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zh6U3Sccse2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zP2wGZ2wBcr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum lease payments on the New Facility Lease as of June 30, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zJzPz7ppfTHd" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230630_zWKna9DGYzt4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years ended December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zd4yJcUfaqGg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023 (excluding the six months ended June 30, 2023)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,759</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_z1ZScqB3RxS3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_zdTkTXn4dKXf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132,503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zUavNQ1kmXBd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,473</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree_iI_pp0p0_maLOLLPzNo0_zA6sVqZQ0plh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,654</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_zVKXRJsKnsRl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">472,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zIKcrs2wPP74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,513</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,519</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zMedOLXE3C44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11491 The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027 10055 0.03 14747 P5Y 582838 <p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zZjFXvM6bqT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease cost, cash flows and other information related to the New Facility Lease were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zlLvKtrcGpI7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Lease Cost</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_zrQKEyqjgrqk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_z0NMY1Sq03r2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use asset</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">409,981</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zIoTMHAo9ajk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_znndkWhWGyx7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liability, long-term</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">319,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining lease term</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zMDu9uRWql85" title="Remaining lease term">3.6</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_zXQTYCk5DkQ6" title="Discount rate">3.63</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Six Months Ended June 30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating cash outflow from operating lease</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--OperatingLeasePayments_c20230101__20230630_zQHvYb53uay" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Operating cash outflow from operating lease"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,138</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 409981 122272 319247 P3Y7M6D 0.0363 62138 <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zP2wGZ2wBcr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum lease payments on the New Facility Lease as of June 30, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zJzPz7ppfTHd" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20230630_zWKna9DGYzt4" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years ended December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zd4yJcUfaqGg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023 (excluding the six months ended June 30, 2023)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,759</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_z1ZScqB3RxS3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_zdTkTXn4dKXf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132,503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zUavNQ1kmXBd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,473</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree_iI_pp0p0_maLOLLPzNo0_zA6sVqZQ0plh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,654</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_zVKXRJsKnsRl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">472,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zIKcrs2wPP74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,513</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,519</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 62759 128643 132503 136473 11654 472032 30513 441519 <p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_z7qB7Pc6Y7n5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 – <span id="xdx_826_zBUY1mcg3Czg">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z2ezwSlqXWW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zjHguFmlZGb7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Inventory</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_zblrNBOOWNBd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20221231_zkJydaM6yec9" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_z6PEocLH8EL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">398,455</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_maINztRx_zcMHoOSgJ20e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in progress</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zuLTmm5D99hb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,180</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,608</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_z359j1V1YNOh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for excess &amp; obsolete inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(131,480</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(70,907</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_zQzSRv2ITt84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">397,155</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">348,411</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zvlZil9rIFkf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overhead expenses of $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20230101__20230630_zgPPEEUympeh" title="Overhead expenses">15,055</span> and $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20220101__20221231_zdumSxpuEcXk" title="Overhead expenses">12,770</span> were included in the inventory balance as of June 30, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $<span id="xdx_909_ecustom--PrepaidInventoryExpenses_iI_c20230630_zrq7J4Pqj2Dk" title="Prepaid inventory expenses">10,000</span> and $<span id="xdx_90C_ecustom--PrepaidInventoryExpenses_iI_c20221231_z4ynGco2f519" title="Prepaid inventory expenses">1,176,000</span> in advance payments for inventory for the periods ended June 30, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z2ezwSlqXWW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zjHguFmlZGb7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Inventory</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20230630_zblrNBOOWNBd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20221231_zkJydaM6yec9" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_z6PEocLH8EL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">398,455</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_maINztRx_zcMHoOSgJ20e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in progress</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zuLTmm5D99hb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130,180</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,608</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_z359j1V1YNOh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for excess &amp; obsolete inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(131,480</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(70,907</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_zQzSRv2ITt84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">397,155</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">348,411</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 398455 270555 155 130180 148608 131480 70907 397155 348411 15055 12770 10000 1176000 <p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zBI2vgBF9tBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_826_zU2xmtq1ZyEh">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zNPdMC0gSnsl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zUoTPuYAy0cd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Property and Equipment</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20230630_zncT0bXLnhJ2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20221231_zStIMTQQQvL7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ziL59byBQlF" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,389</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zl38imPbhV69" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_ziocqUNSdCD3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">293,389</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_z7Ysfzzr11V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(237,769</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(224,876</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_z2FxH1I2YV5c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,225</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,513</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zegWuUWGhHd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense was $<span id="xdx_906_eus-gaap--Depreciation_c20230101__20230630_zOrP3TDKTIg8" title="Depreciation expenses">14,988</span> for the six months ended June 30, 2023. For the six months ended June 30, 2023, $<span id="xdx_902_eus-gaap--Depreciation_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zygdklI1O4y6" title="Depreciation expenses">1,749</span> was allocated to cost of sales, $<span id="xdx_90D_eus-gaap--Depreciation_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_zrUiwwxv4hLb" title="Depreciation expenses">437</span> was allocated to inventory with the remainder recorded as selling, general, and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zNPdMC0gSnsl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zUoTPuYAy0cd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Property and Equipment</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20230630_zncT0bXLnhJ2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20221231_zStIMTQQQvL7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ziL59byBQlF" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,389</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zl38imPbhV69" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_ziocqUNSdCD3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">293,389</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_z7Ysfzzr11V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(237,769</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(224,876</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_z2FxH1I2YV5c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,225</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,513</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 275994 278389 15000 15000 290994 293389 237769 224876 53225 68513 14988 1749 437 <p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zExxZxnoyUMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_827_zv8SubsE78Ej">Accounts Payable and Accrued Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrBjBiHsfC76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zdxaqf0Cktw6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Accounts Payable and Accrued Liabilities</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230630_zNJTOz2AvoFe" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20221231_zv2BUgvCR7Z1" style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_z0xlznRVQsj6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,763</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,162</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zLxH5AoY7Qog" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales commissions payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,061</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,951</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zUAccadrvzL3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued payroll liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">231,182</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,094</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_zbviQZMp2Op8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product warranty accrual</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">193,498</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,457</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zerWOINvDh5i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,120</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">224,594</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_z5x3u98xosJ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798,624</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,207,258</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zgYkTsKxS0Ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc. <br/> Notes to Condensed Consolidated Financial Statements<br/> June 30, 2023 <br/> (in US Dollars except share numbers)<br/> (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrBjBiHsfC76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zdxaqf0Cktw6" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Accounts Payable and Accrued Liabilities</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20230630_zNJTOz2AvoFe" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20221231_zv2BUgvCR7Z1" style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_z0xlznRVQsj6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,763</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,162</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zLxH5AoY7Qog" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales commissions payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,061</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,951</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zUAccadrvzL3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued payroll liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">231,182</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,094</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_zbviQZMp2Op8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product warranty accrual</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">193,498</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,457</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zerWOINvDh5i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,120</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">224,594</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_z5x3u98xosJ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798,624</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,207,258</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 280763 311162 2061 25951 231182 465094 193498 180457 91120 224594 798624 1207258 <p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXP57xl0Iha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_82B_zf63GYS2qcD6">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Commitments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zVBWAmgUub5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_82D_zr7ci49HiLn3">Stockholders’ Equity </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company had <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20230630_zqhJpL3L19d2" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20230630_zvKaaoRSuc76" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock authorized at a $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230630_zoAjgwM6ytKg" title="Common stock par value">0.00001</span> par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20230630_z36ssHmSqdVb" title="Common stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20230630_zGBry7NzJiBb" title="Common stock, shares outstanding">8,076,372</span></span> shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors Remuneration</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company issued <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220101__20220103__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zuLwGO5zPzle" title="Number of stock options issued">3,125</span> non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220103__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zgHUC9B02ba7" title="Exercise price">4.80</span>, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company issued an RSU grant of <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z1lxJvypPRUk" title="Shares, granted">3,367</span> shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zlNeuD49WPM4" title="Shares, granted">1,684</span> shares of common stock vested immediately on grant date and the remaining <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyThreeMember_zw9CAMS2ppcl" title="Shares, granted">1,683</span> shares of common stock vested on January 17, 2023. <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember_zqR6gtQiNy59" title="Shares, vested">1,684</span> shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2023, the Company issued an RSU grant of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230103__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z8LB69zyPTza" title="Number of stock options issued">29,758</span> shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230102__20230103__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zunFHiy1wWVl" title="Number of shares vested in period">119,032</span> shares of the Company’s common stock were issued in settlement of the RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revised Compensation Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The Plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The plan is divided into two phases: from the Effective Date of the Plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-uplist phase: The Company paid its independent directors an annual cash fee of $<span id="xdx_908_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember_z7hO48poHQ2h" title="Annual cash fee">15,000</span>, payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zluBieRnz05h" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBBjV2dk4Rg6" title="Vesting rights description">Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $<span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQOQDBI7f9s2" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company pays the Audit Committee Chairman an additional annual fee of $<span id="xdx_905_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__custom--AuditCommitteeChairmanMember_zfh28K5cRw14" title="Management fee expense">10,000</span>, payable quarterly in advance, for services as the Audit Committee Chairman.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company pays the Chairmen of any other committees of the Board an additional annual fee of $<span id="xdx_902_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__custom--CommitteeChairmanMember_zSvB6fC1BSkf" title="Management fee expense">5,000</span>, payable quarterly in advance, for services as a Committee Chairman.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-uplist phase: The Company will pay its independent directors an annual cash fee of $<span id="xdx_90C_eus-gaap--ManagementFeeExpense_c20230101__20230630__srt--TitleOfIndividualAxis__srt--DirectorMember_zqLtRsczCGTd" title="Management fee expense">25,000</span>, payable quarterly in advance on the first business day of each quarter. All other terms remain the same.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee directors do not receive separate fees for their services as directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20220112__20220117_zwhtKQM7zt6l" title="Reverse stock split">one-for-one hundred and fifty</span>. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An additional <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_c20220112__20220117_zOlYyJ6PH4na" title="Reverse stock split">6,798</span> shares of common stock were issued to round up partial shares following the reverse split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211230_ztMTf7jFL866" title="Common stock, shares outstanding">240,125,224</span> to <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_z9iS287EPYGd" title="Common stock, shares outstanding">1,600,835</span>. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change in Authorized Share Capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20230630__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zo59m1RPAK7i" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20230630__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zqeLiRonCwUk" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity Raise</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20220214__20220215_zyp8Sos8dp2" title="Net proceeds from sale of common stock">22</span> million for the sale of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgJgQ521Hfhk" title="Net proceeds from sale of common stock">5,811,138</span> shares of common stock and <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zN7KyDjlb7eb" title="Number of shares sold">6,572,808</span> warrants, each warrant to purchase one share of common stock for <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6mXovyUgXK5" title="Warrant term">five years</span>, exercisable immediately, at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsVxANW1TIG7" title="Exercise price, per share">5.00</span>. The Company also issued to the representative of the underwriters <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zIttUpB3qmk1" title="Stock issued during period, shares, issued for services">290,557</span> warrants, each warrant to purchase one share of common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zIxZRB0g3fd" title="Exercise price">5.1625</span>, during the period commencing August 9, 2022, and expiring on <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zTVwVs315Kg2" title="Warrants maturity date">February 10, 2027</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrant Exercise</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 21, 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220620__20220621_zZnV9jr9AAbd" title="Number of shares issued">169,530</span> shares of its common stock in connection with the cashless exercise of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220621_zOu91jPupM2g" title="Prefunded conversion warrants">170,382</span> prefunded conversion warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 200000000 25000000 0.00001 8076372 8076372 3125 4.80 3367 1684 1683 1684 29758 119032 15000 25000 Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date. 25000 10000 5000 25000 one-for-one hundred and fifty 6798 240125224 1600835 200000000 25000000 22000000 5811138 6572808 P5Y 5.00 290557 5.1625 2027-02-10 169530 170382 <p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zLlzemrghmUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_826_zWczgrBAZZF4">Equity Incentive Plans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2017 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zvo3Zdydn0v2" title="Number of options to purchase shares">333,333</span> shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, no shares or options were issued, or cancelled under the 2017 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, of the <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zisJxyh5jomb" title="Number of shares authorized">333,333</span> shares authorized under the 2017 Plan for equity awards, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQjuHefWd2ha" title="Number of shares issued">163,692</span> shares have been issued, awards relating to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_z6tH3pyRuUTe" title="Number of option remain outstanding">147,132</span> options remain outstanding, and <span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zMLuzLxjuF3k" title="Shares available for future equity awards">22,509</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zFg28sSq0tG8" title="Number of shares grant in period">666,667</span> shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zqyCfQqDoMJ7" title="Shares issued during the period">122,398</span> shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--FiveEmployeesMember_zjNxrh10CMQf" title="Number of share awards granted">138,489</span> non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--FiveEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z2oSyg1WMgkb" title="Exercise price per share">0.8955</span>. An expense of $<span id="xdx_901_eus-gaap--DeferredCompensationLiabilityCurrent_iI_c20221231_zhtP0nOs2I0g" title="Accrued equity compensation">89,970</span> in respect of this issuance had been accrued in 2022. An additional expense of $<span id="xdx_908_ecustom--EmployeeStockOwnershipPlanAdditionalExpense_c20230101__20230630_zmdyZI89787k" title="Additional expense">32,376</span> was recognized in 2023 upon management and board finalization and approval of the awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, of the <span id="xdx_90A_ecustom--ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zAk5j0c3RDZf" title="Number of shares authorized">666,667</span> shares authorized under the 2021 Equity Plan, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zU2Mt09e2te9" title="Number of shares issued">132,568</span> shares have been issued in settlement of restricted stock units, awards relating to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zmF7zmzOYVnl" title="Number of option remain outstanding">198,170</span> non-qualified stock options, and <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--IncentiveStockOptionMember_zjxSooFOGo9g" title="Number of option remain outstanding">40,816</span> incentive stock options remain outstanding, and <span id="xdx_908_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zGj9EnB1vsr8" title="Shares available for future equity awards">295,113</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There was $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zBK1YQkUvONe" title="Unrecognized compensation expense">30,753</span> in unrecognized compensation expense for unvested non-qualified stock options, and incentive stock options at June 30, 2023 which will be recognized over approximately <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zB0Yc6O467a7" title="Weighted Average Remaining Contractual Term">2 </span>years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-Qualified and Incentive Stock Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zMho5Qlzxxya" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the six months ended June 30, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zO21cqn4K6hi" style="display: none">Schedule of Stock Option Activity</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Contractual Term</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z81qdo4AbMR1" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLYhSkcyDFN9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.94</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGQoIbzZLAcg" title="Weighted Average Remaining Contractual Term, Beginning">7.6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUkHazr6TdM3" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvqUkkXKFEN2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,489</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHVzuSXzJrK4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zuwO42kFhZV4" title="Weighted Average Remaining Contractual Term, Granted">6.6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z80HIEjNG4td" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zDat2SV73Hg3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1032">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zlyWi7swMlNd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,567</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z78XhE6ricmj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z1dy3NQSIwqf" title="Weighted Average Remaining Contractual Term, Forfeited">8.9</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqZCW0wj8Nji" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1040">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zsSixVr2gQQ4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1042">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zS0Ee8H48qHi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">328,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zWLfR9AF6uC" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.58</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaziVLh5cNud" title="Weighted Average Remaining Contractual Term, Outstanding Ending">6.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdYXPJOdNnO" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYBkSpwHAQPf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">303,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVp22NsJMcFj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.61</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zm2HAhCw18E5" title="Weighted Average Remaining Contractual Term, Exercisable Ending">6.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb5IiQygVE99" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">      <span style="-sec-ix-hidden: xdx2ixbrl1058">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zNbYiJEOYUmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zs9d7xYSGGya" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the six months ended June 30, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zYJr8x42uAbh" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Grant-Date Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant-Date Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z52TDunj04S1" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,756</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zWKMO2hnC236" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.73</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTN7CpfGWDxf" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1066">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXl27EDv9ph" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,932</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z3CGDV6O21Mk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,489</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zMFuY4KPGu37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.88</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zpVHhWAQr76l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,870</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z1S2QiNXe4Ck" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(141,822</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyfstCMEEUbe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zWWy8acZppng" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(131,094</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zklfRLYNBEa8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zbSHhe3G8jG3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znK4QJJUduEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,222</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znpH2iOCqmyc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zThRoN45brce" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zBgbeQazI6Ck" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zosaUXwUIa8d" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,090</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzLvT9J2Pw0h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.98</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zA8gOudcstJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       <span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znPrx2k0hFf1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124,486</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zpAlC0yqj4D4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the six months ended June 30, 2023 and June 30, 2022, the Company recorded $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20230101__20230630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_za2IA8zLiUA4" title="Compensation expense">60,944</span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zCr53WZlrJV" title="Compensation expense">75,947</span> as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_z2JYlCTB7Jp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the six months ended June 30, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z8wIUfa9cbS6" style="display: none">Schedule of Stock Option Activity</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Contractual Term</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value ($000)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYEvsvnXujo2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,122</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zcvrLmFhxTR4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.44</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTtkYDQO7WN4" title="Weighted Average Remaining Contractual Term, Beginning">6.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNyNgySAku37" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdjmgFAUMfFi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zo3bolXLn9Qk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zE1MA4vwFzOk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKCQIzN8MMwd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTVq3J8E3Fvf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1124">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0JpfObjRc0b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1126">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5NWPUxinvph" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zipL6HPPDMw" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1130">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoDQ8Hvp2jtg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,122</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXTOTuQmklLl" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.44</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z6SAnHEU4J19" title="Weighted Average Remaining Contractual Term, Outstanding Ending">5.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zz1U1f1KSssi" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1138">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrzmURt2smrg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,122</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7uYMTSa9pX4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.44</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxmTWK6kxDB8" title="Weighted Average Remaining Contractual Term, Exercisable Ending">5.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zRkx3qolHCm4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">      <span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zfaPpRjmM7a5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the six months ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023 and June 30, 2022, the Company incurred $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20230101__20230630__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z2wmEyb94qQ5" title="Share based compensation">0</span> and $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20220101__20220630__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zy8DF5FbeZs8" title="Share based compensation">29,656</span> respectively, as compensation expense related to<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230101__20230630__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zZwmDaW7TNx8" title="Number of options to purchase shares"> 0</span> and <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20220630__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zJTIYgV5Gvv6" title="Number of options to purchase shares">6,250</span> fully vested options issued to directors, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Units</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 3, 2023, the Company issued a total of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230102__20230103__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKNigjpqOgWk" title="Number of shares vested in period">119,032</span> restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 17, 2023, the Company settled <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230116__20230117__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zwbAhLQOE6Nf" title="Number of shares granted">3,366</span> RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023 and June 30, 2022, the Company recorded $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8dJvP91PgK1">101,316</span> and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zzXDlHGwi3rf">36,168</span>, respectively, as compensation expense related to vested RSUs issued to directors.</span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zQPueA90Pgm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zN22Uz9TZYhg" style="display: none">Schedule of Restricted Stock Units Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Units</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Grant-Date Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXOU8c7RzzY8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Units Outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,366</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zggcXuU3nEDk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.42</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6MH4jby2YRg" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7rpNng1Vrc6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHesQQYjpog3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zwwdQ0Z7z3La" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and settled with share issuance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlKf1JZKpAnk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(122,398</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaYIJ8Enb2ef" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztiqssJh3QBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/canceled</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWfTZFqgi3y" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztNQXl4lZI41" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zv4m9K7HQGP3" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zm6hXCqGZmMd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOZyzGml4LGj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHPdnLQoWRja" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       <span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zcbBz0h5Ifx" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 333333 333333 163692 147132 22509 666667 122398 138489 0.8955 89970 32376 666667 132568 198170 40816 295113 30753 P2Y <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zMho5Qlzxxya" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the six months ended June 30, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zO21cqn4K6hi" style="display: none">Schedule of Stock Option Activity</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Contractual Term</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z81qdo4AbMR1" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLYhSkcyDFN9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.94</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGQoIbzZLAcg" title="Weighted Average Remaining Contractual Term, Beginning">7.6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUkHazr6TdM3" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvqUkkXKFEN2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,489</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHVzuSXzJrK4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zuwO42kFhZV4" title="Weighted Average Remaining Contractual Term, Granted">6.6</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z80HIEjNG4td" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zDat2SV73Hg3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1032">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zlyWi7swMlNd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,567</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z78XhE6ricmj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z1dy3NQSIwqf" title="Weighted Average Remaining Contractual Term, Forfeited">8.9</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqZCW0wj8Nji" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1040">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zsSixVr2gQQ4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1042">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zS0Ee8H48qHi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">328,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zWLfR9AF6uC" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.58</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaziVLh5cNud" title="Weighted Average Remaining Contractual Term, Outstanding Ending">6.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdYXPJOdNnO" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYBkSpwHAQPf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">303,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVp22NsJMcFj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.61</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zm2HAhCw18E5" title="Weighted Average Remaining Contractual Term, Exercisable Ending">6.4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb5IiQygVE99" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">      <span style="-sec-ix-hidden: xdx2ixbrl1058">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 192073 8.94 P7Y7M6D 138489 0.90 P6Y7M6D 1567 4.15 P8Y10M24D 328995 5.58 P6Y6M 303905 5.61 P6Y4M24D <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zs9d7xYSGGya" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the six months ended June 30, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zYJr8x42uAbh" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Grant-Date Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant-Date Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z52TDunj04S1" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,756</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zWKMO2hnC236" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.73</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTN7CpfGWDxf" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1066">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXl27EDv9ph" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,932</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z3CGDV6O21Mk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,489</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zMFuY4KPGu37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.88</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zpVHhWAQr76l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121,870</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z1S2QiNXe4Ck" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(141,822</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyfstCMEEUbe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zWWy8acZppng" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(131,094</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zklfRLYNBEa8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zbSHhe3G8jG3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znK4QJJUduEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,222</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znpH2iOCqmyc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zThRoN45brce" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zBgbeQazI6Ck" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nonvested, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zosaUXwUIa8d" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,090</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzLvT9J2Pw0h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.98</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zA8gOudcstJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       <span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znPrx2k0hFf1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124,486</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 28756 4.73 135932 138489 0.88 121870 -141822 0.92 131094 333 6.67 2222 25090 4.98 124486 60944 75947 <p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_z2JYlCTB7Jp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the six months ended June 30, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z8wIUfa9cbS6" style="display: none">Schedule of Stock Option Activity</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Options</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Contractual Term</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value ($000)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYEvsvnXujo2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,122</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zcvrLmFhxTR4" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.44</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTtkYDQO7WN4" title="Weighted Average Remaining Contractual Term, Beginning">6.0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNyNgySAku37" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdjmgFAUMfFi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1116">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zo3bolXLn9Qk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zE1MA4vwFzOk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKCQIzN8MMwd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/Cancelled</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTVq3J8E3Fvf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1124">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0JpfObjRc0b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1126">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5NWPUxinvph" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zipL6HPPDMw" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1130">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoDQ8Hvp2jtg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,122</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXTOTuQmklLl" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.44</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z6SAnHEU4J19" title="Weighted Average Remaining Contractual Term, Outstanding Ending">5.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zz1U1f1KSssi" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1138">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrzmURt2smrg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,122</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7uYMTSa9pX4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.44</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxmTWK6kxDB8" title="Weighted Average Remaining Contractual Term, Exercisable Ending">5.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230630__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zRkx3qolHCm4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">      <span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 57122 9.44 P6Y 57122 9.44 P5Y6M 57122 9.44 P5Y6M 0 29656 0 6250 119032 3366 101316 36168 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zQPueA90Pgm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zN22Uz9TZYhg" style="display: none">Schedule of Restricted Stock Units Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Units</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Grant-Date Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Intrinsic Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXOU8c7RzzY8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Units Outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,366</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zggcXuU3nEDk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.42</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6MH4jby2YRg" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7rpNng1Vrc6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,032</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHesQQYjpog3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zwwdQ0Z7z3La" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and settled with share issuance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlKf1JZKpAnk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(122,398</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaYIJ8Enb2ef" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztiqssJh3QBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/canceled</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWfTZFqgi3y" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztNQXl4lZI41" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zv4m9K7HQGP3" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zm6hXCqGZmMd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Units Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOZyzGml4LGj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHPdnLQoWRja" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       <span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 3366 7.42 119032 0.84 122398 1.02 <p id="xdx_80D_ecustom--WarrantsDisclosureTextBlock_zvCaDmeUFlCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 - <span id="xdx_829_zmdgTckURyNh">Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_z23mXVshgXf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zZ0mpSMLESV3" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining Life</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In Months</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230630_zxKAIUME2aH4" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20230101__20230630_zZud8IvaYiDa" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Exercisable, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230630_zp5eEMZJvMoj" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630_z67Y09dbVps8" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">49</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20230101__20230630_zPNIutfUAPO6" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1206">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20230630_z9osTWyUeDPf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1208">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20230101__20230630_zVcvVfMtdpk4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1210">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20230101__20230630_ztRHzooFfZob" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1212">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dt_c20230101__20230630_fKg_____ztUgsIK5rkE" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230630_zvctrHD9K2c4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1216">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercised_c20230101__20230630_zxUTNe4XNqT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20230101__20230630_z3Xid98kc2h7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20230101__20230630_zHm7oH3G1uYa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dt_c20230101__20230630_fKg_____zG97IYnr3nf9"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20230101__20230630_zOZ6EWdE2e97" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20230101__20230630_zY8b9MQFSQcc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1227">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20230101__20230630_zLbvjttae2Df" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1229">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20230101__20230630_zTBw035lPdsk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms_dt_c20230101__20230630_fKg_____zPg8Gs6IwDH3" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1233">-</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20230101__20230630_zXm8X6SFtwj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1235">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230630_zeoVIvbNlGG8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20230630_zH5MD405qfW5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230630_z9G3Rq0VE6sf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20230101__20230630_ziL9xdChLBs7" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">43</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230630_zPLt1v8CSidj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       <span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zVq6kIau5wMd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhELW6TSRyZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zEj1CHEgDg05" style="display: none">Schedule of Warrants Outstanding</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Months Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zAlAfjRLF1vb" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.45</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zjGIPz02mfVh" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,982</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zOhjdrCtm2a3" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,982</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zyGjytgbSxg3" title="Weighted average remaining contractual terms (in Months)">15</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zfpGhosIFYJj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zm3IjuJDe0o4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,737</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zjjIPyKXCfyi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,737</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zSsO5DWhyTh1" title="Weighted average remaining contractual terms (in Months)">16</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zLpFvbbLFyz" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z33lo7iHk2t5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,105,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zzW4LxSEkbL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,105,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_znc1fwqfQAtc" title="Weighted average remaining contractual terms (in Months)">44</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zjAt0cmHIoa5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zdLEwRCebWd8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,557</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zXQLhXrPALna" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,557</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zSniUK4qrFK3" title="Weighted average remaining contractual terms (in Months)">44</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630_zx83J5P9fqc1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630_zoQT4OyVVd2e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630_zSFRw7UYEV9l" title="Weighted Average Life of Outstanding Warrants in Months">43</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_ztbDXNUnhWX9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_z23mXVshgXf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the six months ended June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zZ0mpSMLESV3" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining Life</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In Months</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230630_zxKAIUME2aH4" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20230101__20230630_zZud8IvaYiDa" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Exercisable, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230630_zp5eEMZJvMoj" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630_z67Y09dbVps8" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">49</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20230101__20230630_zPNIutfUAPO6" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1206">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20230630_z9osTWyUeDPf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1208">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20230101__20230630_zVcvVfMtdpk4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1210">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20230101__20230630_ztRHzooFfZob" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1212">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dt_c20230101__20230630_fKg_____ztUgsIK5rkE" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230630_zvctrHD9K2c4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1216">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercised_c20230101__20230630_zxUTNe4XNqT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20230101__20230630_z3Xid98kc2h7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20230101__20230630_zHm7oH3G1uYa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dt_c20230101__20230630_fKg_____zG97IYnr3nf9"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20230101__20230630_zOZ6EWdE2e97" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20230101__20230630_zY8b9MQFSQcc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1227">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20230101__20230630_zLbvjttae2Df" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1229">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20230101__20230630_zTBw035lPdsk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms_dt_c20230101__20230630_fKg_____zPg8Gs6IwDH3" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1233">-</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20230101__20230630_zXm8X6SFtwj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1235">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230630_zeoVIvbNlGG8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20230630_zH5MD405qfW5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230630_z9G3Rq0VE6sf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20230101__20230630_ziL9xdChLBs7" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">43</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230630_zPLt1v8CSidj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       <span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 7623772 7623772 5.14 P49M 7623772 7623772 5.14 P43M <p id="xdx_89A_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhELW6TSRyZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zEj1CHEgDg05" style="display: none">Schedule of Warrants Outstanding</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Months Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zAlAfjRLF1vb" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.45</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zjGIPz02mfVh" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,982</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zOhjdrCtm2a3" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">192,982</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zyGjytgbSxg3" title="Weighted average remaining contractual terms (in Months)">15</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zfpGhosIFYJj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zm3IjuJDe0o4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,737</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zjjIPyKXCfyi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,737</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zSsO5DWhyTh1" title="Weighted average remaining contractual terms (in Months)">16</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zLpFvbbLFyz" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z33lo7iHk2t5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,105,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zzW4LxSEkbL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,105,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_znc1fwqfQAtc" title="Weighted average remaining contractual terms (in Months)">44</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zjAt0cmHIoa5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zdLEwRCebWd8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,557</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zXQLhXrPALna" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,557</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zSniUK4qrFK3" title="Weighted average remaining contractual terms (in Months)">44</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230630_zx83J5P9fqc1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230630_zoQT4OyVVd2e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,623,772</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230630_zSFRw7UYEV9l" title="Weighted Average Life of Outstanding Warrants in Months">43</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 9.45 192982 192982 P15M 10.40 34737 34737 P16M 5.00 7105496 7105496 P44M 5.16 290557 290557 P44M 7623772 7623772 P43M <p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zWZfZRraCrdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_825_zg0ZGARtMmq5">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_c20230630_z8MtstLYHrd8" title="Operating loss carryforward">27,074,000</span>, of which $<span id="xdx_901_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_iI_c20230630_z1wlLlfyPAj1" title="Net operating loss carry forward expected to expire amount">11,196,000</span> will expire, if not utilized, in the years <span id="xdx_903_ecustom--NetOperatingLossExpirationTerm_c20230101__20230630_zDRkLOLY9Kag" title="Net operating loss expiration term">2034 through 2037</span>, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_909_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20230630_zXrCTEgl1Mca" title="NOLs usage against taxable income, percentage">80</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_zIKl1dokKv73" title="Percentage of ownership change">50</span>% within a <span id="xdx_90B_ecustom--NolsCarryforwardsTermDescription_c20230101__20230630_ztojClICX514" title="NOLs carryforwards term">three-year period</span>. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_zqSj6MTZCgV4" title="Percentage of ownership change">50</span>% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of June 30, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 27074000 11196000 2034 through 2037 0.80 0.50 three-year period 0.50 <p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z89Ult6BTQah" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 – <span id="xdx_82B_zbLDLgMg1CZ5">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the six months ended June 30, 2023 and June 30, 2022, the Company paid $<span id="xdx_908_eus-gaap--PaymentsForCommissions_c20230101__20230630_zBxgwcDD20G5" title="Payments for commissions">18,273</span> and $<span id="xdx_90D_eus-gaap--PaymentsForCommissions_c20220101__20220630_zVNNgv7uKMe2" title="Payments for commissions">9,884</span>, respectively, in commissions under this agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The agreement totaled $<span id="xdx_903_ecustom--ProceedsFomDeposit_c20221012__20221013__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQftvamYefYg" title="Proceeds from deposits">2,500</span> with $<span id="xdx_905_ecustom--ProceedsFomDeposit_c20220101__20221231__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zFQFNlM6i6qf" title="Proceeds from deposits">1,250</span> received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $<span id="xdx_901_ecustom--ProceedsFomDeposit_c20221219__20221220__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zXU5XthTiq97" title="Proceeds from deposits">10,900</span>. We entered into positive change orders in March 2023 of $<span id="xdx_90B_ecustom--ProceedsFomDeposit_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zkig0fdseQZ9" title="Proceeds from deposits">3,577</span> increasing the total of the second sales order to $<span id="xdx_901_ecustom--ProceedsFomSales_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zy6KscQbfrfi" title="Proceeds from sales">14,477</span>. During the six months ended June 30, 2023, the Company received $<span id="xdx_901_eus-gaap--PaymentsForDeposits_c20230101__20230630_zNV3XRUCgH61" title="Cash payments">14,035</span> in cash payments for these contracts. Revenue of $<span id="xdx_905_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20230630_zFcklYkIheD2" title="Revenue">16,977</span> was recorded in the six months ended June 30, 2023 in respect of these agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 18273 9884 2500 1250 10900 3577 14477 14035 16977 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zFYwr2llWYK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_82A_zW7Ovq5KdUc9">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date of issuance of these financial statements issued and determined no material subsequent events occurred after June 30, 2023 for which disclosure was required.</span></p> EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 174 318 1 false 60 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://ceaindustries.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://ceaindustries.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://ceaindustries.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies Nature of Operations and Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Leases Sheet http://ceaindustries.com/role/Leases Leases Notes 8 false false R9.htm 00000009 - Disclosure - Inventory Sheet http://ceaindustries.com/role/Inventory Inventory Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://ceaindustries.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 11 false false R12.htm 00000012 - Disclosure - Commitments and Contingencies Sheet http://ceaindustries.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders??? Equity Sheet http://ceaindustries.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 00000014 - Disclosure - Equity Incentive Plans Sheet http://ceaindustries.com/role/EquityIncentivePlans Equity Incentive Plans Notes 14 false false R15.htm 00000015 - Disclosure - Warrants Sheet http://ceaindustries.com/role/Warrants Warrants Notes 15 false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://ceaindustries.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 00000017 - Disclosure - Related Party Transactions Sheet http://ceaindustries.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://ceaindustries.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies Nature of Operations and Significant Accounting Policies (Policies) Policies http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables Nature of Operations and Significant Accounting Policies (Tables) Tables http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Leases (Tables) Sheet http://ceaindustries.com/role/LeasesTables Leases (Tables) Tables http://ceaindustries.com/role/Leases 21 false false R22.htm 00000022 - Disclosure - Inventory (Tables) Sheet http://ceaindustries.com/role/InventoryTables Inventory (Tables) Tables http://ceaindustries.com/role/Inventory 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://ceaindustries.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://ceaindustries.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities 24 false false R25.htm 00000025 - Disclosure - Equity Incentive Plans (Tables) Sheet http://ceaindustries.com/role/EquityIncentivePlansTables Equity Incentive Plans (Tables) Tables http://ceaindustries.com/role/EquityIncentivePlans 25 false false R26.htm 00000026 - Disclosure - Warrants (Tables) Sheet http://ceaindustries.com/role/WarrantsTables Warrants (Tables) Tables http://ceaindustries.com/role/Warrants 26 false false R27.htm 00000027 - Disclosure - Schedule of Revenue by Source (Details) Sheet http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails Schedule of Revenue by Source (Details) Details 27 false false R28.htm 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Sheet http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Details 28 false false R29.htm 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) Sheet http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails Schedule of Share-based Compensation Costs (Details) Details 29 false false R30.htm 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative Nature of Operations and Significant Accounting Policies (Details Narrative) Details http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables 30 false false R31.htm 00000031 - Disclosure - Schedule of Lease Cost (Details) Sheet http://ceaindustries.com/role/ScheduleOfLeaseCostDetails Schedule of Lease Cost (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) Sheet http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails Schedule of Future Annual Minimum Lease Payments (Details) Details 32 false false R33.htm 00000033 - Disclosure - Leases (Details Narrative) Sheet http://ceaindustries.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://ceaindustries.com/role/LeasesTables 33 false false R34.htm 00000034 - Disclosure - Schedule of Inventory (Details) Sheet http://ceaindustries.com/role/ScheduleOfInventoryDetails Schedule of Inventory (Details) Details 34 false false R35.htm 00000035 - Disclosure - Inventory (Details Narrative) Sheet http://ceaindustries.com/role/InventoryDetailsNarrative Inventory (Details Narrative) Details http://ceaindustries.com/role/InventoryTables 35 false false R36.htm 00000036 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 36 false false R37.htm 00000037 - Disclosure - Property and Equipment (Details Narrative) Sheet http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://ceaindustries.com/role/PropertyAndEquipmentTables 37 false false R38.htm 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Schedule of Accounts Payable and Accrued Liabilities (Details) Details 38 false false R39.htm 00000039 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://ceaindustries.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://ceaindustries.com/role/StockholdersEquity 39 false false R40.htm 00000040 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 40 false false R41.htm 00000041 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) Sheet http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails Summary of Non-vested Non-qualified Stock Option Activity (Details) Details 41 false false R42.htm 00000042 - Disclosure - Schedule of Restricted Stock Units Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails Schedule of Restricted Stock Units Activity (Details) Details 42 false false R43.htm 00000043 - Disclosure - Equity Incentive Plans (Details Narrative) Sheet http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative Equity Incentive Plans (Details Narrative) Details http://ceaindustries.com/role/EquityIncentivePlansTables 43 false false R44.htm 00000044 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) Sheet http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails Schedule of Outstanding Warrants to Purchase Common Stock (Details) Details 44 false false R45.htm 00000045 - Disclosure - Schedule of Warrants Outstanding (Details) Sheet http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails Schedule of Warrants Outstanding (Details) Details 45 false false R46.htm 00000046 - Disclosure - Income Taxes (Details Narrative) Sheet http://ceaindustries.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://ceaindustries.com/role/IncomeTaxes 46 false false R47.htm 00000047 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://ceaindustries.com/role/RelatedPartyTransactions 47 false false All Reports Book All Reports form10-q.htm cead-20230630.xsd cead-20230630_cal.xml cead-20230630_def.xml cead-20230630_lab.xml cead-20230630_pre.xml ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 64 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 18, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 584, "http://xbrl.sec.gov/dei/2023": 34 }, "contextCount": 174, "dts": { "calculationLink": { "local": [ "cead-20230630_cal.xml" ] }, "definitionLink": { "local": [ "cead-20230630_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "cead-20230630_lab.xml" ] }, "presentationLink": { "local": [ "cead-20230630_pre.xml" ] }, "schema": { "local": [ "cead-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 489, "entityCount": 1, "hidden": { "http://ceaindustries.com/20230630": 66, "http://fasb.org/us-gaap/2023": 63, "http://xbrl.sec.gov/dei/2023": 6, "total": 135 }, "keyCustom": 73, "keyStandard": 245, "memberCustom": 40, "memberStandard": 19, "nsprefix": "CEAD", "nsuri": "http://ceaindustries.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ceaindustries.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Property and Equipment", "menuCat": "Notes", "order": "10", "role": "http://ceaindustries.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Accounts Payable and Accrued Liabilities", "menuCat": "Notes", "order": "11", "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities", "shortName": "Accounts Payable and Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "12", "role": "http://ceaindustries.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "13", "role": "http://ceaindustries.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Equity Incentive Plans", "menuCat": "Notes", "order": "14", "role": "http://ceaindustries.com/role/EquityIncentivePlans", "shortName": "Equity Incentive Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Warrants", "menuCat": "Notes", "order": "15", "role": "http://ceaindustries.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "16", "role": "http://ceaindustries.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "17", "role": "http://ceaindustries.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "18", "role": "http://ceaindustries.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "19", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies", "shortName": "Nature of Operations and Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://ceaindustries.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "20", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables", "shortName": "Nature of Operations and Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "21", "role": "http://ceaindustries.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Inventory (Tables)", "menuCat": "Tables", "order": "22", "role": "http://ceaindustries.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Property and Equipment (Tables)", "menuCat": "Tables", "order": "23", "role": "http://ceaindustries.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "menuCat": "Tables", "order": "24", "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Equity Incentive Plans (Tables)", "menuCat": "Tables", "order": "25", "role": "http://ceaindustries.com/role/EquityIncentivePlansTables", "shortName": "Equity Incentive Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Warrants (Tables)", "menuCat": "Tables", "order": "26", "role": "http://ceaindustries.com/role/WarrantsTables", "shortName": "Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Schedule of Revenue by Source (Details)", "menuCat": "Details", "order": "27", "role": "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "shortName": "Schedule of Revenue by Source (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_EquipmentAndSystemsSalesMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "menuCat": "Details", "order": "28", "role": "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "shortName": "Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)", "menuCat": "Details", "order": "29", "role": "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "shortName": "Schedule of Share-based Compensation Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://ceaindustries.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "30", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "shortName": "Nature of Operations and Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Schedule of Lease Cost (Details)", "menuCat": "Details", "order": "31", "role": "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails", "shortName": "Schedule of Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)", "menuCat": "Details", "order": "32", "role": "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails", "shortName": "Schedule of Future Annual Minimum Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-28", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Leases (Details Narrative)", "menuCat": "Details", "order": "33", "role": "http://ceaindustries.com/role/LeasesDetailsNarrative", "shortName": "Leases (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-28", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Schedule of Inventory (Details)", "menuCat": "Details", "order": "34", "role": "http://ceaindustries.com/role/ScheduleOfInventoryDetails", "shortName": "Schedule of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Inventory (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://ceaindustries.com/role/InventoryDetailsNarrative", "shortName": "Inventory (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Schedule of Property and Equipment (Details)", "menuCat": "Details", "order": "36", "role": "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "Schedule of Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Property and Equipment (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "Property and Equipment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)", "menuCat": "Details", "order": "38", "role": "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails", "shortName": "Schedule of Accounts Payable and Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://ceaindustries.com/role/StatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_EmployeesAndConsultantsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Schedule of Stock Option Activity (Details)", "menuCat": "Details", "order": "40", "role": "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "shortName": "Schedule of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)", "menuCat": "Details", "order": "41", "role": "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails", "shortName": "Summary of Non-vested Non-qualified Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Schedule of Restricted Stock Units Activity (Details)", "menuCat": "Details", "order": "42", "role": "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "shortName": "Schedule of Restricted Stock Units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-06-202022-06-21", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Equity Incentive Plans (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "shortName": "Equity Incentive Plans (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "CEAD:EmployeeStockOwnershipPlanAdditionalExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "menuCat": "Details", "order": "44", "role": "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "shortName": "Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "lang": "en-US", "name": "CEAD:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Schedule of Warrants Outstanding (Details)", "menuCat": "Details", "order": "45", "role": "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "shortName": "Schedule of Warrants Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Income Taxes (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForCommissions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Related Party Transactions (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForCommissions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "shortName": "Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://ceaindustries.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Nature of Operations and Significant Accounting Policies", "menuCat": "Notes", "order": "7", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies", "shortName": "Nature of Operations and Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Leases", "menuCat": "Notes", "order": "8", "role": "http://ceaindustries.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Inventory", "menuCat": "Notes", "order": "9", "role": "http://ceaindustries.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 60, "tag": { "CEAD_AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Dividends on series B preferred stock", "label": "Dividends on series B preferred stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of restricted stock units issued to directors", "label": "Fair value of restricted stock units issued to directors" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital fair value of vested stock options granted to directors.", "label": "Fair value of vested stock options granted to directors" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of vested stock options granted to employees", "label": "Fair value of vested stock options granted to employees" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_AdvertisingAndMarketingExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advertising and Marketing Expenses [Member]", "label": "Advertising and Marketing Expenses [Member]" } } }, "localname": "AdvertisingAndMarketingExpensesMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "CEAD_AuditCommitteeChairmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Committee Chairman [Member]", "label": "Audit Committee Chairman [Member]" } } }, "localname": "AuditCommitteeChairmanMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_BookedSalesOrdersFromThreeCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Booked Sales Orders From Three Customers [Member]", "label": "Booked Sales Orders From Three Customers [Member]" } } }, "localname": "BookedSalesOrdersFromThreeCustomersMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash proceeds from sale of common stock and warrants net of issuance costs.", "label": "Net cash proceeds on sale of common stock and warrants, net of expenses" } } }, "localname": "CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_CashlessExerciseOrPrepaidWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cashless exercise or prepaid warrants.", "label": "CashlessExerciseOrPrepaidWarrants", "verboseLabel": "Cashless exercise of prefunded warrants" } } }, "localname": "CashlessExerciseOrPrepaidWarrants", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Exercised", "label": "Warrants, Exercised" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate intrinsic value of outstanding warrants.", "label": "Aggregate intrinsic value of outstanding warrants", "periodStartLabel": "Aggregate Intrinsic Value, Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants exercised.", "label": "Weighted Average Exercise Price, Exercised [Default Label]", "verboseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercised", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants expired.", "label": "Weighted Average Exercise Price, Expired [Default Label]", "verboseLabel": "Weighted Average Exercise Price, Expired" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExpired", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants weighted average exercise price granted.", "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceGranted", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_CommitteeChairmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Committee Chairman [Member]", "label": "Committee Chairman [Member]" } } }, "localname": "CommitteeChairmanMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CommonSharesAndWarrantsIssuedSharesForCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares and warrants issued shares for cash.", "label": "Common shares and warrants issued for cash, shares" } } }, "localname": "CommonSharesAndWarrantsIssuedSharesForCash", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "CEAD_CommonSharesAndWarrantsIssuedValueForCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares and warrants issued value for cash.", "label": "Common shares and warrants issued for cash" } } }, "localname": "CommonSharesAndWarrantsIssuedValueForCash", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_CommonStock0.00001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, $0.00001 par value.", "label": "Common Stock, $0.00001 par value" } } }, "localname": "CommonStock0.00001ParValueMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "domainItemType" }, "CEAD_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreement [Member]", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ConvertiblePreferredStockConvertedToSecurities": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Convertible preferred stock converted to securities.", "label": "ConvertiblePreferredStockConvertedToSecurities", "negatedLabel": "Convertible preferred series B stock dividends" } } }, "localname": "ConvertiblePreferredStockConvertedToSecurities", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "CEAD_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three [Member]", "label": "Customer Three [Member]" } } }, "localname": "CustomerThreeMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DeemedDividendPreferredStockOnDownRound": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend on series B preferred stock on down round.", "label": "Deemed dividend on series B preferred stock on down round", "negatedLabel": "Deemed dividend on convertible preferred series B stock on down round" } } }, "localname": "DeemedDividendPreferredStockOnDownRound", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "CEAD_DescriptionOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of Business [Policy Text Block]", "label": "Description of Business" } } }, "localname": "DescriptionOfBusinessPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_DirectorAndStaffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Director And Staff [Member]", "label": "Director And Staff [Member]" } } }, "localname": "DirectorAndStaffMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Directors [Member]", "label": "Directors [Member]" } } }, "localname": "DirectorsMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Future Annual Minimum Lease Payments", "verboseLabel": "Schedule Of Lease Cost" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://ceaindustries.com/20230630", "xbrltype": "stringItemType" }, "CEAD_DisclosureWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants", "verboseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock" } } }, "localname": "DisclosureWarrantsAbstract", "nsuri": "http://ceaindustries.com/20230630", "xbrltype": "stringItemType" }, "CEAD_EmployeeStockOwnershipPlanAdditionalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Employee stock ownership plan additional expense.", "label": "Additional expense" } } }, "localname": "EmployeeStockOwnershipPlanAdditionalExpense", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_EmployeesAndConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees And Consultants [Member]", "label": "Employees And Consultants [Member]" } } }, "localname": "EmployeesAndConsultantsMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_EmployeesDirectorsandConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees, Directors and Consultants [Member]", "label": "Employees, Directors and Consultants [Member]" } } }, "localname": "EmployeesDirectorsandConsultantsMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_EngineeringAndOtherServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Engineering and Other Services [Member]", "label": "Engineering and Other Services [Member]" } } }, "localname": "EngineeringAndOtherServicesMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_EquipmentAndSystemsSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment and Systems Sales [Member]", "label": "Equipment and Systems Sales [Member]" } } }, "localname": "EquipmentAndSystemsSalesMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_FiveEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five Employees [Member]", "label": "Five Employees [Member]" } } }, "localname": "FiveEmployeesMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impact of Covid-19 Pandemic On Our Business [Policy Text Block]", "label": "Impact of the COVID-19 Pandemic on Our Business" } } }, "localname": "ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_ImpactofUkrainianConflictPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impact of Ukrainian Conflict [Policy Text Block]", "label": "Impact of Ukrainian Conflict" } } }, "localname": "ImpactofUkrainianConflictPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_IncentiveStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Stock Option [Member]", "label": "Incentive Stock Option [Member]" } } }, "localname": "IncentiveStockOptionMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_IncreaseDecreaseInAccruedEquityCompensation": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in accrued equity compensation.", "label": "IncreaseDecreaseInAccruedEquityCompensation", "verboseLabel": "Accrued equity compensation" } } }, "localname": "IncreaseDecreaseInAccruedEquityCompensation", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_IncreaseInRentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase in rent percent.", "label": "Increase in rent percent" } } }, "localname": "IncreaseInRentPercent", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_InflationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inflation [Policy Text Block]", "label": "Inflation" } } }, "localname": "InflationPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_InterimFinancialStatementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interim Financial Statements [Policy Text Block]", "label": "Interim Financial Statements" } } }, "localname": "InterimFinancialStatementsPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_InventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory [Member]", "label": "Inventory [Member]" } } }, "localname": "InventoryMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_JanuarySeventeernTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 17, 2023 [Member]", "label": "January 17, 2023 [Member]" } } }, "localname": "JanuarySeventeernTwoThousandTwentyThreeMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_JanuarySeventeernTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 17, 2022 [Member]", "label": "January 17, 2022 [Member]" } } }, "localname": "JanuarySeventeernTwoThousandTwentyTwoMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_LoneStarBioscienceIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lone Star Bioscience Inc [Member]", "label": "Lone Star Bioscience Inc [Member]" } } }, "localname": "LoneStarBioscienceIncMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_MiscellaneousMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Miscellaneous [Member]", "label": "Miscellaneous [Member]" } } }, "localname": "MiscellaneousMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_NetOperatingLossCarryForwardExpectedToExpireAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net operating loss carry forward expected to expire amount.", "label": "Net operating loss carry forward expected to expire amount" } } }, "localname": "NetOperatingLossCarryForwardExpectedToExpireAmount", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_NetOperatingLossExpirationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net operating loss expiration term.", "label": "Net operating loss expiration term" } } }, "localname": "NetOperatingLossExpirationTerm", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "CEAD_NewFacilityLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Facility Lease [Member]", "label": "New Facility Lease [Member]" } } }, "localname": "NewFacilityLeaseMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NolsCarryforwardsTermDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nols carryforwards term description.", "label": "NOLs carryforwards term" } } }, "localname": "NolsCarryforwardsTermDescription", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "CEAD_NolsUsageAgainstTaxableIncomePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nols usage against taxable income percentage.", "label": "NOLs usage against taxable income, percentage" } } }, "localname": "NolsUsageAgainstTaxableIncomePercentage", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_NonQualifiedStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Qualified Stock Option [Member]", "label": "Non Qualified Stock Option [Member]" } } }, "localname": "NonQualifiedStockOptionMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NonQualifiedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-qualified Stock Options [Member]", "label": "Non-Qualified Stock Options [Member]" } } }, "localname": "NonQualifiedStockOptionsMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series B preferred stock.", "label": "Conversion of series B preferred stock" } } }, "localname": "NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend on series B preferred stock arising on down round.", "label": "Deemed dividend on series B preferred stock arising on down round" } } }, "localname": "NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Customer [Member]", "label": "One Customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_OptionsIssuedForAccruedEquityCompensationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Options issued for accrued equity compensation liability.", "label": "Options issued for accrued equity compensation liability" } } }, "localname": "OptionsIssuedForAccruedEquityCompensationLiability", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_OwnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership [Member].", "label": "Ownership [Member]" } } }, "localname": "OwnershipMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_PaymentsForRedemptionOfPreferredStock": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redemption of series B preferred stock", "label": "Redemption of series B preferred stock", "negatedLabel": "Redemption of series B preferred stock" } } }, "localname": "PaymentsForRedemptionOfPreferredStock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_PrepaidInventoryExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid inventory expenses", "label": "Prepaid inventory expenses" } } }, "localname": "PrepaidInventoryExpenses", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_ProceedsFomDeposit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds fom deposit.", "label": "Proceeds from deposits" } } }, "localname": "ProceedsFomDeposit", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_ProceedsFomSales": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds fom sales.", "label": "Proceeds from sales" } } }, "localname": "ProceedsFomSales", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_ProductDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Development Costs [Member]", "label": "Product Development Costs [Member]" } } }, "localname": "ProductDevelopmentCostsMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "CEAD_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining performance obligations related to engineering only paid contracts.", "label": "Remaining performance obligations related to engineering only paid contracts" } } }, "localname": "RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining performance obligations related to partial equipment paid contracts.", "label": "Remaining performance obligations related to partial equipment paid contracts" } } }, "localname": "RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block]", "label": "Schedule of Outstanding Warrants to Purchase Common Stock" } } }, "localname": "ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "CEAD_ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, number of shares authorized.", "label": "Number of shares authorized [Default Label]", "verboseLabel": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised", "verboseLabel": "Warrants, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations", "verboseLabel": "Warrants, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted", "verboseLabel": "Warrants, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options exercisable, including both vested and non-vested instruments.", "label": "Warrants Exercisable", "periodEndLabel": "Warrants Exercisable, Ending Balance", "periodStartLabel": "Warrants Exercisable, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award value issued period.", "label": "Share based compensation arrangement payment" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value, Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value Outstanding, Forfeited/canceled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value Outstanding, Granted", "verboseLabel": "Aggregate Intrinsic Value, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Life, Exercised", "label": "Weighted Average Remaining Life, Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased compensation arrangement by sharebased payment award non options expired weighted average remaining contractual terms.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms", "verboseLabel": "Weighted Average Life of Outstanding Warrants in Months, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants weighted average remaining contractual terms.", "label": "Weighted Average Life of Outstanding Warrants in Months, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average life of outstanding warrants in months, ending balance.", "label": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average life of outstanding warrants in months, beginning balance.", "label": "Weighted Average Life of Outstanding Warrants in Months, Beginning Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.", "label": "Grant Date Fair Value Nonvested, Forfeited", "negatedLabel": "Grant Date Fair Value Nonvested, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Aggregated Intrinsic Value, Nonvested Beginning", "periodEndLabel": "Aggregated Intrinsic Value, Nonvested Ending", "periodStartLabel": "Aggregated Intrinsic Value, Nonvested Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.", "label": "Aggregated Intrinsic Value, Nonvested Beginning [Default Label]", "periodEndLabel": "Grant Date Fair Value Nonvested, Ending", "periodStartLabel": "Grant Date Fair Value Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by sharebased payment award options nonvested grant date fair value expired.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired", "negatedLabel": "Grant Date Fair Value Nonvested, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.", "label": "Grant Date Fair Value Nonvested, Vested", "negatedLabel": "Grant Date Fair Value Nonvested, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values", "label": "Grant Date Fair Value Nonvested, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.", "label": "Number of Options Nonvested, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Options, price per share.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Options, Expired.", "label": "Number of Options Nonvested, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term, Ending.", "label": "Weighted Average Remaining Contractual Term, Outstanding Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term,Forfeited.", "label": "Weighted Average Remaining Contractual Term, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term, granted.", "label": "Weighted Average Remaining Contractual Term, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_StockIssuedDuringPeriodSharesCashlessExerciseOfPrefundedWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares cashless exercise of prefunded warrants.", "label": "Cashless exercise of prefunded warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCashlessExerciseOfPrefundedWarrants", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "CEAD_StockIssuedDuringPeriodSharesCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of restricted stock units issued to directors", "label": "Common shares issued in settlement of restricted stock units issued to directors, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "CEAD_StockIssuedDuringPeriodValueCashlessExerciseOfPrefundedWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cashless exercise of prefunded warrants, value.", "label": "Cashless exercise of prefunded warrants" } } }, "localname": "StockIssuedDuringPeriodValueCashlessExerciseOfPrefundedWarrants", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of restricted stock units issued to directors.", "label": "Common shares issued in settlement of restricted stock units issued to directors" } } }, "localname": "StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_StockIssuedDuringPeriodValueReverseStockSplits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common shares to round up partial shares following reverse split", "label": "Issuance of common shares to round up partial shares following reverse split" } } }, "localname": "StockIssuedDuringPeriodValueReverseStockSplits", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "CEAD_TemporaryEquityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity [Policy Text Block]", "label": "Temporary Equity" } } }, "localname": "TemporaryEquityPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Equity Plan and 2021 Equity Plan [Member]", "label": "2017 Equity Plan and 2021 Equity Plan [Member]" } } }, "localname": "TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndSeventeenEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Equity Incentive Plan [Member]", "label": "2017 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandAndSeventeenEquityPlanMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2024 [Member]", "label": "2024 [Member]" } } }, "localname": "TwoThousandAndTwentyFourMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2023 [Member]", "label": "2023 [Member]" } } }, "localname": "TwoThousandAndTwentyThreeMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Incentive Plan [Member]", "label": "2021 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Plan [Member]", "label": "2021 Equity Plan [Member]" } } }, "localname": "TwoThousandTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_UnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriters [Member]", "label": "Underwriters [Member]" } } }, "localname": "UnderwritersMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_UnpaidPurchasesOfEquipmentAndOtherAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unpaid purchases of equipment and other assets.", "label": "Unpaid purchases of equipment and other assets" } } }, "localname": "UnpaidPurchasesOfEquipmentAndOtherAssets", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_WarrantsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Disclosure [Text Block]", "label": "Outstanding Warrants", "verboseLabel": "Warrants" } } }, "localname": "WarrantsDisclosureTextBlock", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "CEAD_WarrantsRangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range [Member]", "label": "Warrants Range [Member]" } } }, "localname": "WarrantsRangeMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range One [Member]", "label": "Warrants Range One [Member]" } } }, "localname": "WarrantsRangeOneMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range Three [Member]", "label": "Warrants Range Three [Member]" } } }, "localname": "WarrantsRangeThreeMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range Two [Member]", "label": "Warrants Range Two [Member]" } } }, "localname": "WarrantsRangeTwoMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsToPurchaseCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant to purchase of common stock.", "label": "Warrants to purchase common stock" } } }, "localname": "WarrantsToPurchaseCommonStockMember", "nsuri": "http://ceaindustries.com/20230630", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r527", "r529", "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r562", "r620" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r201", "r202", "r203" ], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r198", "r501", "r575", "r617", "r618" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r198", "r501", "r575", "r617", "r618" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r196", "r354", "r383", "r384", "r385", "r386", "r387", "r388", "r491", "r500", "r505", "r541", "r567", "r568", "r575", "r617" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r196", "r354", "r383", "r384", "r385", "r386", "r387", "r388", "r491", "r500", "r505", "r541", "r567", "r568", "r575", "r617" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r201", "r202", "r203" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r562", "r611" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities", "totalLabel": "Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r17", "r504" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r199", "r200" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r21", "r494" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales commissions payable" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r42", "r131", "r377" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [ "r140", "r141", "r329", "r330", "r331", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r140", "r141", "r329", "r330", "r331", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r72", "r504", "r621" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r292", "r293", "r294", "r405", "r558", "r559", "r560", "r605", "r623" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r288", "r299" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Total share-based compensation expense included in consolidated statement of operations" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r106", "r132", "r152", "r183", "r190", "r194", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r314", "r316", "r328", "r370", "r441", "r504", "r515", "r572", "r573", "r613" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r127", "r137", "r152", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r314", "r316", "r328", "r504", "r572", "r573", "r613" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r152", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r314", "r316", "r328", "r572", "r573", "r613" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Noncurrent Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncurrent Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r259", "r260", "r261", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r283", "r284", "r285", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Financial Statement Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r112", "r372", "r416", "r436", "r504", "r515", "r542" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash balance, amount" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r28", "r129", "r492" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r29", "r105" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash, Cash Equivalents, and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r28", "r89", "r150" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and\u00a0\u00a0cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r1", "r89" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r542", "r616" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalent balance, amount" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Federal insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r124", "r133", "r134", "r135", "r152", "r170", "r171", "r176", "r178", "r181", "r182", "r204", "r214", "r216", "r217", "r218", "r221", "r222", "r225", "r226", "r228", "r231", "r237", "r328", "r396", "r397", "r398", "r399", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r417", "r428", "r450", "r470", "r482", "r483", "r484", "r485", "r486", "r536", "r556", "r561" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "periodEndLabel": "Weighted Average Exercise Price, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance", "verboseLabel": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Prefunded conversion warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r63", "r371", "r427" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r98", "r212", "r213", "r489", "r566" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Shares available for future equity awards" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r506", "r507", "r508", "r510", "r511", "r512", "r513", "r558", "r559", "r605", "r619", "r623" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par or stated value per share", "verboseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r71", "r428" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r8", "r71", "r428", "r447", "r623", "r624" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r71", "r374", "r504" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r33", "r35", "r60", "r61", "r198", "r488" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r33", "r35", "r60", "r61", "r198", "r394", "r488" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r33", "r35", "r60", "r61", "r198", "r488", "r539" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r64", "r115" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r33", "r35", "r60", "r61", "r198" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r33", "r35", "r60", "r61", "r198", "r488" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r55", "r496" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r240", "r241", "r252" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue", "verboseLabel": "Contract with customer liability current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldOverhead": { "auth_ref": [ "r551" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indirect cost incurred related to good produced and service rendered.", "label": "Overhead expenses" } } }, "localname": "CostOfGoodsAndServicesSoldOverhead", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r83", "r152", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r328", "r572" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r34", "r198" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationLiabilityCurrent": { "auth_ref": [ "r46", "r102" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Accrued equity compensation" } } }, "localname": "DeferredCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r543" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r5", "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expenses" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r5", "r186" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and intangible asset amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r418", "r419", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r458", "r459", "r460", "r461", "r464", "r465", "r466", "r467", "r478", "r479", "r480", "r481", "r506", "r508" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r56", "r57", "r58", "r59", "r418", "r419", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r458", "r459", "r460", "r461", "r464", "r465", "r466", "r467", "r478", "r479", "r480", "r481", "r495", "r506", "r508" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of Revenue by Source" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r255", "r258", "r289", "r290", "r291", "r502" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Equity Incentive Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r143", "r159", "r160", "r161", "r162", "r163", "r167", "r170", "r176", "r177", "r178", "r179", "r326", "r327", "r367", "r381", "r497" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r143", "r159", "r160", "r161", "r162", "r163", "r170", "r176", "r177", "r178", "r179", "r326", "r327", "r367", "r381", "r497" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r31", "r32" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Income (Loss) Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Accrued Incentive" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll liabilities" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r603" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r8", "r125", "r140", "r141", "r142", "r154", "r155", "r156", "r158", "r164", "r166", "r180", "r205", "r206", "r239", "r292", "r293", "r294", "r306", "r307", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r329", "r330", "r331", "r332", "r333", "r334", "r344", "r389", "r390", "r391", "r405", "r470" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Percentage of ownership change" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r555", "r564", "r565" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "negatedLabel": "Loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ceaindustries.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.", "label": "Goodwill impairment charges", "verboseLabel": "Goodwill and intangible asset impairment" } } }, "localname": "GoodwillAndIntangibleAssetImpairment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/StatementsOfCashFlows", "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r7", "r40" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r82", "r152", "r183", "r189", "r193", "r195", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r328", "r499", "r572" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r80", "r108", "r183", "r189", "r193", "r195", "r368", "r379", "r499" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r210", "r211", "r455" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r211", "r455" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r153", "r301", "r303", "r304", "r305", "r308", "r310", "r311", "r312", "r401" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r111", "r122", "r165", "r166", "r187", "r302", "r309", "r382" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r353", "r554" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r540", "r554" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability, net" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r172", "r173", "r178" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Potentially dilutive equity instruments that are convertible into common stock" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r110" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income (expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r146", "r148", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r546" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r136", "r493", "r504" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, net", "totalLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r548" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r39", "r549" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Allowance for excess & obsolete inventory" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r547" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work in progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r209" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Provision for excess and obsolete inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of Lease Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDescription": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Description of lessee's operating lease.", "label": "Operating lease term description" } } }, "localname": "LesseeOperatingLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r610" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Future Annual Minimum Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r343" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r343" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r343" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r343" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r610" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "2023 (excluding the six months ended June 30, 2023)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lease renew term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r152", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r315", "r316", "r317", "r328", "r426", "r498", "r515", "r572", "r613", "r614" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r76", "r107", "r376", "r504", "r557", "r563", "r607" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r128", "r152", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r315", "r316", "r317", "r328", "r504", "r572", "r613", "r614" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r15", "r66", "r67", "r68", "r69", "r152", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r315", "r316", "r317", "r328", "r572", "r613", "r614" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Noncurrent Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncurrent Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r62", "r452", "r514", "r622" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.", "label": "Management fee expense" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r84" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Advertising and marketing expenses" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r147" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r147" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r89", "r90", "r91" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r81", "r91", "r109", "r126", "r138", "r139", "r142", "r152", "r157", "r159", "r160", "r161", "r162", "r165", "r166", "r174", "r183", "r189", "r193", "r195", "r204", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r327", "r328", "r380", "r449", "r468", "r469", "r499", "r514", "r572" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r145", "r159", "r160", "r161", "r162", "r167", "r168", "r175", "r178", "r183", "r189", "r193", "r195", "r499" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r85" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r183", "r189", "r193", "r195", "r499" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r337" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of minimum lease payments", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r337" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of operating lease liability", "verboseLabel": "Operating lease liability, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r337" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current portion", "verboseLabel": "Operating lease liability, long-term" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r338", "r340" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating cash outflow from operating lease" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r336" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r555" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Amortization of operating lease ROU asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r342", "r503" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r341", "r503" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r92", "r93", "r94", "r104" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Nature of Operations and Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r86" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForCommissions": { "auth_ref": [ "r3" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for commissions during the current period.", "label": "Payments for commissions" } } }, "localname": "PaymentsForCommissions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForDeposits": { "auth_ref": [ "r552", "r553" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.", "label": "Cash payments" } } }, "localname": "PaymentsForDeposits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r3" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Lease rental expense" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r27" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Payment of dividends on series B preferred stock" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r88" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r70", "r225" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r70", "r428" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r70", "r225" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r70", "r428", "r447", "r623", "r624" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r70", "r373", "r504" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r550" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r2" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Net proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r87" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from the sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r21", "r570", "r571" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued warranty reserve amount", "verboseLabel": "Product warranty accrual" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r96", "r116", "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r97", "r130", "r378" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r6", "r369", "r378", "r504" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r144", "r207" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r254", "r348", "r349", "r421", "r422", "r423", "r424", "r425", "r446", "r448", "r477" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r254", "r348", "r349", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r421", "r422", "r423", "r424", "r425", "r446", "r448", "r477", "r612" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r345", "r346", "r347", "r349", "r350", "r402", "r403", "r404", "r453", "r454", "r455", "r474", "r476" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r65", "r300", "r615" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Product development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r73", "r100", "r375", "r392", "r393", "r400", "r429", "r504" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r125", "r154", "r155", "r156", "r158", "r164", "r166", "r205", "r206", "r292", "r293", "r294", "r306", "r307", "r318", "r320", "r321", "r323", "r325", "r389", "r391", "r405", "r623" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r184", "r185", "r188", "r191", "r192", "r196", "r197", "r198", "r250", "r251", "r354" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue, net", "terseLabel": "Miscellaneous revenue", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r184", "r185", "r188", "r191", "r192", "r196", "r197", "r198", "r250", "r251", "r354" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r123", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r490" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Total remaining performance obligations", "verboseLabel": "Revenue remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.", "label": "Schedule of Remaining Performance Obligations Expected to be Recognized" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r198", "r538" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r16", "r77", "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Summary of Non-vested Non-qualified Stock Option Activity" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r13", "r14", "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Schedule of Share-based Compensation Costs" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r256", "r257", "r259", "r260", "r261", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r283", "r284", "r285", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Restricted Stock Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r13", "r14", "r50" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Warrants Outstanding" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r543" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r84" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r544", "r545", "r574" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation", "verboseLabel": "Share based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Vesting rights description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Number of Units, Forfeited/canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Weighted Average Grant-Date Fair Value, Forfeited/Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Number of Units, Granted", "verboseLabel": "Number of shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Weighted Average Grant-Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of Units Outstanding, ending", "periodStartLabel": "Number of Units Outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant-Date Fair Value Outstanding,ending", "periodStartLabel": "Weighted Average Grant-Date Fair Value Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Life of Outstanding Warrants in Months" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Number of shares vested in period", "negatedLabel": "Number of Units, Vested and settled with share issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Weighted Average Grant-Date Fair Value, Vested and settled with share issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Stock price volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r256", "r257", "r259", "r260", "r261", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r283", "r284", "r285", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Warrants, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Warrants, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r9", "r10" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Warrants Outstanding", "periodEndLabel": "Warrants Outstanding, Ending Balance", "periodStartLabel": "Warrants Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Number of shares grant in period", "verboseLabel": "Number of stock options issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Number of Options, Exercisable Ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Exercisable Ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Number of Options, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of Options, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Options, Granted", "terseLabel": "Number of share awards granted", "verboseLabel": "Number of Options Nonvested, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending", "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r263", "r264" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Number of option remain outstanding", "periodEndLabel": "Number of Options, Outstanding Ending", "periodStartLabel": "Number of Options, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r263", "r264" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending", "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Number of stock options issued", "verboseLabel": "Number of shares issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Number of options to purchase shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r259", "r260", "r261", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r283", "r284", "r285", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted Average Exercise Price, Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Exercise price", "terseLabel": "Exercise price per share", "verboseLabel": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r255", "r262", "r281", "r282", "r283", "r284", "r287", "r295", "r296", "r297", "r298" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Accounting for Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "periodEndLabel": "Aggregate Intrinsic Value Outstanding, ending", "periodStartLabel": "Aggregate Intrinsic Value Outstanding, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Exercisable Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term, Exercisable Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Number of Options Nonvested, Ending", "periodStartLabel": "Number of Options Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Number of Options Nonvested, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Beginning", "periodStartLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term, Beginning", "verboseLabel": "Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Shares, vested", "verboseLabel": "Number of options to purchase shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyDescription": { "auth_ref": [ "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.", "label": "Product warranty description" } } }, "localname": "StandardProductWarrantyDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Product Warranty" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r124", "r133", "r134", "r135", "r152", "r170", "r171", "r176", "r178", "r181", "r182", "r204", "r214", "r216", "r217", "r218", "r221", "r222", "r225", "r226", "r228", "r231", "r237", "r328", "r396", "r397", "r398", "r399", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r417", "r428", "r450", "r470", "r482", "r483", "r484", "r485", "r486", "r536", "r556", "r561" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r8", "r26", "r125", "r140", "r141", "r142", "r154", "r155", "r156", "r158", "r164", "r166", "r180", "r205", "r206", "r239", "r292", "r293", "r294", "r306", "r307", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r329", "r330", "r331", "r332", "r333", "r334", "r344", "r389", "r390", "r391", "r405", "r470" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r154", "r155", "r156", "r180", "r354", "r395", "r417", "r420", "r421", "r422", "r423", "r424", "r425", "r428", "r431", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r446", "r448", "r451", "r452", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r509" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r154", "r155", "r156", "r180", "r354", "r395", "r417", "r420", "r421", "r422", "r423", "r424", "r425", "r428", "r431", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r446", "r448", "r451", "r452", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r470", "r509" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r8", "r25", "r45", "r100", "r223" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Common shares issued and warrants on conversion of series B preferred stock, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock issued during period, shares, issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r8", "r70", "r71", "r100", "r396", "r470", "r483" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Number of shares issued", "verboseLabel": "Shares issued during the period" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.", "label": "Issuance of common shares to round up partial shares following reverse split, shares" } } }, "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r8", "r70", "r71", "r100", "r268" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Number of Options, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r8", "r70", "r71", "r100" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period, Shares, Stock Splits", "verboseLabel": "Reverse stock split" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r8", "r26", "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Common shares and warrants issued on conversion of series B preferred stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r71", "r74", "r75", "r95", "r430", "r447", "r471", "r472", "r504", "r515", "r557", "r563", "r607", "r623" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r99", "r151", "r224", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r239", "r324", "r473", "r475", "r487" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r36", "r37", "r38", "r113", "r114", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r506", "r507", "r510", "r511", "r512", "r513" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants maturity date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r169", "r178" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average number of common shares outstanding, diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r167", "r178" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding, basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r516": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r517": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r518": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r519": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r521": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r522": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r523": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r533": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r534": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r535": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org//250/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 65 0001493152-23-028379-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-028379-xbrl.zip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end

_B-I^&?^>Z%48H*' M^X*SAE2E"T.#/&GWME ZJ;M;7@OZC&EX*W%07G&)^TCA(/]IWX^D\!V!>\N/ M7J2C%^GH13IZD=R@\NA%.GJ1CEXDMVA4>2J4%9U=["I=%YJ8@&^*KV*Z=$7W M%-(\ROF:?82!*[6CTDIN#+F>]E,J84WKG")-93$5U=P@3D,A];ARQ3H6L2?W MGH;GEE,4V@)JJ1HWVH8CL;5K?V5TB?2N>JL4M%_<"%JN!([,(75'GUBYFZ6F MZNOFR>I>$-.)GR=V2VZ]#9ODF-.5O1.*@NHN4KC-O\5W1OTL"VJJ6I^5S><. MJO(#L]H7P,.),OC56F&K!+8P46=3>7[.:+RT&-.34?[,$$B.+C= M*U4^G^C.\'H=)@E%4H<>637PHY\N-*EQ &>K>@7P#N6G4S4[I61,HRKT.LV< M-6T\P)ES[CUP>Z$2QBQV?PY\@@]/I2M$V@L9]7MRBGK0-XK,6==# GS@ZBQ# M351:&[D7[MTD%Y_I:]^DA\K]CA4-:4"_RH MF__@?#W]T.EF5Z9,FY<+L9,D#IB[\L9;*\_&[7S-$>7@*?9^<)(5^2TEW,7Q M?]!U8KY;RY)@GP MMCL[+5[P8H6SQ(N#Q0OM]V8>HV*C1+6"_INJ!^N(=+(R; -Z[E+/.IU L13\ M(.Y+#UXZT/&+BW0,S\(P^[)S:F@U]F6[8FY8I:'V93NY:@+,(YM[Q**4$")Q:US27T@-DE$+T*Y^@>;4#5,'1"S-$AH] M8<^]]F6GW@9TGN=A^&FC8F<&24A:,U?T7SM31?_QQX(=@[!7)Q>G"0WQK Z5+S'%YH6$*5+,S;R" MNCY"5P>(6'AP!]7V0E+A0F,K=!RSPQRYPTI1;?K;#STY:UX'H##W9K=4;BU! M<3?HTE+%_;!VOD#PMT#7:QSGAY?J6Z"MHKKFSMJE$*E6M:Y_"D0%-VUEE+R* M@+UBNN!;.Y R 9\K(CCP-97( P*2DRQ=81+^N0L;EHZ#=B7@NVQ=PRK%0T6$ M"SAWMU6(N2%]JGK0]]P&HE /'G 6:YIVZY$YR:?6@+TJA&X1R;NM-1+%E:&/ M[898FJ4([IX1<0/$W1+0E^6\'3,3H '%8RDCL,3Y[ZR MBD2^R=A>=KXLU];/7A@Q_]PE)CD*%DRA\HN::OC3U-6P)R637B#GLCVHP7D0 M#-'?4$+I:2*ET-7!OZ:IIS]/04\M43%=NUA%G"VFQTI ]?1SU[L%9)=(E2^X2G6)WYIN)">8,YQFA6E?8L&+%O.NO M- Q(MP6X&$<+_!I@-NE-\2W!/D)!K*RJJQ*N>YNU M48(?\!Z+9,S[U-P>5Q[O!9VD$L^7I_8V:T679>>=N!VP R>\C ]B"0J+%47M MJ&R!R%H9%26IJ4NLZVY178S RQE[H3GI65VZA"E^?XG)/2+/%(2NBS]..W#7)T9< @KQ SLG_U'5,U^J#AZB/,99;>('3RYVT MMLM1Y#.%9!FDO2A"P>GFPO-7S;*&RP&SIL%#YVTN#;J@[-Y30;6LB2=TJ_*\ MR\6][7,]!?"FH M;[M \\&.^.;"X/8M%H68CJ,J^S$\2ZE_0E+ M3UPOTR/S?_\O0%M+HP<"A@(4W"AV]O64-KYV;ED<9%APP(D_!9R^9SAWY5 > M.!4KG>-+GHKCR]0C*?QURF&0L71/?:@.0-O#*2BWX8WU":M\CVNK8KSN$)OJ MZ._/<)R?,=%5/(M,_*!0_[$[ YT3RNY0@*'VD%8>5U3$,$Y"/[\V-XKMWO\D M=/:J*5AK/DV'89][(-1,PO*)X,3&*;;L8]#YNYQ57@DU[MO/;S5KD[5K77!J M:C6/T^@7#63I"49=#.6P<9-5;B_OP_0'.C_9\)H.#*@K-EMYR;<4M1JSLG0[ M'=J"3CAFSX)V!A9>)_H:_THDZ*GJ^'BNDOL1DB<(T(SNY M[6V#N!^#3BOF[#9(0HWY.O*78AT9HT<6].[VSETU4CG !E?XYZ YU%SU_YV M9-5FUK915\VE_ YMC&H] L\+=RA[HQ;+DU]!7+P^A:0(*;:_@N!^##S5G+-+ M" DW[NN=>L'>$@YL#V;8$_#T>.XN SJRZKXZ.QS2]8?^:;^]C'[.&E$N7(.< MHE[$CN_$#B2LRT2_#_ <:S@07=!Z9S9LSNS3',C*>"C;LT-<3H#':9F8WPD> M@MF$S06#"Z[+Y33$KE+97AIS/@6>(=-9S17R89;%V!\!S>$Y!MT>X M[N"$QO=8:(G1$BVT))F,03H#GN+4[DB X=:-5?0PLC?79N.H;^N;X'E:IZ"E M J8&-]$PN3^S]=HCF_GR!L=OGHNG$>E/_^1D@M#*"/J^E1&T^ !+"+K[Q*SQ MC6.F4)-VCYE"CYE"CYE"CYE"CYE"CYE"CYE"CYE"CYE"C=%W-%/H,3?:N+G1 MX%)8'G.C#6*GCKG1CKG1K/OL;G!<^D4:[SK:<]@)/WC0>=+L,708J4F&P&?/ MWY[?JV;ODUUZ(=$)YABI#]!VTGU%UR826O"\PY2A@C] MDG[Q\#*;68?LT-6S&*?VE+%J__ RE@T,D!N*!AY#=$Q/YFQHD%YZL@D^)#TH M+GW7KF-VY-M-<6:'4D?OY&]GF7;/><9UT(F-^\ECPK&N-$U0P^RFO=/Z\N$E M(AL-N@-QCOX&[5?2[L!A)RH;C\+I6 G)1@*NZQ[(M=QD0Z#4 M3&H%I!F4==@4M-L[X3> M(?8W/RW3T7R)PS31RD;SH96-IFR3I:/9M5HFH,G;/>:?.>:?Z?T)-^[I'O// M'///3.%R_A!(6>.29?<"[Y0K_$"@>4-&&,A C'1%G] M3)4R4=; R6*.B;+:'$\X4=9Y2)!/:S$C8)PQ2U'Y4%)G:6$$?B.B,!'T _)U MW%ZQ [>.?*%K=\L=W;X)I=Q)$@>ZZT$[7W-#<[A:/]A3C#+Y>QKFWCK$\RW> MW7\16NZRGJ(:]*K5YLC84PLM ,'->F3'_:-Z" M0\B\"P>=*6Q,%K_=O"'ZB$%D9ABT=\X;:X>'RV0RD<&%*"G!/'E\)'DD8?.E MD=I#?A:"E@;IU>$E/G,"UD,:,5;,3S./#,3\LM^#P\O#-CJ$![]3@$]H-7P7 MCUG=QE(#UZ[&=)WI+.4MZMV=PTO:!HOGP9OS9LPOA+7>[\'AY7\;'<*N2V_7 M;H2- ):3"QCC+AY>#COW,'9I*AAS+A1F'H/R,ABF))O0/1YH1%U2<2N#?IL> M!7+!P^G$X677@T#Q6U'?C&J'D^L6L_X=>+(]!Q ^+)^+M0QD W3H %/D04-Z M\-;29WS<3YY1-#7; MMC7+&]OFR9AMVSMFS#AFS##\A!O78(X9,XX9,Z9P$6\(I(X9,]SE]Y@QXY@Q MXY@QP[(7OM:+Q0OMP68>(W,N)%6A8V.-B%!",#H+C3U+1SJX;4"'R?7A10** M?8+X@_6$=;)>IL=HZO\%<)?B .;/'%'PLYYCV@S3M!D#)Q0:<@]W3)MQ3)MA MEC;#,%V&H;&&.S"UEB9CE*G[!L?_D7E1N S+KY9><.ELK*H$/L&.09H.$([, MO+ );.#BXK^U##;GB(3/^?'*[GSK+DR^RA=<\EINS**VUU]R#,"SF.VZ=X;C M_""!*:]J626OY0:Q.BHKY(HGEAV_G,#0=YDE#PZBY0&Q+(#N5 M@WSX:Y;?9!+R,M[LUB/I9D$7* E=1C)93S?UO\AW_B9M'/A:K0,BM6P_\"J@ M\@7PRKI!J;DB2S@;Z2V'DP[FDU\'W%4N5B*N<91)#FX3.\<\YK]-;C/BK]B? M+C')?]WCQ-+X2\=\W&:<3%?9JO?93X(@9%6\J!#U)$M7F(1_*M/!V/HH=%2@ M>SJH3]5TU;&0Z"I),JN)6_B?GH?-WL&9$'G"#X&YI=$"G/U&L7 M\*Q=Z1=_"OJTQCU%5=$";A&I/&L1_DEV!U*P/?87!GH88 ?A-KYF:>>0_$9S8 MN%LK^]@Q=ZXY-9U5-D7$=845>N5U7CZX>$7$#Q-T2T+9:FW43AQVGMQQJ9RP MXI^7W:UC=1UZ#V$4IINSC# F99&:.K4/-H^M"7B6C\B+$+N7F"K4*LPOZNU\ M?Q>OK'<\PU,_(M%JX0"SLQIC8)5/E7R:NPB92WZ;PG/0SQQRKE,+?$QZ>;\= M+H@\TVF0C]$VF5^.1[+ J1?5_\XR#MW@]#]1>H=\_!@S=.IWD<2SSDB?!X^W MMC9OCPN M]F&XG;0%YQ-BNC4]^$2=0H2F3WZ/0?-;+:MUM<*Q9_'X7X.+57?=I,G8F;[: M=D'\<)\[?#_!4Y"1671C^6E%X,D^%0Z86L$]M56^%3Z$I0;)S[V[]%!?9K-, MVE3@!:Y"9&N!&66Z[2T(C:3=/^PG[:[:G^'EK/:%6?6)68IGU4=FQ5=F^6>V M>;V[9?,67@FK^E9U0))_N[A,):XP,5MU@TMU;JO[".%O1E^'"EA7,3YP5(DY M(3T?!;A//9+V62!V](AW@* \Q&-A-D*=U''^#O-IL/!U,XT<#Q WU+%_'&?D M)(Z)W?,O]0X/][^,2G_FKR7Q')V:PXL4KV3O>N%&;3&#/TDXG;0='!3 M\APRO=[NZ]D9L#CTCD8.C"]+Y\K<@57KIN#U(($6=6X-++K<7 UZ(@9MC%S< M"^1;73O7!-7?!(L\=V7AOX<^4 !+OR6B6(/L+T]--6EXWZQK"W:Q1HU^NF R M[(2C@09U.9"BL[;C3AU2K!Q8,/-*^U )CDLEA%XVA?AXL"=VUM M+%,LITV";*77R5QH-@@7;CW"$GD*VC# PFTK)OP2NT-7X,*D05;9G'T*B:>X"F7[NW!AUJYXS3DT3'2+(%.G,=;# M'=3J\%WH.!:7_X?^-?4/T(<)(\,R M2#S911P<8_--/VVBE(=_HN&61AY$>+Z)@D&?>_25TP6E<2E"WZ4 ?7TM/)"S MC^YTN;$6''-!7,-*L48$ZY6N]D*?EC@!EB5##'S%?#OG[$25WB;_J^PV^?8& M>?U:^?'2N, @*=XV+%+0[%(@?J$DDUJF.)9F,SG=--80=VPD-!X\Y)@S?N@Z/_I_SXU'+,<9NUJ.D_Z0UOU#DU-. M'HCR5W"M?.RHEL/B64O>,#F5;,ND>JW7RL<<44E[0]NF>;3[L'"U*LD_)7U. MF%O2S8<[!QD;=7^%!"5+H42-+\YC VIJA=U\.M N.RVLQB!H\8+U":H5=O,M M-;L$M; :A2!:U& ,-8J[^9"499+:>(&[35TX[G'TM?2A-L].Y'*:=*;BR81K M'-C:3:7*8Q(ZR>AR\% -5Y]D'UHA ;,P3LR6*L_*ADFJ9ST_]+32[4W*.MM4 M$<[ 3DAO8KICVCAO:*D/+^\86NN-'S>^4$;!Z,_[A^,%BW,\B:VAZ"S;2O= MCD-[VX6M7+N^2DY.RUK22E#/:GMIKJ2JT\Z] J?W*.=;#]6X1N MO+7H2(PVV:_%*9#86T@[AU$*ID5=$IXET4JJ.L!L]2:BQ:M*8#O'-]N7;J6^ MS58IL,6E!E#MW9) 2/"-S?P)L054_'B-D^2,KJ8V2TS8JE0R_UO7Q;?9H\[^W1UO\#%M<>3-'U M*$H/KUT;W$VAQX09&. S"W]%LGO67D9?V89!$V I_4TG'F-8+(ZMQKS'QO,Y M2GP2YEXGR:"25P./!] >33KBN^) NT,1%2NX]4BZ61 O3CP_]PWJ>=-^VO>F ME\HG.&(=AL7^-9\Q,E)S,Y'?,&?Z\)HWTL8 M[EMNN"=T]4)X*6$X0.#=A@/(HN%P'/8K;JB1O<&X'X$R*'CPUPL6M.WYLM93 M^04!0?%O3 D$*( 'YK&Y#RW2+ %,#0^Q%J;-'MLQ M.]8"[:IGR^OXB!\ M#H/,B\3GT(*BWXJ=$2-0TRM XGX/TU6^CV42K,*G!5:8)9Y JD;@SZ>E"BOC M2B5:3Q/7B<2S58B6%Z_(SY@VSI?+T$=$: !I#6D%R./KCNI8(TP#"_ #B#+& M,KG$Y ROUV&2A-(L]J+RP$?:-CP\>QL;.5*6#B!N"?81"NA'U^?H"2>AZ*"; M5Q#Z(-LF*2*9QV+CWHN0*&-PNQCT,?:(3#2 <81@H3<( "Q,0 M"@ &5X,S$M,2YH=&WM6VU3(DD2_DX$_Z'6B-EP(D!DU+U=88E :'>X<]1# MW+C]6'170YW=74Q7-\C]^GNRJH'FQ1EF14-GG(D0N^LML_+)S">+LOZQ]^FB M42S4/SK--CX9_:OW.KT+IU&OV$^T5K+F^ME5^R]VT_OKPOE]SU=1/?94D*L2;O4;]_.JREY>Q[/-0!M/3K\UL^FKY/V$%V6O\ M'/7UJ%:OT(38C>L5/;:7.:]Q+ ?#Y%G5J)\UG/NA[,ND6#BJ'E3KE;/&#I3Z MB@;+6EL[OTCC6,&?06+8H>5T>YWS3JO9ZUQ=%@O7M]V;VR:F[UVQ[NV%PZI' MO%P]WN?O&8\\5CWQ[--.+?8\FMY>MIUNL=#[Z+ ;IW7;[?0ZS@US_M/ZV+S\ MPV'-5H]=G;/J;T?')=:\8."56#(4K#64PF?.O7#31(X%N_)]Z8J8*9^UG";K1!X$BB46 M[$3N 1 4DW@8RI/3)]^%[*6,/$$3?C@^.#&F>#6AY;GTJ!X4"QTVY#!@+,92 M3(0'$TG-/J<\ALL'4[P?J3AA*F+G*@XQKOSOAXSLJ]A@8S%XA'65QP04\-@_ MTTBPH\,2^W#XX>@[V+SO!00? ((SKF$A&#FXL]D*-TATRG] M6(R?B%ADDY &H=2!X)Z,!FPBDR$TU"/A&@DQ;[&0P=958XSS6'^:WXCOP.+? M"W*/OH161ONXDF:N40X2P-T 'X5,&;6TT8@E^LA\P,UT3-P MQV(@$5PY5N+TT@H.,:UN%J)Z)LU"7)+C#:8O2H]CP+2W9-*?8_TY536= 3%C M1Q2/5,:CR-@=QF-A@A-@(ON!,!E6 ,S]0.HA=:=N(8(Q!61Z]J1V Z53C*,P M':O XFL4*U=X> U\[ -/G@! +6B<>W?(HX%@343 ;AI -5-DG.R+7)%!3_91 M4BT066#3 HRB9 [O%GXDS!<6*A:65O*75O*QTHQ+Y-T /8BJ[)0_FO\P^3%L M_B.A_/C7@]]VK C*T&+!$QJKPN F!7\=CB6B!RY/]?9#*$WW!9NO9!._2F-, M@+ XEIJ"K>$2(C(34=6QX!SY8!^+@!NLVM2?@ULI2P34*!&S(8Q6@?1X8B3M M:^E)3MP7'2U!,>DGHIE239S!^#;\C2B&"Q7";/P?!;7U!'A'V,%]Y.Q] CP7*.LI^3"-9R%N#1Y 8^]&2#A(Y+W92"3*9&33>N2@QKL&EA: MUUKJNB!@Q8))8O>92J,T'L$OM*%3KJMBSTA@:/E 1"!) =P#+6)$CD==4'-8 M%X"#RA&RR)L3O% G<.$$8LR#U 1- HCP?5!D.89E]0:J.^=%6V0!^[C"?N?' M%8 \!B* $^(!.MY7:?*P"-LD*C[O+:B$\//1>G.IR/JSXL3X<;85$*@&@2+O M#;8O$[8>Q6X+B'5DT:E'QF--RT;X?D/$)FJB7#>-"3XY&K ^:[$0*IV@@8[C M,9EV,5-VUL;V'Y#$AR<@E*[TSB1'U2G,B0T=YD3I7+#W5JPAUW/61$'8.([P M0*T0PO4DUMF-G^9$<9/=ZG/SM1$J"YU> ,COQ,-1IC/@\HF*]9RLF!>8,PQED@CQA6S45Z!# MU.Y)"&@FV8<+(/9K.L#!)U446!]%!Z6'SZF$ L9+T\@UISSOWZK6%QKMJ6JE M@SSBS!)HI:,&.K5PI0"\,J(Q+QXG@M\1<;",U5 'P[;-*??L3&\+T.92@"WS M4,T1D#=$5.YAI!;S@/H@P#..CB% *9ATR=(7#>UU&F*CH;;1)DME&\\_WZC) M2P8KE97$0/P8T:L$Z @3<0$^\[U&AM*2S=\R&JM@+"B)1WR0?3\39T%:A*- M305:)T-E(S-?\@%@]@L4IUC8&N 'K^I;[V?"RBY%;E-Y52PTTP'F9M5C^PWK M3K?]Z7>XUSR[<%C+N;BXN6ZV.I=__+YWN&>>KYOM]NSYFS682"\94M?#=S7D M\=@3<=E50ZW+S FL@-N/;-OHD9[V36Y>J_]MP4^>K?+ M+3^;+NA'K_T8\;(MG%WBZ@?3PYU:9<41(")^=%\*%)]6T\>(]?JN(M;/&AE K=Y+*%VY%F;V MY0GN[F'R1^_\#P/]F7R;]NLQMY-W?5N4;N%9 =>NXBT!ZW%VS^W&PDP5D[$; M.R5'YNKSTW.-G\IE=BY%X)VR:Q#C&H9_3E'MT; :NQJ9BOV477#0J7)YMG/M MSI\SF5;BQR]4V*QDQK/5S BU%APGSVE6.4^VQH-D9874K.-BX4 ;W&)YPP/A MFQ%S4.2F7K?[S.;U"O9BMBVYS:S0;M*.O6R^_ HIOA5YL^ 5^I,+^S<8]*<: M_P=02P,$% @ %H .5]8HY_HL" >C H !E>#,Q+3(N:'1M[5MM M<^(V$/[.#/]!SMU6 M^HZGK>QQ]_AB\#>[&O]]9OVRY:H@/F+MW3!F8^D+S<[%@HV4SX-&>J/!KD0D MW2UT1-?+O%\LWL=-[LEI<,1L$<0BZK"'RNHPGT=3&31C%1ZQW>)RHN)8^;BS MU>N>7IR/RSHV7>Y+;WGT,-(?#R_.Z[7+Z]'5=1_BQQ=L='UFL?8^;[8/MOEKQ@.'M0^=]*I2CWT> M2Z_/!]:H7AN_M=B5=7(]&HZ'UA6S_CIYVS]_8['^R9A=G++VS_L'#=:_8OW? M+708/*VA_R0ZENZR8DMS('YAF@\;]=J0!^RW'7;)8^$U6#P3[#*2@2U#[K%3 M&7!\Q">"8M^V51+$,IBR"]>5MHB8 9HB4A72>'ST MY#.2W92!(TC@WL'.85AI\GSJ-/.Y[&COP-ULQN>"16(NQ4(X<)'4[%W"(X2_ MM\3]4$4Q4P$[59&/?LT_[G.RJR(#EU7G$.,JAPD8X+!?DT"P_=T&V]O=V_\* M)N]K <$>0'#,-3P$)_M+=A.HA2>!6,==3"YV#.Q)3B>3*,1*GFZGB4#.U+86H MSK59J4MZO,#T6=EQ )B.;[GT^TB_2U1'9T#,V!'E(Y7Q*'+VD/%(F.0$F,B) M)TR%%0#SQ)-Z1LVIF8]D3 F9KAVI;4_I!/TH34?*2_$51LH6#FX#']O DR, MT!0TUGM[QH.I )N+V2CQ8)I908#0PMGXH ),E#>.")""GP^&K'(4PW)5!%7H+@F0:!C2 0<^XE M)FD20(3K@B++.3RK-U#=@A<]H JDEVOLM]BN .31$0F<$ _0\8E*XOM5>$BA MXD5K04L(MYRM-R\5V21?G)@XSJ8""G6@4."\P/9YPM:AW)T"XBZR:-%X#=$'%+&:JB#8=MFESO?TWL :$LE(%WF835'0-Z04;F#GEH4"?5>@&<< M'5V 4C#I1DI?-*S7B8^)AMG&FJR4;=S_?*$FSQFLM*PD!N)&R%X-0$>8C OP MF>\U,I0VTOHM@[GRYH**>,"GV?ZR=3R&;M@_0;UDJG_>EG>-P_/K/8B75V=G79 M/QF>O_EE:W?+7%_V!X/\^I,M6$@GGE'3W5<=U/'($5'35I['0PV%\D];YCA; M=SSZ] 'F1'; K7/_QBK#_ZWP_JLJI_QXN:(?X\%CU,NF,#_0-?&X M?WXES']":R \$=/[C>#[ER_3?/UF//&59\* MG4GAI@JN3MUEQ^QN >MQ?B_-QLI-+5.->\_^!//]IRR_:S8Q;<)SCA"*4]&! ME'<)%G34N\,N0K,H/V)G'(RIV3R#[1V62M^Q^O%#SJM:$R9 MMJS3FFR,>_G(&F^Y:_HJCC9$Q^UY]X1K>A38*(F^Z_[<]=T6YB*?EM)DMF@V M:<:>A!+GWFO1;P?2'Q/0;P[^ U!+ P04 " 6@ Y7O<'*'@D% "H&P M"@ &5X,S(M,2YH=&WM66UOVD@0_H[$?YA#:M1*$-Z2J@47R0&G\1T%"L[I M\G&QUWBO]JYCKYMPO_YFUY@ 3=6F(G#S/VKAP/@U[Y9)Q M89D#_ ;U8SBV,[1Z1CW_QM'Z:M@X&P^N8.9<#:T/%5]PV8%F(Y;@L(BF,*(W M,!41X=7\1!5F-&%^!2?BU$DQ3]);62,A6_ .N)1+FG3A9WUU(2+)@O&:%'$' M&NO#N9!21'BFTC/.QR-G$V/-)Q$+EYT?>=:V*?N'YD JO2,^3^.N45<.,1N3 MG3@>BEGCW0P^88M [A.P<=:S;@,V9[)<:K>.FT;]K/=X\/.UVS/^(N=/#GC? MFCKVN=TW'7L\*I-N&\3GH6PR: M[ZIP.;(=:X!P3,>:07\\L*I@SL :A\7%LS,Z9DYLF:U\5]# MZPK,OH,CY5*KT6@];C+_SE+)_.7J).,>50X;QZ>,/Z5[\3\*P^;EDBLXIZYD M@L,-DP'(@,+GC"3(R7 )4QJ+1 (.GHLDPFFUS^@FT5;7N150A.?![QFGT$9& MM1JM-KQ6!D>A=YV);N[C*-$';T#XT+=,L+F'028, =O"D]"K*L-RJ1\PZJ,K="W95PICWVWU,-9%[CEY:374_"Y'WKHCB4!%K3;:$7F MOO;>%#S9H.::EJ:K>=%\WS[1;":1OG.ZBKS/*Z7/D2:M%4T8Q_H7$;WV6#LE M81QK$N.K\I!SB#!5/..$IHHN535,PA##P7K)2(AD2F/D3ZJ+#I8U3KBKSJ-# MCVG7JJ"A51;F;!,Q3?0UTW+IFU)T_.AUY?')X9AGV'GTK>%P-C'[]NCCATJC MHH\GYF!0'#\XK!OFR4"9-EYU82X2CR8U5X0AB5,$5/Q7T5K#<*8/O\!75?U= M$A8)0R5062D7PQG\,N#3QJM'S+DSV ?$PT6X6NA"ALU#XGZ!IJH(D(J0>>L8 M3O8;A&'WZFD]!WY/BV'4[=YFA/@Q/13F'>A:[A/6"!^XG8-#=5\K^D*2%UC; ML+XC2UZ(\K_!&F O=X#5)%M@QP;-DUR'W\^/NFZV>D^S43QHR$[ L$'/=P3P M;LH[>5>)2<*5%I0X_H/=E3A+T@R;>K6=4&A,M;-6"$N2S FG:6U\&])EH2G5 MQIJ6#&F@= 87LER:4_ HZE5OM6TR7VH'?0UFJ7=Q\%JQ2.FVGGWW"QIV:[]G MT[C8OD'Q-,O< +93<\-RL'"'%:.>*Y'E"H2&DB<'GE"?)I2[:@0M-'X6,KZ M#"^?[,*]0]G>1%E%F5XN*=M-B%6@MRZ-9;%_@PRA*OT!D5L)4XI-0U?[ QL M4V!R"^-SD&._U6IPSFCH=6!"%K2+TZ\S%1Q.Z\(XUE*T T."Q:96*VK?P/ZS MP+3S)N2MDNT[;?G9;EN.8=W)P$W9MRL+5]?XKI[;T7W?]NEW3\A[GGO;*0^I MKV>LR_J&Z[OL%?6UJ*U&'7-1I&4CF765396QPR;%+AWJZDU;_NI-O:'[%U!+ M P04 " 6@ Y7YPK7W0$% #_$0 "@ &5X,S(M,BYH=&WE6&UOXD80 M_H[$?Y@BW>DJF?H/]-UW*D],MOY)ZZVBV7S>C[Y M""OWX]1^VPAB+@?0[2027!;1%&;T'I9Q1+B1WS!@104+&K@1MR[*?9(^R"8) MV88/P*-<4C&$B(@-XTT9)P/H["_7L91QA'<:HY=\G29#L[TX4O:M($J=6GT5 M@6";K6R,S.N1_;!E:R:AWVOUS/;UZ-\;^ZP_AQ#R(&@,I9NGL/XE.V-[Z3HW MSMARG?D,%A^6JP_6S 5W#BM[K.]U^Y<= \:WUL*UE_7:51_F-Z + KJO#?@P M#ZQ#;!68$WF"W7_.8UO.E=:QZT-*VMY;I+%'.Z9W(+< M4GB?$8%9"G?UVI(FL9" JS>QB!!(\ST$L=!B=[D84%3JPR\9I]#'?/4ZO3Z\ M4@(O0_\NBX>YCI="7_P,<0!CVP*'^PA-,/3)X5[K:,>&X1KA^UU&O492"%B( MEO8X5]3+!)-*!>$^V _>EO -A7$<12Q-E4_X4I(^D12V5- X,,#!%^'P:PL6 M>#LTM,1",.ZQA(1PPSC!K_A-*;4\+\ZX9'P#\R!@'A7U&GJ@MCRB-+3N]0[+ M6ZAHH\I8BZQI*I7#T0X^\?@>T6^HLD?DX"2YUO^]B];%92*_)>\HBI(G+;G$8DB2E./2*;PW-;DQW61KX2[4+CX1ELG!6-PH&9+J3 M4JI0?MEY\>B.._F\W%?$"G@E$5B'Q/L$754/D,8A\_?>7"A-YLT<1V@E(,V M1"S<#;X6$BV;LK]I'D'4Y(S::?N@]9IM!R>MLC#26/%M^7TQ>M;3$X*>8;<8 M5"&>P\CA-#I'0,X]'Q$VKHK MC<[!^\[/+!LC=\O2@OE@-O-&[ZE)3K@:Q%(M[REE,4V01%4I99*)-,.NKWA3 M.>$55R_'.A%KPFG:G#^$=%=.=,75]4A)MVH.\5@BWP*?(EGP"ZJ(E$SM'VLP M.\U16@ ??!H(DN>BFFE M*OI(3*L!J]?41-?8D9Y5$:: OU*K&$\SK[^MAG]J-K'9T- ?8,_R0/5;)P3"8. MQ^Q3%G#$%I[.R2\VR,,(A330.XXY@%)]P )TLRD;C=G&6)1AJ02SK:*I(G:. M'.ZSUU8/>D&5K MIO'OB7@JG'#(4$Q5,SK_GKA..U4X^7]G;]]\ZCKX/GRO8?][TG6<_H?W[Y^? MGT^?TZ>FU7DO%HO%]R_DGA/OI@\O,^^3!$%\_^OZJJYT44].:8;MR(:"AE_2 M->-A_O/)I\-;6Y:NC=U*K@0O2;^?>C3^5!U](7QS[KWWX=BMSLQ;L]ZM3G"K M9IL92^=RS9L-NFU9,=/(;D M2=F4(*6D7.@A*1LI8P_"OY]VS*>ESRFDTF+PG*G!&>\I^;@EVT.)JVA"W,$[ M\0?X&U(ZN-%"[;F/S;W'GP8WNHXU]\;B>_SI\$8[U9'E_O#FMFRWZ(W^!V.O MQ])_ M./8JVW*F&X4OCMU4KI0NAG_KWI&P:#C*<5 /WYX13O-_^/7'0B_/> MX_I[\KWW_F,__4\JQ5UJ2%<_<'7D?.1NY![ZP+VH+Q^YZ@7]H2E(Y>9]_;_2 MQ>=2Z1;_0YK'I5*K?CLM-DE_FU/]; ;]7.-AF;+W+5$0-_EZ5F@B#&7<"?Q? MQOF&!DT!J[M,06PP]M]1#AHK_.I>ZW&FV9=U& MZSQ*##VJ[%H6>9!F*[+^&\E6Q5 O9 +" M5-S>\!VWR-),]1)?LYO?I36>F3O'&+EHBDU?>7H/QY?6>8;4K'=E"]E-J4EM MA?<0FUY;YSD7I"VW_K/24TW:[N'%YJUKH68F_)0^OK)> ^N/+G[QI6DZ3:&) MU:#?FL>VL\YSLDT-$[R#+/P0_Z?UQJR..F3P\=?]G_ROMTQUP-G.0$?_GK2Q M$OG B4+?X1I:#POK!CUS=V9/-GCO H]?86EMJJY4[2GXGJK9?5T>?. ,TT#T M0^WE ]$[R"(*C?ZFJ2HRJ'HCO^(;;S 8+4WQ-->+RPOFJ<*3LY2*5'" M)C^6M\[5#B=GWZ4(WZBI_YY@3$H:(17V3 HS1M83P!WJFY:#7=VZ(SND';^1 M'6-#BM,-J>(G6;+B:$\(#X#LMVM90R[I5TS#?YSOU7RX0&V$OZ^6S5X?&3;U MXZXTN:7IHRZ?C+6^9-?:\ULL"MC+< W-NQ!A8_#CBP'9\K:9)F;TW3?*X,MVT;.1-N[7\H:T[IO+P M0]9=M):TR*4]-6F>E,BEB)OTV3359TW7\>AA7LE&1VOIJ&3;R*GV^K)F]:;P M/V)O!K-WO@ E,?HQW::URW0-C3@C;F_-Z2+KQC3,/M98A!I5 SO>J/)"= V: MV5)I*%=I3CO3N!RR68W;L$EX(Q&ST8 MUY2AN$2&A<@:2,)3;$F,)X0="TSH<37I?X#4AEE'BFMISI1Q61F9N>B0&56C MEZ,U%QU:(Y3T4@3GHD,P;?8%0CVD7FA/&@Y9U/&6UXP+\]FX,UU#W1 9^>BL M_=:M70Z)?'2.0!2R78J%O!1M>TOJ7]?VW,Z&65)5C=R XR-9PWY!6>YKCJQ? M8G^ NEBU]@]D.T%O^N16^[,E&Q3HE5Y?-P=H58W2])5IDSB^ID$?>8UZ+61- M]CDM1CQ&^^_S'7)DS4!J1;8,[,O8\SH>?01T@QT\:KVN3#N&D8K>'=BFP7/& M=E[C(U:S.X29N.F I2,VX_OO\XK42D<\V+0/5=MVL?+']M[H>#-,M)_^,-#Y M6>^6JE%'CJ,C(JA:^PZ1I00ED,0];I9_7\.\T"RD.*85DQ@R$9N3O8IAD>%, M9Z+3I9L@/8XQ7D[OS'Y5VCZ!7=R/)=IXJ++1,3&*!J]G.K/[)=?&9F0J/EAC MP**.'/;?YQ6IE6=5DVXUVA%/'22@TZL.=\334PM=!-GNZLBV*R_(4C0;=YQ$ MT#A>1NI/V2+XCJF3A8@QO9-.3OS^@5HG,Q=FT MQ T'+",P&B//[_-J"B(C)':PEZK_C0=;3.QCTZ!ZCXJV&_B"F M1[8'PGY9OY^QCS"Y)2F=7G&XI8B=_$6HOT-DWP.BM]3[NC;?Z=M\("-&;ZS= M6:[:"=.RX(-.=$]ODKXC!>(=Z.%3T8C5:20/; M]%I+USK4A;7OD"Y[*V78+3<0LBCL] %1:8$0%NZ"#/K6>#8;7=PMV5 QWAO/ M6-T,&ET+H3G]C'J==)_]O#1=:TXWBQ%/I<3=S>D.1&_72[IN*J29=)+R'!NI ML>W!BW;O+4I#M['72MS:.^VJJS@76-/J)O5):'PQKU/1CQ@QRH9C6H.?IO50-6A(-#FCLI@1 MA73TON1L"9=(.-:AZYWG@]$M?N!9>I8MU5\"K[D.*2VETAVP#B:]K2E+MS\' M8S+,D?!VF-NN[I HT!N3X";LTWQW95UK:^.+[^-WC2O'.K&G#D*&-W5"9B*H MRIQ6H#4#C>Z9"081-WM7"PO>VDFXE\&DYD(W;!KMC$AV;-G,Z_PN,&TO 74@ M=!O3E([+3Z1UNE@?E;""E#LH^/S6TI2Y:HCM@9F _.WN!F?IV/0URW,Y@M$Y MR!'())4:4^(_.G),;E)*#CG6L\9L2C_")>(QL;>6B[VUV%[(+1V-BUT\)+E' MG7>_I="Q1+R,S$ /#7.V9DM]$]\S3GE&7?PA GD^47D&O[NDV;5V6/&OZX9& M*+^5QFU*R&,)_5NKZ5CD[ MVPHK2U&)2A6Z(:L8D/SG]M+V1C%;ZTP)F$^'% MJ-.)=JR6-S&&<:KE8@Q9A/N<8QFF*"?,GQ CW-00E: _>_FJ/G _6ZMO4TZ\ ML'.)C";'!1Y=()G<<2C$%CK&/*.86)%*29THB6T.,;E#D=B)D4O3:B/-<2VT MX:QA223\9PC\& B02RH!MIXV3Z[,(PWQV9@H3^Q@3.Z#2PX!MIH:3ZZ\ M8XI6]S89GEA)1YC$O[6DO<96#1N_VMO%0')K&UW9\,52ZG0LU)&=B1$(<6"5 MJ8.EXIPS;S4<0WG6',YH)]GTONJ[^OT<\>>2LOJPJ>S]6A$1SR[N< 0B3!;? M&P&\F4EVQZ 0T]KG)G9UZ1CX( 'E";,,= M;<'^-%?6&\CJS>WK\L,G$SNWL%C@49]#-0NS*ZT[+VXF:^ID^RY'N[B]F4*) MH!=[5RGDA/AH5J5"(8]N@+ ,3"U^%"W>8]S3.GF2+H=#$)NFEISN[" M/DR>N[M[S92.03/-2B@_(+VT/70C/&8LZ1'[5-\W*R!*+G8U547T=R(**RB. M9GMWZ)KQ\,%6NAAG^-'<"_V]:Y&W*$A64Z1)0BXMG+[8F*_>Q\Z@CT5H:[V^ MCN/G]Z-7C3_<>YUMNE;P-GP;Z8WVP>\X[>0" /A?&GX-T?/FAU>'UTE%'(>L M,EL<[0IN7==Q^A_>OW]^?CZUD7+:,9_>EZO?3LX$01 S!2F;$3^]G_SRZ'7O M9[[/?UN?+HM,MP*/JT5GQLY&W0F>-/ILZFO(4$-?(OT>O5X=^TIP?:P!P45? MI*O*>7IR*%3;33@5B)QN96^"SY_!V==HC 2,.H1JH0_\CU3^KBF:X[65 M4S5\)ZG]%$ZUQ;*D%20\<^453GK1[).S_ :PU*6-I&RM!LIBX-$DYG5_C_E!GZ=@LQ9QQ7WQ4 MP'%@8*$,C@P/<\X9.0X@S.[\<2" ,2N[8R$%.S3 7";'7,8:6,T9=S"7R367 M^\ #F,LDF1-F>5D'%)CNO9MN9B D@C%+M#%+6/;P4N" ,4NX,6,-4&#,$F?,D@FAZ:/+ MP9@ER9@E.9]Y#G# F"79F#$(*#!FR3)F28:0",8LT<8L8=M&E@('C%G"C1EK M@ )CECACEC (391(!1.6G!237>P,A[G!A%N@/>,!#,C>#>WM!RDY1\'<6"LF2[Y M-KQE?N]A;72]21P 4A*!E+RIG%4/WB6'WCARN\TVA&S+^=#0'!W5VE5#U9XT MU97U4-G)V;T%W;.:[@'() ,R2=8RF9E:YEJS%:3KLH%,E_$@@>#EUC)55W%J M%K9#3YJ"0G"9T=-]JQ=6Z%O*KD0>WG9OF W8- M91W9-4M%EDV01^\KTQN0Q3B\AC-2Y-0%(O40MI;(:#G.UFE 8]#'YC-T-$2H M(2N/PH%/H4]@N&8,^\\V")?Y3U,=/=1Q7K[1U!=#V3041(ZL(;/(=YKM!ZZC MT)YPY8Z<0.JB&^2,*[7@(5BL;.-FM*0R(8WS 5$G$^LNBT47K3:;T:)S9"C= MGFQ-3D/,&JEH&D-H=2W_-:VAE@R?QS$)@GV[#8EU,7=!16QJ@8K'3L4A"("* M:^Y8!:L(5(R4BHFQB@D+IG=+1;"*0,7D6,7CIN)HW@?(>,1D7&?Z[QCIN& G M.CBI0,9(R9@,)S7)^VAW045P4H&*"7%2DTS%>5O:P2H"%2.E8F*L8F+SJ[:, M%TN*8KJ&@\=80=J3W-(1L#&Q;)PW6$='R,1&C+LC)'BJ0,CD.*M 2)A4!4K" MO.KZ$>3$H47@M@(E#]9MW3".'#L,A7%"@ML*A$R.VYI80L[=.$MB5CSA@!'"<01@SX1 MX"B!.&+0,P(<)1!'#/E'PQR[KM;O>]+\(ANJCG\\5 -D]7F=7G?.H@5GPBP MDS#L,.0' 782AAV&?!_ 3L*PDUA_9VX<#T4"P4:M&F,!5D"O;%50DE6TQ%H? M,EK8[+<8XRQA7)HNXY49UQW^48\/=?27UX4S;:?6/H"UR6#LJX9B]M#P1(4K M4Z'I8I.G6DWT>M^!#&L3* ";_<,FL7[I@BTI )N]PX;!:1. S?YAD[S(9ED& M34E]0I:CV=[DT[5L/2 '_UQYZ>/A. HD4<=W)3'L6R.QXO\ M-B"%D,^$D"+ M+6@QY$D&[2''#BO1X-I!9V?]]:BC'?"J"44"BQYTL! ME!(*)?9\)X!20J'$D*\T.LE<)VE0GY&!+%G'/FA)[6F&9M/*!D_HB/SQT>GF M:TADWYJ+%7\*X,8^W!CRN0!N[,.-(;\,X,8^W)+GN_G9D8'Q3\KXCRD+?W36 M4Q83L(E36>P-#DQP:ZH (V/B2GA5O8DL[\ YNG0M0W-<"V$OX%)[(3\=B"=T M:YE84L[@5I=IO:%A[:%952KGBV&/%FT76?^3Q4X!#\G%PX1^B'472("''ZBK M*0>35;D6!L:[?F1Z ,9]_^,>*]^7SM+-E9DG@,--O5X++$NDM!P]D4_N)"LI M/+'SA9L#WP_YJ\83OF9: T#]'E%/YR(FA@( OW2"'/^4'LY=F<9W5]8)JM2Z M8RH/M3Z1KST.]]#N6&]K;,U 9-B=0976W->>$$'#89"!;@\>P=Z;\%HHIF@A M3R1Y(_?F[$Y>+G\FY^P))O?#@*/"-F KCGDU^@XQ/W0B[I#M6)KB^+KBWM < M^ZY^#SIUTI58**CCUJICH2"%5\Q3 !M ^*MLN+(UJ)/SD1V$+&-*HL-C;@#U M>T']K%(G:XP:4##I%%Q+@&OP]L"*/1VXZ=F!2DA$*:Q8:1@.%$0I:80\E',# M@8X[MM!Q!V2BM$% -N)P7(D.-,2'@.R8:1CGFFQX3B'&M3DI!&8?IA>:A13' MM%:>H@V9FY7XP"JT22W8AN;HJ-:N&JKVI*FNK(?0-2&X/:(Y5EL2.:EC7R]9 MTX"D=S5;/.8$8G0-J7>P/"$?C7<2_(M-X7&TRG83$!VTEF,(Q@>-60!0_ * M:DFYJN:4S5Y/K\3N+$?JH)I**7$S/"G+&-DF51$I#-K*R+2[[C5_;B40UM3>CW3H*$MQO)&G!^RJ3F@7-4H!GK,P!F3GH6P&2? M,!G/ PJ/]V[L]^R1#Z8L[@T56<^6YB#K0+9"QH.)*.9+IF4-*FMME07 /4;@ M[EZ)YE+XW^ GUNOZD,ZLS7/2[[AYSJ!LQZ$8%M*.BAW,/.PV2+HT)E-U6->* MBS.4%O4<)IKCP-.\M79 6Q26>+VU?L#Y\EGL-=&]N+X @#Q*D%_@\7VBU7NK MV'):+NG2G68_+"]@L'93K%V<=/:46XF, MI608Q@3XYC)^H:N37A](:);L^J;;#F&T;;U#.G8PU%OLG P:EFS8LD+E MX@'I5YF#C =I7YV[W- M+K/*II65^V9SGC!WG8#4L?V<-@QT!;H"70_+% .W@=O [:1F7,WVE^?,W@,M M(Z)EK)/\0,1#](F!DD!)H"2[?B_P%_@+_$V ;[M2 J$2U)H>;#PWZM'"7GR M;*$P :0%/P[,1S*0R!)Q#\E[6K/:VVIY/H>=\9N4XG"[RLG:(K!*9"XP,_X: M4 ^H=UC48])#!)X"3X^,I_NM:N.?VV#?R48''081ZEW90N>RC51R6 7^5"9S MR_2J77*=KFEIKTBEIT>$YIX)'>SS0>4%68IFHUN,#T2%$H+P#&$=*EJ6.52 M&[9PPZ0W,":WF@$X6P=G0WF!B@+TL(,>]A45]KH!:FM ;2@O4%2 'G;0>3T580F)G0GI''@.DA*B4)*E(8_I0-0^+/&FM$I=3"=2,_&UP6N M3 /5,:3/-=-6-&0HJ&HH_BVD=%RYJZ$V)JWBDA+1M78;T]9B&V&!'B.SW;5V MB:B<#I5,"#YSY1;-K+N*M ]7J"/K%2JRT(L7C$?LBP_DHP7CO5+3RC1-!8#LL6S%K*7E:I=Z"X3X#6B95Z&Y4H&LMAB8EZ^!UB,?A)$@Z6 M-RR#AX[1!N"1=EC?*AW2V^ R@''P^)H45!'J+7[-D MR/KXQ\U!\>CBCEV:IC/W+:YC?; ?V\[&[] PZCLS='OP(*JD_)LV[XBG'Q:_ MQ+]IQ9=\>J^]?,"C;KJ6@FQRB5[I(EFE*NK3>SR:^%_ROT]]SG8&.C9#;4SR M#YR8ZSM<6=:UEJ5Q5UJGZWSD%%,WK0__(6>I@\^< VLD&WN!CUS=V9/ M-GCO L_5L2IJ?^3HO;;VBG#CA#X6U/_]1\P)'S^])P\\^_2^3WORZ7]2*>Y2 M0[KZ@;MS=92ZE3N(2Z7./N&^!J\=:WC?F6XZN?:LJ4Z7O$OX[\G8MUNFA>7G M??M_>)H-OK&Q0*;Z3\;2__^0#-Z/"6'F M2.-V+I.])Q\JF-'?_8PO ZTOD-9_:IW=WU0;E8NW;^J-4J-2__2^=<9P9^J5 M\OU=M5&MU-^^*=U<<)5?Y2^EF\\5KER[OJ[6Z]7:#:,]E/P>_I3M+G9N'=/@ MW[ZY."V?-6TP?2:SDB_K2+ IB$^%H(96Z,!67V$,2 MM305XMP*(OZP27_*I87F:^;JU^O/;*/5L+#"_(2-GV$:U*W2%,[W9N]0>S)F M=,S1M/X)9\@D.B/A2?A])V>BD/I.#>KHF2.@ &96:?U?''!K[4&4S<>@F83+ M^01;N*K>UNP9W>W]7OR_=-+A& MCFN=H=)V;?J?]PM4NN\:7"C?3X2(67R@WRL5A,9P"Y^VJ]I^W> MOB&#-!KQ;&K17O)!^-JS+=P^_I:YD=/+92&"M MXC?U\/>ZJCP8(!R*&;/0/=:PD[.O]S<5+BWP4QW*3'3H4K,56?^-GWN)K]BS MN_2KT[CX_//V5T;;O$O339YX]0F=.YFK[L$*)*KUQ AH9[4[/# P"HFRQ<5) MUXV&H6&GH'U7>9$5 MY^T;(G7.;'/64-J<;'-V'RFT[B.G86 X-J=T:1#X#X,H7\!11VYA[:D@7K,)T?=N,&9XG]WX?[.F3+S6%\U%-/"CHV7V.W@H*QLNH9C#KGK"AT+!=Y2 ^%']G!];U[UY B,W-S M&H"C^GPJ712QU LKP@C_GY44G8+%PXII>$?9&TY36/['M#C3Z2(+AZ:69JN: M0@8.F]$Q T-%QXH4M+ ^\]I..FEU9$-[I1?#MG];!<",KF()Q]73N]/ZZ7I M]NO]6.P"=UQY>HV_,4^GT#K2CN^IVW<&WNO!>:\,L76I8U)250O9MO_/E68@ M<;93\OO9+53$SH^+AW1D3LF,EY^K(4M!7.D)&2Z:X\I, MK[>DEPA#FBV,[M_OY^8W\^O/SN9KH\N%@;V_NJLYB"NO.@'!E$I=&J3YHBCC M'VM6PWPV9@_&Z\7WR\;+72UWWHUZ,$:O/CF[,EW-?M)T?2ZZ?/FOTB?J#-:L M6QSZ89=H3L39OWSZW;-?[Q[,2)8J5XLX9S>0S ;KV&U3S3F=7S(I[#_UUL3O MU_]H_?EAMEO\^NN_[G.Z]566\U54C*#= MD^\\.2L6TZFLE!>3LV@7'8E'BY7_]Y^").8_8F7J(!WUB0 X@TJ Y[!6U5T2 MF7,R'M$)PC/69<83@.K8KEF:HR$\4-[:)[*0RO5=RW;)(JACXJ]ZT[JB]*[U M#S&+3A=QE1>E2W:@F6WV' M;AB2E2ZGZ+)M'^B*80SC).YFG'# C4GB=:@^Z+5,_1UQC6&45IRK%78Q2B1O M:)Q,*-#>6*T_=S5\9:3[HXP MPKVYD7W,LNW[)O>;K MC_.G6_>KWAB(ZTQI3]>E6_:FL+\ZV4\OS3)84:+/X+G_]1_#]66+>R(/6I;+ M&,]$S]YUPE86>]=0#O(9?:WMZ>M=X%C)?_V;;9]7<\(ZD>!V.![KI%>F!#": MR"[,VV(4:*(@U)B;=ALQ6I\J/;>7[_;=W^OL2-T$K9-K'\0L3R][S)+#"3;J MMBH_SIT"(1@HRWW-D77N6K8>D&.#49_:EA>]40_JYS;,6]?"XV6C$ P"A#UD M>JKTW'^Z4=9)$Y]?WGC!RQ:;]N !WH#B6+_O/P8:%_PE03607)M%:B-7$KP1:54RK#[G<;;>]3E+& MAJ!ET]#/0TO8 5!,,G-J_'N277N:E*$LM1F3Q^LD@,W]PXP PLL$ZW1P^9)" M9[BD,+62P)2$YD"$F?;?F ;:7ZYP#"M;C"_,D3*G"MV0T1IP2A^)M_.^CJQ'R8F-#KG^]DW?0@JBB[:BQ-&"(C;W#G\;VS;.=I4N9W=- MLC>2\PJ3XB_)#GUB:$OELSS>)M(@[\M^B__A.=E0N7>2UZ,6MI#X\]9?W%YR M/[GU[1O\+=(,_T'$%[!I*\C+L%/@<$6!4^6!?][-02( M,XF]BWE53!X[6>E"OZQ]Z\@3 TUL>DI[274U5448#OA-DD9*/0I"NG!R]IN4 ME@O[H9Q?.HB[J7'#L@6[6O7WL>I?U RR;P!_X32K&4"_M>@7 C8!*\9I3W,< MC&RD8[Q:ID%<)WW (>Q&#;@JT=BR0I/(+F1'YFC)@@F&CIX1-I>D0N3;-QDA M2TAZASJN+E/ZUE,-[AT1=/XC)Z6E4_\.IZO1GV5K"B8=Y9,R$-P:!%3,O,JA^.HU,P/[!XF+'Z+%=B#MV\4LX?[-N")H<3/ MP^:&B*7#=2SSV>ER_L>GN$.(-DY%;2(RL?_.<'@5W:@95/UACM%+2VS<) MK9\%1"LN1YFC<$4(XC6L%((WL9%6#/DDD;=_ECF)I*G1BSHD7Z]YK LY27L4 M8LZ^%J8J65EE/) =TQK,*=60N;?4JR_"Y9_(=FAYYV%0PZ/X[YZU3VNL<71^ M(6RXQI 7;W60.$"8BX[I$3>O[ME^KSG#N)8K>U8]J:V>5X30@Q+MT[EK:P:R MYP3G';=]WOY;K[K2WRB /J\8\(SV+"L$?"S:*MIJ$X?>+(SYBN]X>^WY['G? MC/$T.\;3H$=>7_RNS.;K;=7^<_7[A_OMN1,E7Z?JA2YHV+*2H?.)NZ/9<)@J M6#Q5T'[[9GY$3G89>5,)W/A,@M:>-7E'I^QPP&&8=,;-M;UH'O< 8?&KG#.L M-QM,CI%),_(N?4 Y_*SA=^/W<@;N@$EB[R?-I@&Z(1N*)NLD^B>ET4A3R?G# MJFRI-D=VNFOJO.6Q]#MYYL3\Z6CZBM'!8QU[&TQ3V5VDZP$\N7<8='2NR"LN M.9ICF37>WI3J[TH]&/>YA>9]!X6\:J'^?33S7ZJW^1]__L@[T+_A]N!0H#:O M1L,LWYHU:#".[))-)_E*;@<_FQ,S/$>&G*>0]/9O$H":KD-U&%5F]. Z&+U;U[>FK\<-TJ=\<[XJXW>T]2J/I0+8J;YBE[U7%:Z=*7L*(?RDBXI MX!9,XF_1"3=H#< M(0.)B.\C?MBC2TZOQ>_T9$FCKFE@S#TL< IG.1HXC98/PLL%D\L)X^^87@>8 M6"^8CL]&$PI+,Y)UU*;?& :48UP(AB6(>H*()SB/KAG*ZBF>9X"X-SR![^\:;VB4;>"^QB\)Y1]TQW3GML./;A#<*[K+$$M$+'6E@H'U2'3\'\MN"H)X:>UC M"PS$7$->BW.PG[N:@Y(\U*NON"5V!*>[ )253LYN2W<-K[U5FCTH2A^YR^I- MZ:9<+5UQU1MR%G2I0<\99YS"\0, :'P(HQ@3C3]ROI.9(O,TX[MH8Z!V^N2L MBFVOUP?QE+L>F=(#2^21&(' M>9?X5QI/T1SK"'(:H$ZMH+=VW2C8,S)F7I+>$K[.N( M-',Z(F[?$?3&T>B-W#IZHTRSU6R2S$8S8+JFKB++]NO G&;*@&4 S'(-F*)#]H X:U1TE=!_J MBG$U,6LRDGFFYX#IP/1$,#V^I84OLK?0/UI:D$ZY:]F0.Y3$P0%1W(5F*ZYM MD[Q]8M)+AJP/;(TZ!2/N$^7@;;\B]]PAV]4GIRN85PH2V'_0"D>A%:2P5DB? MDHQ/LD]'IL71",'Q!3WXG>@'W;1=LLFHU#)=QZ]SR]UI]@/SI$_#= "0_BA( M/Y9ED#FEN<.6J=N4\+>6J2"5)R?F#2_-T+GZ-1E'=&9;S^C9G0T#PVD[VU$/O0-.+ >6+_O M$036K\;ZPL2D^ 5JRW25Z[Y/SOI AF9:(;8#LX'9P&PFF%V![-"5Q)^',SB*MDD_Z=/D^\_D!<%YY8<6>GL M:=1-EI8/B3 0WD>N,>CC]U^9S\BB _21NY%[R!/RC4F$J(U5P0Z^24O='W1I M;E:+[>Z(J.0<+NVL:I!JR9H=*I<\HR8TS[F&CFR;,\D,Q;-FH^&Y2*IWJ(=_ M#'!Y[-A?/KC\C":ON'9P-+!I!==,UQH>5(S- #D Q^3*E1(W47Z;K%#RY) < M"W%ROV^9?4O#+>$Y'&[ARR8Y+=U\)D?BV&[+UE1-M@:GG]YK9[NK+\QX(?@8 M:MC2)Y$36X+*K4%/6F?ETCU)^2S=_7[[IMXH-2K7E9L&C%6RU$4#*XFW;Y9H M"Y^-3^CJ^C7I#5:$9')EYX22>GL$C:U[-H6?94E.Z:3[X1Z4%50*< MKNS@ACZ9^A.B"L(ANX;P.RW-?O"R'UQL'RWR(+)">LHUN@@KO 6/E"WT]@TY M\PW+R#$M8O>YMJPX7,MUR(?8&R<;DG%O%->R\%?PN 9RX=!+'SL\7I^6-(X? M;QE/&TM5,GV=:=G\VS>VV:.Y&SAJ4[K>V]' )#>Z%A609>KTBZK6;FL*%BQ1 MLWT+87WNT \4T]7Q_\OD^#K\6)>\WA\!?"?Y&GYA#_<>JUVB:]N6V<,M-VUR MTAU^D$TK-6@&/>U>Z_5U#7>^-:"&8J$@3PF6Y@G90CHYA@^WH.TZ+NX6>O*J M/EBT9_[%T4%Y&"AT'AU+[/3MFY^(ZR #8X< '!BRP<9JN3UZSNT24_!"J_F5OR.W)N_NZ;$Q=)..O:'W< MKJF/E/##@XL:*:6O3MWKD)/1G:F68./Y=U93Z&%6>.1FO;:%\( ^35]'6 _U M9GW!Q];T=9-4_<=C-6K6R!D@+= ,-W <.+^:AX$Z,MW/YQT,1@Y8Q*/DH8 2 MP=:P?I,M[AD[\1A0)5T/C2KOWX1I9H0'&S]L1-VW;PB9>$J=2;WA4:.%.!7A MR^HB UU(4_5 %$/.FX;*4;@F#P]Y-&7/F4^;H)%$.UB/P8'[C96MOCCMH8; M@F3+(#G4I),Z_@0327[QSGPD:A3_KI"R)VU:]F0HB!$3\#M[]D?ZQO$^$X%Z MH./(X6H.ZA 7BSRA1=OUA+QCW$+:BE15\:EF#E7QU+,M/$H6M0.!PAM]K2I6VG>@;_TZB MM0)U8'#N2"G,T@8+6MM'WF%T6 ,3-'>\[O$X6"/I[(HN:SV;@I0,@*K9?1?# M?99D0TJ=M(52IOV1MG/Z9MFVW9X7 &,%KQ+S2AI!;O0'B81='1-?7'K8&U,^ MQ4&Z25@G80VRT%D@EIT0C!BS!P.'*K[7X?T\Q]2'0#)E]L/*R;/;&/UOWTP8 M;W+BXI"S?(@<2N!M8:1KCRZ.F!QLK4.4X8FVL3VCA9]!/#]R4*'7,*5+S$$O M,,8!G8/78I<$V\UG1S8"\IY'2LXM^-7+CP0(PT!]$VI!U$UY'A\95=RS_>/:Q?RP_8<*%9TRE5[1-+DT,NYX^S)P!,0F=8)[ [BA\[GN.7Y M<%!TBU>#G)PQ?I#/G!G[+>;,A^?>Y.,=R>UF]H>ME*:.YXDEVB_F\L6HVAYS M8ZEA((T;JJ:A:A]JIM$5>D@O=L->L'?L^23J\%/BA>-(WL'QIF5'N'05+603 MB]'=3D$QUE9 4!)&)3JU%EX<2OKD[5!#KOK'?*+S2K,=ZM&4Z'C\VM4ZQ($G M[BYV&QV.>'R>!M:,MDY]='Z]9@P5.@Y,+9=ZJ)SJHF%AQ-J/ZD5*+')83BK" ML;>W<'/_8,DDD1S[OOS0 -ANOX^];*5+)E/7%$;(D541":C'W3,*(&:P,.5? M@G8"[;171&)ZKD?(0.48U),;*@D:09,K1/M8KH+#U<#!4TS;"992Z*2?[,]1 M.O(#,DAI=CHGI5FVLUY3'KW5(Z+^AK67_7E>7T%:2&Z3S =0&: R$JTR=L=S MS2"TP"P<30C2>6$"F:?@NHUT/Y$*.P ]A#"E=8W<9*%' M5[.\J2UPNA,V[&RW%1"4A%%A2,M9J./B8,>T!GZPHY,2%23\\4NX_L6Q$PVI M0FH./P_1M4*Z%.#-@'O9 73=0!D>(<.'YMK;IJ5X2YAFFRR8&H;<7 MO=6QPJN,5A&Y4L>B"5WX_G]&Z["RG_N%#!P-(43#/+*VJBEHW&'T)GWZIDVG MKKRV/&M.UW]S\$ >\+PPW9; 4%)&!6&U.4P,L8.G$YJEV&?#[7;WHHD2?WW MTB?&IKO"\_">[@N2-H9+F\.E3$]AMDBD3:X;N&'!8P"X"<,"VVT%!"5A5!A2 M?<.E21KNDCGYKM:WJ9/FI?>/Z3#JT&GSDS.BWW&ZYXVD:=@S&M6>4=@T&E=R M(F02LI1).#.G=2R]\&B-T= /]Y=P96^W0YLS2-:XC@D_H+,2W@8=?ZW72XM9 M;K+"#CNY+>3K>ZXY)ZM/)#4]>(V?IC)/S7I@ M[/D*^QG)=/=0N!&&[+@666?3;)G4B,>7NDC6L9;NRJ^RI>+?\57+M#3;2PAZ M\O?_A+(>\6?D2A\[U13E_I71GL2>_'>XJ<]?\//W=09)Y:-]G?Y=1,_CUI") M'=F;Y,&=45&/;K(9?9G,8/LFQ)O:)KGK;5KJOC4@.P+]2>Q@RU%HOXW?#F_6 M"+B>,/JPW59 4!)&A2%K,72J9ZISNOV/[.GKROT^,KRMRL-EP6"!+NP[MV3C M@7Q="78>VEVM376H;SH\54JT^^C93\.E2-D(]&\HCY2\+Z2!YZPM#EU^+[V4 MQ :VJ;M#DT:K==AT8L'1![R?BTIWP(//GC18LMU60% 21H5%+>SG1(S2;4.) M\\.YBF&&16B2@N1PZ,A!7L4=F6Z<'Z_,XVV.H7GYU#?V=W@3C2K3KUNHBPQ; M>_*;XA<+"9Z,U2A@/&&P8;NM@* DC I#6M)/M VV*8SO+_(+7GCI9^$]"G[! M(6^GHU[Y;J8/_H32Q@P6T"MRGAH\*0EO.*N 89]W1I MDFLAXMWH)'?:*R/NE7I&*D M8:/'=EL!04D8%8:456.T9CDZ-F14"X-F;<@] M'/#XAWSXA?G)(X(RKR0FTLW.[/5,@V!J> OVZLRA3B39V#1F!',6PV^-7#A @47:II#MX0#O=MV^>$>+?75H33+;Q@)+IUO"A'?ZN@85'?O"CTW=(=;'PU[W3-\CI2W26O$7< M'UG![A0Y@O+M&SJ'96-_R#O^A _.[YE[SICLGRLR_299M\W1B5.CMYQR58/# MHNZ&=DN,CH09/S?&/S:)3,O;_O8\.73N%#V7:5[CAN!?>.K?! &](U'04 C^ MH2BR5U+(VXM!!VF4^>'5VPA.G.+(06KD2?[!,FIP0,N<\_F" T^"HU"0K5A: MB\C4"J8D-7HX3'"R&#DL\.T;L41_%\6/W!U^,'?IJ9/@N#$_-:5D&.0$G>EN M?QMN/AD@F>0_DRY?( 7U6G@,TB)/*MQ*=&W%[:NT--W4X@I^B3<\H5-3Z1&) M;>QVD_.^AAKJ_K1^BGF AY]NNJ%"J+QXSCWY=D_S#E1\%SJ*M5XI^YWYYY3[ M;;KA<<)R5Q Y:\JEE?,TLI'R[1LOM7L)+_QC!;VT2(/LRAD>):;2JBOM%3!S M2EJ/L.:0[: <*=VG0_,NVT@E&Z8X>]1?4J6/I[0FQV.1,L2X&Q@SNG]$%^<% M(V25"X^*)W#*X,4]05[BY8BM=/)*<7[G9P_P*_"4Y_]ZI M2U[]1$R]4-6O'I+I/@/<6!]8"]H28D]PBK>4+P7X" &XY.WT$HOI-.6(W/-> M/P;@L=N'6#XH&[9!D8L,%+F(K,@%5+E@R[.,_5QJB1SYY?6D=79;NFN\?5/U M_ 3I(W=9O2G=E*NE*ZYZLP9@GA6R;,MW*EA.GF;6(D5K]J**-OZ1 M&F(:"YS+.BU>4N\BY-B,=_*3=O:.A#+W=>Z". 06F7FA[KW=I0=0NB0HLO_Y M]%X[8[^K ?]F]V4U?XK@_T5]:::%8E,4Q>;KW_K7LI+6"ET[A[TMMX?[-Z"W M8(]F&(ZGN"&R,^U2#6B:.G/?=JI&P\/"0R_^> M2",L98J9)CE51\BEA>:KT'LH9^QTZ8]5G'3?%X0(:W4V;KI]=0U_13,M\,D? MG62V:AEF"@0SV+M-8R7TNU,5*L5K2^BE6<5,, /GXT9D 3>1KF."8HV,)&PR M@)B Y$L\F:TZ,!Q(R9=X',IOUB+T3V\1&K3B]FDG&^';G]1-H QW$#2^NS=D M5\4 5/\9"QDC:_4>I)M0P_ M+HF141%$;%;R=ET? M(.&'F,[&:E861RV)LNPB;'JG:[,GEU_3K1?/UQZ^7JGWQD!7N MXS5!*TP<(.2UBJGX-]H/1Q?UEMC*B@4 M\M_$*H]@'7^&Z*-L\_]&)4HQ]]^8U6#81J7Q+&C.\3D'GZDS\H/*Y'R MA"9;XT;>H?:_)R6[UB;++RDAETH+)YR70_[OB?;B?##\!]_>+D3,SP8C'/9PK93^_'6[AXYC!!((A(40.I@%0!J:24**72 MXL:D*O"Y=)X7Q/V28\B@>I_+LO MEBU-V6=0NXD#%[/K$,@PJ ,32)+G#.1 K)$(/W['>FP1K>+P":1BFL_G\M'K MKL0/,Q#D. BRI7V7^%RFR#P]9MOS5PVRR=2T!EB<$_:[\O>I]+K;WXM:Y\5XU"#R#LO? M%Z778.0)U!Z5NF%+4ZV:/YY T,??B1UKNQ4X&H=7D)4$[#+GF%>"P#7@6NQ< MVW;&G\\4BGQ1.E27(S\O5XTX%PWL73B>=T&\C+Q<;;Y^OZT7=\J3&9NP9J+CEJ+G;G0;V3Q^X]]3D4D(K-])"-(;D^ !8#< M8A8-Z0%)#@"X46QZ:Y%30YW!K2YC:V.H).^/'@0_MH+]V)*;KWU+N.V9M:S8 MTMF-4&.?$O?$.J;MN;8DU/'$W;]1OI\]S>?OM->TXQ%[W$9]$!PH):.42W-HTU,>\;S&=@> M!MPX1&YL:Z8/@QO+]X;5^LB2'>ST7"'91G=D1&OM>]OSBB:,=?[NF]"I?6V\ MWA":VL!>20SI(0I7'X!AFAR!<+[*?! M LN 93&R;$LO(Y.3^$(^ANHRB7 S<@LRR$+YYL2U&.:;%WNUOY5Z!ST66)L/ MB#7??"0X)C/*0,DE1\GM8F8ADR_R^0+[2YE +"!6M,3:TF'(9O)\,7=8#D." M)Q*.7;TD%C^)F[ED,Q$7 @ 3(P=& 6.EU.!(]EHY(>+7ICXY_;;MZMGZ?MY M0LJ6)6+S4:/6*%UQ+![=--,%E*@+J)IN2T=)<63G%56.K0-[<6)CVHE<*!3X M3 8JF0"=@$Y;[S\6>4'*\4+VL J80C"8E :!+YZD-B92C ! .!.DXJO-+FE MZ9JC(;MDJ'7'5!ZZ./!"EDWV9CF#L6-\D?3UOF1]N9?N($05N_K__:<@B?F/7.7[?;7Q&Q1$(L@'"@( " #< MOQ@A4@$: @T9%", $ 8>Z12F!.IA(.2+X.&?:]I6N:YPU14$E,, K1.!&6 MU@! .#^Q;C\U/>072G/K,7ZY;I4+'_KW-S6VL=>B[4<+L0:$AQP/A%\ LX# M & ^Q?C"N6__7-9;^4!.92U9*CXBN4B==H:C7:,YTW4?+T:U"N7V2]/V=MD M1#N;B'^G!X7W/1'3&JVR)V1.!].U34/GY1@E1&FL=B3R"M2+(VDO7RSP.8G] M_29 %:#*,JIL7=A-$O+8^A28)\MLA^ \Y!"4\5-([WYJ3K?LVM@J(RN0\F"V M)_"2OO]>*3D7C2]_H7;,>+VW-L("\\\KM= 3,EP$RBL1WO>.-=@JM(K#RN>D M+%\\@&.6@2A E,5$V;9>"Y_&$68V?Z@%7,6Q JZ>72J;/7(&JTRZN<3&ZX5N MZR^JM>I?NQ#NSP_WB4_JGTY.LU8Q4$P*6TH%X'HX<%U2B76Y;8C#_I*SN0_6^.;G5F5=8G9[ M-713N7EY:EUD(+2>NP#<-RV*9+/-F8%T_4JMP03[@"UM!L6?DJ,1%Q,VEOWT MDL1+>8EY90@T YK%2;-MI_5%'&.FV3^U<'F)UMF+^4'5'>QH$(?C;Z_=?)7+ M:J56ODCG-)'=.#_Z(JV^U-A--0--EQQ-MYOU?9'/9G)\06#_I L@%Y K:G)M M6ZR5SVYT9,1/B9BM])(7+!A*9D$ R4 0 [E^,RXN&SYDFGG4*M?#5 M:;X^_'ZL?"E_T;_D8 $U+/R9YUH.5TMYSD .64\-CJ;REUC9TA8P+Y.<>9FE MO(UC#C0M%GGI ,[Z!:8!TV)FVI83HNE\CB]DV=]GL#QY>F88'%I.)5['<#FU M]_+#=6]_RG=I+1GQ\+Y%/G7F);.Q,*B\Y*B\F9P$AP(<"F#73MD%3@2LJ;*C M8Q*+'YA,! R)CD X,K!9&EV,!DZ!Y.$CCWYJE2OO&;_B,W7MO;X6NY+S_8/ M-1E19")65;TC,9FM. P>;B(]W'A2<0LY6U^=V,ZB,O] XHA$:3;6ZTF*0.U MF@"N[, URRY<(?H!TAX4:=ET/@& ,#$V('9I?/JCJD\=$U=199=H?55)[8? MWI0'YU_$3DG6I61$/(E8**M_*=U5OM2N+BIW]?_[3T$2\Q^]YE:^WU<;OT$+ M)()AH 4 @ # _8MQ>36U6\NOD4OMT0]9=]%HTV$'735?A:\5\>[QN_G0]%Y3;:) 'GN?[T7!-(N"M)<:=_*5LVJ.[*#5"KX6V35N[*%!Z#:5,A* MO9!+"\W7\N>'[P^]Z]?;LG;".9I#&CY\4/#:OFQQ)HDYR=.X)_(XKH_P!?+ MH->C1@D;-TH2I;2(O9-?UE-F\+.8U?.;-VKABNMJS8H@Q:%Z[^I27_G8\(.O(V)P\?,@W-R[4;X$-2%P?U'_=%+?]'7*\!:XSR9!,B MA]\FT%NI4=M +FB4E.4QW,C?M1$W)?=IY!66#'S5MMUIU#W^_'VE7O_\?)-9 M.N@:?< TXBIKO=A'F_!\>>U<&*_296?C%V>7O+CF.EAW&JIF=":ZW>W]O?_= MO?G[O;("\1L=3>%JLPIYA=K *X'A]< M17;ANLIYK[V>:B\B6_QJM7'=:$S%BLVZ)(IBN\N8J-YBL6351D%PWSS%D*77N]L'^V M^NJ%NGB(Y\T47"QZY?QI NMSZ>?75JE>1DM0O4: /J?'2<'5+B+A B_DJ5,7QX[@ OM%;H /P(?H3O\]U)-_PTYH254UTC59OY4UM6J4Y;[FR/K$ MC$OM[Y?/M6I9KBB0.A(6^4AZ_J&_6(:<9G"*)T703<>HF^90*@Z3G2GR&2G' M"SGV#PP%>@ ]HK;@F!YB/LT7TCGFZ3';DF="EOP..;)F(+4B6P:.&NV2HK@] M5R?SP!>HK2F:,V'4#?>[!V54H9GDQS_X4WXZ*ZD0XX7#LZB:Q4$K;^\H!@ # Q)B$4529GGT: M1PPM$U%E9^HX"J^QI9L+;D8!'B9K[\QT M)B7J3*JFV])14ESB_UW'&XZB _NKK#^3J+&$GEF^4"CPF0S["WQ -"!:C$3; M,@J51%X@B2;9(O-$&[H<[QT9#SK^^>V;3_WUF]V3K8Z&FTQN'?X=[XV"\#A8 MD2*C->Q2:R3Y/EN=:'31VS>RHI@]_,2!9G0XPW3(OB@+<61[ WY?QY)ULCG, MXH'[E;N8-U41X\N,A3\_>Q'KM8GW+,_D/?5$27B1XYFPG[@)"Z5"M2W MJCVM/NOF=7EX1XZVDI($@T#7_1VL5#N0WW&+E>#W\7=@!UF7^S9N2_#31^Y9 M4YTNZ;OPWUG"&$T)33K@CMF?J2-&JF8:K6.OP_>&A!F(\2/7&/3Q^TL6UJ;* M1^X&ZUA/U#Q)TIEPIO7U3 M-537=BQLCKFJH9PRWM=RH&;?OBF']6Q]J%V)2J[UD253%<1X=S]I9^\TX^V; M^SIW072597/H14%$*9)560Z[2"WL6?V#W9ZS ^CJO2&[JH;'D_D.37AV?NM7 MLU;!3%-:J#1%,4UFC'3[3_5WT=))-H+;PST:T%L^C'#/I;@A-[B5J,&%Q+W! M3-1JQO1D\R455;/[NHQEC]UY-&_FBYW5DY5GW()2'(&C0YV@7473>!#)Y7]/ MI!$.,T6Q23=[9P2QV1QM^\X(>MUXD6L/%6W2Q5JZ>+K1_&/T-"6=87;4F&KL M,H@5";"D(<0D#V+.UY?\=:7<:)"Y 68A)C$[:DPU=AG$!$]WB>-:;""4!TZF MWE4?VPQ##+18(B#F:S%Q7(NUOE]\[WT7E6X6M-A>(.9-JD:8V -N9TQLRK%* MD$O3\KKC=!'7Z%H(<=?XGJ[-57!4IG)?70-Q:8%G=K"8:NS!(JNNO8SCZE/+ MXM[[_64?8S'D8(*JCL_Q89-0X"X#:H[- V:IL0>&&M U@)JCTC6SLZ:S8\5 MGI#AHDO+[)7Q TFNUD_-Z99=&S<2694717=)LTNVC?!_:D-^H85!G@ME_._G MV]?['U^;KU>WYS=_[EZ^_"ZTV2D1XJ^-94B>29RI9;Z(>\N;Z#9ULZ8ZS-#=@X'CB)OFFER&=20EB!+G2O)!+\WDQAL(? M.\)&1%M<@&O M=E[:_9F0':T8YR?[^ M_>[/9<_-L[-F%/LB'I$:V1QF>7+;&A9[7?Y=<\DW@3 _N%J48ZR,=QVI6,CR M@A1#+>N9F&;"D ;@8WKL3&RE2:)SPL%/A=' 2S@(_#Q6/@8X6I4AB^(&3XM M%H"1P$A@Y!86,JH5JW1.XK-Q')&8##["ZA5,G<'4&8-B! " & 3$H. @ M3-#@ @!7/$WBLV7:]JUEMLEIR(UFS_&7K7IRK7KU6E?_-%];9C7=^'Y;_8&* M["Q@Q2EH*C.N3X4&?$\$EW87T QB>"3\J0DBR3"JO&;RM>8K.O_>4/^8Y;OO\?K@VTYG M3\O9OZ*14U"=X5I'9*(/2Z' M= M(LMGRN8$/B_$L)$[$0%E<>S\'AO)EM+%0KY 3T@W^ST<_G%ST] M>\O0*3T[#BUO+5-U%<=KL#J2*(:K[4!$>92:;"''8M[G @8?:'*P-(DLELSF M^&R>_?1EH I0)?Y(,I_C,W$<@9/X(0>R' E9(HLCQ6*6SQ0/-8X\#\61=:3K M.#K_C QDR3H-V7N:H9&,0$=[0K,#2J/]T$:-NOTCWX$%RO 0^-+DO19W/*'2 M54IY3*RP5'G4FFTUTL4<868%7LS&4!4X\4,/I#DVTD06;XJ\4!!XH0BS,T"; MPZ=-A+&GR.?S E_(QE#S.O'##\0Y-N)$%H=*?+HH\H4\^ZEELR/1?+CRGFFJ MSYI.)%TU'-GH:"T=D6-KG6JO+VL6"?XGXM ?F?Z?^N,/\_4/TPN;BZJ$QQ6I M!M+V.J(-)Z#:7QO%M+H;8%D@*)&6&I*M: ML3Q8,2#(,1(D-BL636KP5($7$C634O9^V-RSAZ7L\_K?6DW,..GO M,G,+N;%KGH;IR'Y\;$X5@0'%"8HS4L4YQ=JX"^FG^30#DSJQD9-MO>:$@\?EL#*<' "N!E#S^2(OI@_6 M4N[H.(,(E[43IZ0@Z2:A23=L5G@# ( &1,C ! " !D4G( P(WV,@[#D*JA MF#UT9=JV=X;S<+VK\?N[KCS]^='^_,#8>E>4PAT=::!C$0'+$\&@R%G^;L68 M?426J%><;-RQ?T]24TM/..3,28SM!/D': (T64"3+9:!YM"$;)D2>;' V!9= M( H098D]V7QM9BY5Q*S YUDK*@Q4 :HLL2F;+IC,(4J:3Q*V M42B^_.[K]X5C7B%QN@C+D4J)>^?O^?D'#GY.!IV \@! ""+8@0 @ !@$Q* M#@"XLM>=#>;S[7FZ_E^N6O\[1M-4HLU[.+M7!=V#7W M6CWTSWG.0 XHB$20;]<[D!;2+-ZM]&3C+A2$!JHDARKA)RTH897.15C"*O%" M![@F%:XQ:/;(SLSB\WG&DB6 +$"6-<@2W9E9A2PO"(REX*TPE\+@X/!G@)O#Q"7D9Y?EB>+Q;!8@(S M@9D16FH9]CG"0@;S[&O(+LBLOCB7C^$LS9&M0 M=5#/QF$,"5H%(20===UQV-D9D[*AV?*Z;Y;#Z&<]^@ MS&_"A 9T6YMNL92@SPE\%DK0 ^& 4&,(3$$*)7VJ.+4^ MA4,1/S'N'!FHK3E-'(<$:TMMU3*^]G\_?:ZTV5U;VD%N:#54A3.*A25(9SW" M=-;PDQ84*\QF(RQ6F(RL4B ($"1"@D19S1,( @0Y.(+D@2! $"#(?((4#HX@ ML# "LS(P*\.@& & $ ().2 P " !,TN # 56O9(6>4SM74O.IUWHH(W7=3 M:KQF+IZ;KU_0ST:]@'Z\7"B'M#HB11T'8WEZ#=:Q/"./IR)O[J9A.VT(IYIN M2T=)B=O_=YV0/8H.[#KO#DP7.2J?T]>VI6 MNHD4U\9>;2I5-@WJ\.)HZ=9";6192*T[IO+@?X#4AEG'=UN:HR&[J=TT5\F_7WY]=Q3]N]9B>=F+7HGK!.>0E+U&]P-9&&L9>IJ4I7)BFW;NT;9J)U[RT'-K;K-AQ7Q)Q2]!R&YI& VRITWB1X)A2N<]8*RI72Q8?UO/5XC[9)9_EB(7,HU<%&P5%N%!Q= M(-1#ZH7ODH]+O&9V*85:\X6PF7>2+Q>)!G-2ZEVRX"-?G$J>Q8+(L MH9-E;*[* P !@(R)$0 ( 0 ,BDY .#*B7&Y>64?2D^RILLM'37,LMGKF08- M3KJFCJ,O^URV-658&")8 3(_=S[??W4DZR7-_ I0O#4@.#F0+N>8.,@C\N7L MKFPA7\"PW6Z7;#FN[7;+F0UE)+:<@ #& F/WSU@H- &S[1 M7M;.2&3F5Y% UMAR&?=__RE(HDAZBF,S3C943M5TUT'1;XJ"68*#GB7PGA0L MC!>%3&AAO");!H:"?8NL.D&=M_S=U]2F0J;IA(P@-IOTIUQ::+[^M9W\;?>G M^KN#@WU%EVW;>VB_:SC-^_1=5_W\P_GS,RM4RT+GNU1T_WS^X2K2CX=JY>:I M9>"_G_6'W[_N]#_E\X;Z^5+X\U/46\;=:_5SL5>M%)___/J*GZ'C>Z\[WRY_ MN+]__7B0Z?T/I>F>5!;TY,(CR_R^/"E7N<;EW;=L91]=63)U,W-<(EV\K-Y< MSIFBN:5OM+&XUVJB+_!=-U(X%68E>L^;6HIGMP9,#H/:3[K:%U96^])054J> MJA2OOW^K-ZY^7/W-)D'M2VNH_:F^9-L#Q7V]S5W]*3*M]S== M^IWH^QD<*I M-&O5#_0^Z'W0^V%MF5_#W1?'7611U(Q\OO:YD,XG0>^OY^Y/].7QNI+Y/EEF-;[FZ=1[-KCCZ^9PJDXJU@1Z'[0_:#[-YOJD8;ZTO>3^X^Y[PWSIG); MD9.@^]?S^2?ZTA"?*S];3\(7L\NT[M\T&6?7/G] M2S.R.=-U;$T-WCL!G!/PO169KF$_#F7*4'-EM'YW6/VBU;_7KUY MV%)&ZG"N9_=26C@IM1:2HD]+&LY0K3:%MN:H[J"]!5[(Y_AT7CJ&*;68BMV" M-3L^:U;8RII-)21=?Z[\N'<:[6]/ZJ%8,V%+:S8E(_O%>OP]^"VTO_\%:Q9+ M1M@>K%FT[_.X7J:S4/UBRF/+?]1&>1MIC$9QE>R!U%JAM8-+!H$5FT\RWCLXGD ML?-,(U?J/7[N2[E#L6CBUO'9I(QJWUMBW4&O2A8L6BS9>_N)SR)L;X['8.%S M@G"DUFRX8/G>(578\,]OWWSJK]^;GFQU--QDOM&5K"&P4\MB63#176S-D0]'P[9@H#NKAUMJG<4DF]C'$;?V?5(J[U)"N?N!NL5KX MB!_PZ")#P5_,?>1^R+J+?Y*X5"KP:E3M::%#,'8\F=>MX1TY:IPIVO% Z[K/ M0UH;D/R.&Z<$OX^_0S%U7>[;N"W!3Q^Y9TUUNJ1_PG]G^0"C-(#)Q7W'[,\D M^TB53"-R['7XWI#< HE]Y!J#/GY_R9);FO*1N\'ZUY/JC4D$F Y_Z7WP+?+) M2!\$NN#3>RSG62*WD/R0:B&L=O&S^W3$?"'C7@42'@(P!*L1!/KC3P\WBC36 M&^O-8#Q+;N'F"43-3H!"B-4=9TQ9?6J%7#/+;@I"[B2P=^5*Z>V;JJ&ZMD// MQZX:"E8]K3.&^UH.M.S;-^6PFJT/E2O1R.6N;'3PHS6#JX?.C:#E5^^H:B$L+/$?F$^@M MX2L2XQ+XI)V]TXRW;^[KW 51\I;-H1<%$6M"RQ]YT8+]#_8.SPZ@J_>&[*H: M1COS'9JM&,V%"K>"JC MC$-)3$:L9$HOFCVZ+51%_1J1\6F^6I\'?^Y__12%;(=!E)5ZIFLXB1[%Q#5H M&:S.UX95"5M/,@LFZ[>RIE:-LMS7'%D/(/92_UQ_^/K[^L^KLCN(;>R:^''@ M=!08Y:@0.7GCL.H?S1AS7];YZBI_$BXO'U$A$2236XEK4/0VY XYLF8@-=A? M'["\_6@6&A>%3.EG@45#HBANS]7EX1:4"]36% U,2Z1H*S5?L]]^&9=.7:NB M-H,PF3&[X_79XTRB!\=?SHEP]QD$=5L0(\<@_+WXP>L,C2(2+?3$-6AA:)^4 M,1XY\XF69>(:%,G@'IG,$M<@&,2-_8I(][6#9P'3Q3!=?)1(@"E=UH8^V5.' M,-4*4ZU'0$*8"4U4@PX$# 8,IF+R5MAPD^Z>Q_HQ3UN:S+)"_X6K:4+I<6O6R_K?<\^(V5 M(FUKI&7W@GRI_^YCC]MP*U0A7,QC>K,3!NLL@*^ZSK0QUQ-R7QYK/SOR M<,^4CP;>WQJU 3E\L1;_&_>FNX7;CY9L,"K9M;:W23:=2HN!E)I30HJMO%$T M[-H/=D$71'V^ W/LFK*JL=)+&*_&CYDUJ\8*4 HH=7246IBLMRF],D4^(PI\ MH3CKK N@&= LR31;W.L%F'BMSL8R9M&] M]+7V#V23>AMD1&I]V)-2-E)2VDNJJZDJPF_#AD'27EJ6+J1%,8Q3@"O =3]PG>D4 MEBNEBP\Q."VKG4\0[T2)F.7%7"YZ]S/Q2 (.)I6#JYJ,-)@,@.O^X9I DW'D MQF#V!$0^E*5P@YRJH9@]=&7:=O/U]]-O]/GU3OZBJNSDTL0I5"P?3L>B84MI MQ97&MO^:T1%T J85 +^ WTW\S!SXF0#YXX)\'B /D#\(R"_)I1@+!-:;M)BIML)NHTGQ]N+F[;WV___HGYAF0 M;;,GXM@V-%8C_ #T&#O'9(VV$!47;R&JQ+>%2#_O9*]_7;CMHK1T"Q%#YWE% ML[5HS-]A9FL11!R,:HEYV:,'P[N5LTHC(=Y.-AT!V8!LAT2VV+8C23E>R#$6 M<0 !@8";!_8;,C"NC4I9/B.D^7QVUEG0">;@(4RM ?V2;O^VV,(D2!*?+K(? MQ\5ZNNQ^3A1CYES5]8XX7;TWL1\V=OCE8J!T;%=G7 M#&ZR@CQ#@\)*.P\$/#'5F@?H'#YTXJU,O_\X8)1B>NDGXXGK%:S/R,Z@_UWL MY-PV.YMLXRU8?X$4NK89U*R7H!#AKA).Q=5JUHO1)YS*=;-?$K_=Z??%(ZU9 M+Z5$*;Z:]7F^F$WSQ7P,R_Q0^9=)77!D14FCHM=T^J@ E )* :7B2Q(5\VF^ MD(ZA @_0#&C&0"KH),_BJUDOY0M\/L-NW6VH67^$)(N28ULD?!:*66RI8MC* M<&PUZ_7>7X1*RM?"STT2E:!F/=2L/]2JFE!<#K"WMVT5X2L/PQ3, MGG_(C>8?J)BKMNTB]<*U-*-SBQ]NJG0H_ 4^NO[MW5(UZLAQ=)JA4&O?X8&R M-"48K'LL0?^^AGFA64AQ3,MNOHK%QEWU\545_F;92=")VA;(=Y[-90Q-[,!87I\#N.R:F!G$&E1I_,DUG*$X\B! 9?CXU-FS9<+&V3HK3I"=W_;ZXN-=+U/M0+J.GZXS.?/@-1IFOY*FJ2%? M!VS=@6)O98L':Z\ UP3 -;(%V 1'\Q-!O"#R:9']@\6!A8?#PE6-1A&,QH'# M]6@2=K:V%Y%D[!R(+9@]!Y$/E149.]>R^=HP?VBY\\*UHVGLIM?LH X1%IO7 M8!V+C<6R27#:+.-3$3,QPX#U!K0?']I7]6.S4:Y+ 4& ( ='D"C7PX @0!!6 M"+*DWG^PY.KIN-I=SA(R< M700YOT$1Y$KS]?GG0#7/;WX6D)KP%)))N4M1*Y6@"/)7UT!<6J %D-.1PR7R M9A_2$:C+]E65%A=)KL2W%0H]?_O21]_[>E]:6B3Y8 YL7:EX/#-/)56"MKP[Z3=59DN3!0A+ MTLD7ERQ=VP)9I'=*U_TV4K!K%M#E!ZC/@W7&>(OQ^\&TXGAFO;^LB'-8A/ M<5?P4NF_;^18ZI=/WHW&--8+.*:1V>%L,Y2GY1KHN5O0G<,Z\W+&L4&7:UCF M;D%+.=Q7!K/<+4@>XE.T,JE9Y QCBZ-9'(7HAH@Z@K*(6JX!G[L%K0DFM(=N MZ#QU9KP\^B(>/480V%8L1^&!A%S#/7<+6A-$:!M&. QM/2 <'_9(SS(LR15> M(S)078 [3__O?YMEK?&![8QY4G-]!'/R']LT]ZM0KI0$F-YJU19QHCZ["3&AMIH5M5J M=06!7#E'NY"\X-6-^%T.>X]V*I\,DGW=$SJJ')YL 275\>75]^I#>HE%76 ZK\ M+ WERW6U7EE!:67N44D285Z)<%&94>"Y6Q)=UP==*&Q=M>WNX/A MK^\GUU\*E),C)]Q)ABG]$5)8YP-R>=$MZU*WE.CZ\NB:@XE%S^R0J*OE:O$5 M4$F#ZT.#BXJ,IA09$EU?'EWS*#)>MS#(]D;LQ-X("E\&VKW0LYS^"3S<->DY M[.K^P":^OW]+/,/RX5Q./-(+'9.8/W4/_4-^9S+Y-_QT_?W?3Z>MRUPG/RRU M_PP'C$(X9-#%,!*P46XX<"2?6W[!3_->U&4%)(O@[LIJ@W3@<'_^"<\G7BVJ M#5H09YY0._12O/VIY_! U7^Y949:O:76*J7",WK)7EZ#&O5$:?U,E#:C2ZV@ M$63ND4225T[):TZ)PPO0UY*<6'.J(PI&=$^MA)#TEE-Z6]2)U90Y-1)="X2N MU>*B:[97J)'HI9&:0-B9:/]\UDZN3@_.!DV974+[!)) L0$TQ>("19GON1XS M>66RB<3?(N/OPI)01A\ERK\RE&])E)T?=VOS/YNG=U<7I1)WXKWWT^5M'@]G/H$*52 M6DI_VSQPLCR.'WQBL]O]U26T?!U4+T=G36__JGYOL]NU&9:X:!/<%6:G--16 MK:*V&BMH@BNMCH)R"3FD=*F$-Y.LTI3)8)+8)+'=26RK:9S;4DLM3:VV"F9Q M2 *4!/AXT_Z1%+BJEKJ:VJK7@ X+IG&N@W--DE_>Y=^C>]LT5&QO4VT6+"?S MKM2AO^@,^8]R\#V^70Z^+XP") ??2RR0@^_EX4J8Y7%!\A"?HI-)S2)G&%L< MS4(.OI>8P/4/.?C^M1X]VQBZ]-F&+$?AGOU<0S]W"UH3=&@;1C@,;3T@'!_V M2,\R+,D;7B,R4(V >TK_[W^;9:WQ@>V,N4US?01ST@ K/&%*>T :X%EG4FU\ MJ>_\2%[RR$:?+(J_9>.P*,HPD24F2*AY)K221KUQ3RYJFEK2&)#-) M9@4CL^6DZTW3V8K2].Y$]/>E5K35*:JU261,B MRF[O57WT"+I%A@-V)@W[Y,O8_B>LD%:NJV.?<^S<-86 M><;/Z8THM]1Z3?9?DC28'QI<5&14I98B3N@ \NM2GHGOP^O&R6AT4_JMO>+D M" 9,7ANB6!1,6&3J1P"-"M"]"*[,7T%1,[I'^BE6P4E3147W$ >?[KX4ZEA9 MA=+N^$)W=V]V#DTKJE"Z'P)?ADP'RRD5#MD=L]]'9.0LZP9I7U>ZN<3'\LKO:"J&"IN=,^QS8HJ7? MZY5Q3YF?(W$O[XIF609;);KF %V7%FPMC'-"TU1M#?+#)1&N#Q$N*C/J4F9( M='UY=,VCS'CETB#;'U%:+$/GE%P3SR?TDK.1#8?0F>A_3-+>GYS_"5YS+Q($ M&&W/Z_8 "Q-I#VR]@:O0S2CA2!GIL&7=%FD1/=>VW1N L^(QZ"H^0E;RQ.6G MVE2G&T[/2\S(P/.5)74>+,7&QZ!"(5*VDFU99J\>-YT228 MNMIH-0LO&"2/R9/>=9=RWY)),!)="X.NH'%+=)7HFBMTS=L:-=]8#[)*2N5GHJJ9*$Y- M4I*DI-=,2:LIX]'4!DXA6H/XJ*2N]:&N12WNILR6D>CZ\NCZ;,+@B6Q>JVB% M9_/9_J76_0D"O'S*P0@T;/RXQSX'5MR!=<42/< M%K.@IPDN,2*08M*##\^#&W:4D4=ZQ/-$G8[D?RME5_.II25^2OI9.7ZLI%E-;C9;::DF9)FDN/S2WH >L6I,>,(FN+X^N M+RTBGL#\FR6U5"H5GODO99[UGG5M 8LQ_6/G1!C:]/0ZDUUS1Q\9 VL\D&.C MZ!E$L$)OQ:Q_@JU:^K[6F.O))C02]_*N(-9*4D&4Z/KBZ/KVB1T%YBHF+^-! M\ %*0';3VF2E!NIDP7QW[R3)K2?)+2PAY!A!B:XOCZXO+"$D[Y_C05AT!)3N M#VSB^_NWQ#,LGQSW\!3 KB=1TE-G9!L;?GY,?N+#FA: '=7EB!S-;RR+R?5XU_=?PXOFOFCUEEJK%-]5+-G+VFA-CYTBD!M*FTU5EN0ER2LOY'674?*\]+5: MQU7!B$[ZK-:4WA;V636DSTJB:W'0MH4:B].2(!(>.X0[)5]?W.Y.] MLV_GU;K1NAR59:(( A7@H]@ FF)Q@:[KF<3;8O!_K^S8< "*MEV#9?JN;9GL MJ2\/W3OYQ*HV(5-))/Y*_'V$)*S+8*-$^5>&\A6)\A+EUP+EY[C#1)Y_RA!X MH'_KE 2ZY1!S7_<.ET;\K7/MHN2M-P]T@@#'>,E=_/B";&[IAN$-XXAC' M2#MN $_0/:+ *RQX7]_3;3IU&@N)@@'Q"6*N21R?F/B).KCU "=#68[N&'0X MM7 !^=NK@LS*SQ#6^C];6\J!16SSO7*B]X'7G)$_(7$,N+'Q0:'9VN^5LK*U M)3BO:5TO'A)@VXJNJ%,N0K$=#MJV1[J)WB!*YO@W+,X0?Z??8;BVK8]\6(OX M]$&YL+606>>,:TNSAP1YG$'O.,68Q,O0ZN3P?O; MGMZUC _*$;!'!M4C%P%83=[TE[@+?XGY@> %?_\%<,X"N4?TJZTN >8)SQ[1 M$^- AET)"$<(F$"K& 5&Z:B'-CN MC5_P[?YM?7QK.9L;%V?*'O(O#VM7#8*,$MW3"N@_8'+XH'I;']=@JQ>.'IH6 MG.>:;$BPE^R]+";/1.RI4BIW-*W'UN[GR@F&0,,A[&],+WD?4X&R MI424HBQ$*$H"^(^(K"XF;M]$@> 'O\"T_)&MPTF YD[F17)S$K!=P!O5!7OG MQ5<5 PM."[_^?V_*,<)56PT,85:B8&:%!C,G%W^NNI[>K%FD?G? ,2/)8\%M MKYHZ<3/Y/YY\KNH^I-GK9$3 )\'QVTXP(,J9=:M\@RL&OK)/^Z7\W?64O_A^16Y2_L\GE8\F220G M)%(N*HE(54+B0>&T@^FRXWJZ[!BMPA//Q<9_YL[X FS(0^=X1#P] *.T;036 M-1TAT.[Z <90.M9.9S*NMRL[0?OBI-R4Y*F M^8!N$=H8K&"-N02C1$")@"L74:6YG3&LDM89ZD>[)SL7DQ]MTIG\^M%WCT]K MY/JD8>X:K6,@L@"M,J(%E_^;6YH7WN850W1>4L[#%UK_[\LFO]U? MUU9A=6V!RSXOI;)-4[5R32UIE>5GXSP3!CPUW4T2TZLDID(5B;X(*67+_UI" M_J?ZUI\2@+)AV20%^W/WP49L20,S]K@_:K1W/G\Z_G$IS5@\FP2LE*:Z O:)+TS=G6KVT/"0"2@1\ M>3!FB[Z]A.C;(R-@P9:.\AT^VP0_M!VS/71!]$SH]R#*RFF+^/C;?K=O[P56 MG^3<(IX&./_&PERF()WSN(PS2(*3K5IW4%P%NM/'>;F*[OL@UO0$=!5R.\*\ M*LDY M&W:#7FBW#0/$;N#/2OI_7?=;J?G-M'NKS2:__H7,- M,M#UQC\]D+)[[DV&2=__^=O],W#._OT\D";]XC(?R^E]G[K]W:[OVB0@BB7 M+9G:>C*UNWG:++6M6NK72VI--AB6%)(?"KE'["]((BM(=JNJ5:U@GOQ%I'TE M(>T_Z9:#.6S'SI[ECUR?MGD][K4Q%$TM_*..:76&?D+X[P]+UG6C=U@ZKTDK M/PE[A*,BY+U)P:G;V/F$!O:E@;^F[.MN[G4G@3U?"GQ)NO0ER:PMR2Q?]E?5 MTAI$P;+E?S,A_Z,L]:]$]\DI'O1Q[\(G%-C)I(E]EHDVZPNXZ=4&GW<_GY^% M%>D+F)?8G@ D6S5H!7&2NHVP5TZ/+YBF(+G>:^1Z#Z7$5?L):F6UV5I!R5SN ML4#2S^NEGZ6E"-0T4""TPE//_?5QGUS7O+%LN^V8AU$J.X7YX7"D6QY6[UB70BK"MO2SYI_B3R6DF3D\@E MNKX\NMYMP"\@$U8K?NL5E+_%CW*MH'_DBFWKW%&"Y"$YY2'%+)N5""@1,#<_QN?C\U_#+V;!K+&E-M$< M@*8"=UA.LG\(#3K$Y=JVI7\43")]^Y08 MQ+K&&44@DBJS.4<_2]6K\^/>U^%E5089YP49.2S9BKT(HI)+Y(("GS]M\GYB M6WF%4:NBEK6"N6$*-ELZ'T K L&LB%Y6D'S45+5:\4/OV0K!SIT*@4CV!OLJ M6Q/X>GU]W:OL[E0.ZD6P55&Y37$R-@)8>3'&X>T3U;J5&KWE+K]5KAN9VDG[6AGP?K MT@L3T/*ZAJKU5EEM:@73$AY:;CS?R7*BC]'#@JU:#<,+B?DUCK2BPI#.'SZZ M[IT/Z]7?I1N9/WQ'$&#$@$HU!)V!-1G!EOQ.\KN%B?#9%(AJJ:G6*S)H(&GI M=='2"AJ8: VU6K1 PB(J1>M.E6(7'HE;_6D%@]W0!]%./ '\\:PN,?CU97#T M3_>3]DWF%LP[E#W2(YXGFI-[Y)HXH4PLD"QO 8)[-KVAHC:TLEJOM8K,[R09 MK0T9K9Z*EN9]J*BE5DVM5M:U8%E;+#N>5H[?H2FPD!A6N!A9UW7,XFWQ8[JO;)CPUDIVG8-ENF[MF6RI[X\$=S)"U>U MB1=KDE*NR28I$N77 N7G* B[^^V][-A#MJAZ+OV@ ?*H8$Z$1?2#_83_X(@$ MN[H_H.,]3&+NC"]\8B84LS;L^5JD+6CGG6$0*PA#?7=W_W1W8G\9=R;#[SMZ M[_;VUI3Z_5"TZ!L&%RH?6%0$9VDQ MVZ)(!)0(^*)@?+1)BX62?EH4QXWC=EZQS8K 4@YL]\974!M1(D"Q];8+:J3F M [B2$>1GB1(!)0(^:T.8$WV,S<']<[=M_ DMCX!, H,P&)_8NA.T'>K:'O&9 M$EJJB'SWUZ_.9#_HED:A>>%]M64$=L[!G(2>,=!]XD>3J$8RY!B&FC[ [ MTVURW+M3/$>Y450T[S@C[_A7;_"[=UDPTW'E35T85-F*>VA0!@.B^ #@=1'. M,O#RK +^;H:Y.!&OO#VLG$HM:4_2W@MH*V6P6HM/>_?[$Q;W;*>3M5!C22=K M[4[\YHW;/_N]VM*OE3H6GCMORQ)@EGE;DGD^F7DN3LM2;Y%Z2SY@6QC2>URR MUJ*TMX)D+6R8MS;NEAR[0UX[&\H'ZA3!45O,F*1$0(F Q31B#RQ'=XQYZ5F= MR;_GOO5U; U'-2)-UJRTK0B ,FTKE\0G&81$0(F +P_&; E5SDC;.N[M62BC M'-,_\7C+R+/ -:[:CLF^((Y!Z#MF]XO\CWX>5F60>)4D)A! M.$K9,@6<%;#5?8+#;)0=922 #N\$&$LVD@L2?;$,KFI=9G!)='UQ=%TP@^L! MPF/%W3!K:JM9Z/[SV1*[&7>Y$C _<+U38I+A"'>(T>@DW+-%]*>+7];76O-+ M\URVRYYW&C%,(X$M9?3K8GH+R^B6E-$275\<7>_J,[60L%CU>*Q6LZ26BA9W M?Z!4YE[>J12Q77 M_?EY.3K>^2[[56L33Q-N*$Z(UM:%IJK:V(S#JCPHHI[.B4:E(9467 M]VM5_\?HM%9"2SZZ1-5!]KJ6*+\F*/^8%.0,H;5B5T1+ MK;=JJE8MV R9>S2%'+L'7CL7RBW^Y,Z+6R.T2BY,5_L3SY M&LQVL-!/B1]XEA$0$W\ TSW]1>+*$UB):\Y.JS#LT 3!O7]K#'2G3T[U@.SW M>@33E]'F3-B9I4_.V<6GO;8_D*G,L9U)H:98#K,XT4D=^[1)#'[):W)!Q\^= M5O.\)/O,DQ+JP)#KE8:J M:07+52ZB"T32K:3;B&ZUI]%M6=5J8,*4"M:^9&$]JO9B>M1^9S*>_!GWSLZ: M1LF0KJ*D2L6.C_WO'.V*@.*U3GI5F;(VTPV[-LD+@_[/0WCS,C;PVICS$WN[ M:555:S74:K-6>.XLB582;4&(]JG9FR6UKFEJI;E>*E6.W4"OG77E%G]RYR O M9DA<(J!$P-S(@52Q8&1:GX6CD4VP,E.W421C9[-#APE0D'RI7G"GN\-?_N_1 MP>B[3*"@$$\"CP4;>@ ^Q8KA]U[R@US0FN0'$@$E KX\&.\72(=@UGE@)9[H MEGE$V BP2?7ZJWE5.MFK:5<%BVNON 9=0(O7H /,BD7OTGGS?,Z;!6O!&B59 M"R;Q_17ANU966[EP1=BQ M]08(02E@)<-9 L.I%)?A2'R7^/Y@?*\6%]]E(*T05)];_)%N(XF !8.<1,"% M#:W=J1Q5#)X=N0Y&@N*AAHZ9T5T$LUILUP\]DHJP_:A>5)QO]=ZG"ZNX5ME2 M2Y1=9XL&UA)3@!US?C,L&6_+!TE*MB$14"+@RX,Q6VXUXF[1%P[ZM$Y"SQCH M/O&/>YB3.<*4!A!&W?)[PO]*1Q<[);^M7K5G>*5E^Z8E30!XGOZX#O\YL]+RJ=5MRSHJY6BS8T MXB%UED(76,QTW77A=\^GTSOP[<3?F9WXU)E,_E3J-Y76Z<^)5EQ3=L5:0PS* M-9OP5!CN^?!*]WRRT 55AJ8<$2&1?KU5AB4),3F)ZBE*A?90I6*/D"$QQ>C. MJL6(Y[LF/"LZ M@S!>8P*,%;I]R7REQK$$C4-.EI!(+S6.ATJXU:H?V/RVU2I8\]N%E8]V>A:F M37Q__Y9XAN638P\ CRXE,2&,:1+7.^4?_M>AL:<5S5>Q,L\$!YQ"..1H2R= M6MB-4"W$,$O),Z6BL&YQ4XG&4O0O(/KOE2\KGC>Y_A+\F,X)]W&()S$/7*]M M&!Y\PCA0,-YUAS@^6<=+OEIZU[+A2R;21Z>#YDUC>#3\U9?.@>0A<("R!5L4 MK(A]BLX 2Q,6@C&.KHY J]@"MI)'2A[Y4![Y< I>_AB0--ML@O73*+[K5=*? MI+_GH[^E*2W-BEHO%[\O:J2Y_!7H@ GP>7/C[]'#ESW4O;X%2\9+HW^7BAK= M:/G=&,JCY2XX#7Z#8%N296[B?$ V-T!% 735G3'&*APW@"?H'E'@%1:\K^_I MMC+2O0!=%<& ^ 31&)0H'[0:^$2;T^L!B:H'X'(_@"\PGS9Y%Z'5R;@)N V ?E?#R"][<]8)#&!^4(F"N# MZI&+ *PE;_I+W(6_Q*Q"L(F__P(X9X'<(_K55I< 3X5GC^B)<2##K@2$(Z1, MH%J, J/TTY.+PL6RLWXE7"KKH)/PA$?,8/&2+2W8$GL8&K:>WRF5FF_$UD R M;VX<.F:([9#AJ8>.L:W\W?64OV#'1Y2U!:ZR&_&OW23_.HCXUUG$O\2]GT.' M*)62JJ":'#WQK>4H%V?*'I*8ATY=@R M#Y!]@N3N$L]_%UU[X>BA"5:M^6Z5 M$N/9D(?I&4?A$&XV%K8LB&_H(V08H"N]F6IT?>SU=<>:4*4I/ACX8T?W+?^X M=^*!\'$"]E7H6P[Q_3UXH&=15:SMF*"#N2$VM>Z?P,T&8, Y+&K'QL03I'+A M"FF62HD2PY6^MS-I5X*ZU?[^^\]U\Q$ND^U0\K;SX>Z4'HT=!%W#FB ZG$")8:((H$0H M]%P*TR7P :LW7KE>L$1BH+9% KN.>P+E*!3'XO/5;.0L_1F=!_"Z8*96CETH==9M[0 MO[0/[U3E1O?!MC%<;^1Z5/2#'#\BU[JI8Z[6L1&X(+H5K8;BOM3:5GX2L+QQ MYJVJ$ = 08@'9A,P/!^4Q]O*.3X$P2&^4BP?5D^XF:;T M=!^TLRUR[=K7R(1] MOR?/'SA8.J"--T?,KX&Q\4 HMWA_!PY%J@Y>N]L=+W M".A*RMLKW29P,#>6[^-T:\]4E2&\EWXP0$+Z[]3-C:%E>*ZX(W4_W(%Y'/!* M/6#KLSP?/@'KHR]"F[%/X&Q(,'" AUZ3/J&J/6"#ZR%O1.C"'Q3L0QW@WO-" M*X#W^*$Q4.!$L>#_!@X.,0/6TD7SBO])[_)T?\3_?H=J8![HWQ",=42>/0;8!Y3$+\1H^B_,%U(B0!8!Q0]>(23+OE;?6.S#P#8RP&(!H M@+,,N>EV0$HPU5@@.I_G:;C#(0;CT+H'TY#@2[RARU>L^&,XVR&GA&&,N.8 \?9!*B$JQ:$0\9-S/-:@(-_%$ M8)M#C@R4]AE>ND#*'G(8CWLXE;:-0 <:&KH^\FM0,%/;XD!TB$4Y&9<5B@/' M2?6'2+H@*P&!YA&&_@)+GLF'^J):Z5\I"^KCL@VJ0U C>"XMXLB4&N=P'D2 M$%O'#C"IQ>RK9FQ?/>)AG5'SXT.P(FD0IS"FI' &KW7(SCD#J3L$)^C@T3P?7KQ4+]T/90+ M\$9DOTRCYDJ5:?E>.,(;45VAPV2HX@1VH4VH?NH; V*&8&T@9@+CO23(>-'P M RO! O&''%P,S,,%^@0DAHG%;@2%#%Z.M^*K?9U:+?PI*,OX,!NJ&6YN,%T MC2@+0VP]L$N 8:$J3E"648\:R!QVTFB9@%CA"@(N'W\#-@<:K/T:),-ZTLA> M2*AI2+6GT$$M&]7SL3J-9T,7;!4T+A ).-;&OP;Z%5%8I)_J4Z#(A51%QXL! MNV@PD#X&=,8^:CE(*[;K]+= .QHJUAP^'5$<)\4NH9H-16^>S0#Z(RC90 J MCPJ+90SU,4:1X1[0>KGZ%0CU'5^M>*&##]:O7K_0LM'85KB:KW'5#W4D)11@9DJV/(R/%@S=9HR#=J,@"W58W MV9$0II^#&DXU/J$KLA]!8Z2GN[G!^18R*,K&HI?@34DVLDTC631".F.;P&+< M/B 1/@4[(<"+XA=2J,.ZP%8BQ&%O@,6AX]Y6>B'R)+"1"'+&E8W"J!VIE<+>FVIC65.]_0F=R M]._E^/)WM_WCZG(-U=,JZ-_[PXO@\JAL']HI]30"C2)@\Y*Z:)Y#__DYY-@) M0QV;0D.C[@-D3P8_2?@EN$&VQ@Z9F?BGH>];.ACE\$H44P/]&G\8@Y+H<76- M*JY,IKA1@%--Y#=A I3%_'SHDQ'?;VYX9.1Z*)Y2JF-J33<6F/STI:X#[%M7 M^NBT0 _/G!<+H>(#9X!#[L M)-64(,3_M6WB]".7VH"D%\\L@HLSP( A%I8:J(*S=>O4M8/[CL(DT;&Q-4=6 MC#\BS&U(<_RQ=6[(W8A,2:*Q;V_, RM^9-ML*VT?+P#>DPB=>R1R^E"DX%I7 MZD0AJ@DJALN5M$7QEC?FG8S/*7F)9Q-6D"YD@7!P01>1(\),$JCEF8$!VU MG)B!;$"(>\Q;S8-# ? \TZ<& E\8?3,JRZ[#XUGQ.EEC9PPUT442=,D*_9^G M>R)XX!'4 XI0QD59_A7U0X)N2]MHHYLY>=@D(3"C4[]/+TIH)[6#SN2S]N7[ M6?_VN/RHLN#\B"&F:P@9FZDML-0031I2:/UHN3/$KI1>!( M\;6S);MQ[LPK7746.)"X3"G-$18MV\(6FM_=%G4Y85'/N:,S^=KZU/BYXYK# MFW4,\.QW)K6+X^_77E@__8H!'@&'9[*6GUEN%YMVCC/LBRYA#LZ>'3*/97?, M;2-^D"SA(>FJ1?W?$SEA5+7FOU@Q-TPHAU&R!>BI[C4W!%%]3"15X$,P%X-> M.Y4Q@D^_&5C& #5D%[^D&25MQPHDL3(_-#8/%YJ.@.DLM MFK+P^>OQ^3RV@Q8ZC>Z(H!*&9)*S4J@FSTQ&86Z"O6$D3$&1-T.M"_[ZR&;E MN30^IG")@[ 0K#V;1;I@_0.KC_;!C4Z-VM@_GGA/Y&56T85KP=)YOI&G.S[: M&>S)+)+$+&#A-HCV#Y_1HPU"S*=6*D!ZB#D8H/W@EL94E#%CUX!A#,=?*IS8(F6,@-'V&4Q8$+?#*\!I-&F24>'0)?)EAN M.@\I\ -?+V?V(OQO=:YM4>W!BRNF2B?&=TOBO439QF(/Z$RT3P>5DE6__3)\ MS)#[O!W;M&!N=2:75_N_#QM?ZL=M\\W'@]@9&:F<2K*"16:\KT<$F699C+ M M#F/?"8_EW26Y*%+0=>,BIV7^0>Q2(HIUN+<,PX)<1* ,-- ,(6:FWXS&483? M6"2M?VJW3Z*L=9XOAZXL!Z08Q4F:]7Q%%/3!#H7[#6>XA,,1CV>C5.#2EWG+ M,'M\B OE"=U<^3"CJ6\ORZDKI>UR#8W2%TLH6G5$$NUK:QCQF-BHO9MM5Y,& MU(*/Z$Q^M,OMVNEM-336D7%KG8EW=F$>[4W:YS\)6E04,)L;F3X#R;2+M*79 MM@JA\-0\I'E"5,O!_?74WT_S-!C?9_QX(5Z^N;$@,U?NX^6LX('B:F+1EL.Z ME@C5G*Z$V8HLN8UG* %ZH]ZME;:^\VBL3?"ODH8O/HU"B,K9UK_;RDGH^:'. MA 5+,O)HCEXB'9L9;CQ_:F89V,TB*1Y4S+K&XJ$Q331"CRL%0R;TDT!&H'HF MK9V@6T.0J(D#B4\5#2%,&RFZ^:&*$OSK5NTYX*!SY.FTEY*ZH5T@^B]%@WAF8 LM,2$XZLPB).17#0M M#1%-9/5?-+-*Y&?1H:/3&5H55N;6U6U6M3*@"5/),Z;X.I/8E4QH8N484?Q8 MD&'FB=/XGAYL;B!-*MTPB-,$1/T*AM:YWR2%:3W7#5CO%*[L4 \+H@F+G_*\ MJ.PF*TX(=QT2C4J M-)4%17Z)SB8C:6YS0P!WO8SAY]:CA/F;:C1PM_:TGQR'?,=MG8E_?/#S\T[[ M5_U@';.X]CN3X/>5UPJ&7T-=>_/Q)"'=@ ND0*.L2Q;7NFI'#U&#!.^E_)MI M-S.Z$75/!WXR28;J(0.7IGW<( /TPRX(3DNG!<+*/V/3J3VTO04M+]]-E+6>)POVDC>?[9Z+6U$- '5))%U0ERS/E:9% CTKX"Y9 M+N>8PYY@:I8CJM.-)'*_!@[\ G;[F^?D_Q<^.>[M"]_'%,??27#\](6=234H MN]?VY.;PY#&S[)< H]7;Q?6+\C@\Z?ZY_@>X/.R?LO<(!)*SYY:4OT76S>8& M.O?\!;U[S&B8\O#!F;.)SKPO 0O?Q.7;2<..=2B@1B]-B8SNV]Q(W1;5[ MT29CGA:]R/I$B05-.^2Q,\6,BT^B'#]10\';=G!1T&41RB ))C39+$SP98=W 2#) MS%<6!Z41,EK]@Y$6:AS H>+>+D.SSR'5=4.>%*E[WC@J_K[K^)B))4Q)6)^) M9J0^0F,;2V[05&/;\]W0,V@XT@C"1*055 ;W;X]M(VX:4>K^048MY4O9)R M*M<@WJ/YYAJQOSR6Q>A+QT+\1'20VIQNU\;"*0IA"K\X9LL\ 5&=-^UGX)BZ MC4U8L+";>V 8@*VA"-4*0SBS/L=!BP]#D/3F1ZZ#Y7KR/6(TT^EC+G;R/##] M&N.C4Q>S+N6L*0?J:'$7VZD+3=&+)-!OYYRS*B:9C%D3=-:]1:AOM$3JFJ(E MRRS -A586X\G=,/1DA$PZ>MV3-W82.Q!&:?USF2_I'?W@FMRVQ\4VB[*C\A( M)&0MDMVJE61ZZU+36QO/EMZZ#A 6=',G9&1JKDS-E:FY.4C-C5RDNC]H.R;^ M'W;5!_T#S^B4X&FC!I7].W.*WF%0/^6QG4G_NK;;FI@_ONB%UB2R;6]0E?X8 MI/G[Z[!WT>BQ<74JED3Y R4!"U99%T-,P0ND69[3P[XC':6-$4A,+P7[B_7C MXW5CS+BC=@58HK -8)-#[/K++#AJ.WN$B% A6(9TJN&4?3T"ZVV F9G((1-1 M2V:8T@8.),:J[6FN$ ^AE MZ8 M/077TJ2]=_9CM#N87$5PI=R(+T%] %17 42MJFJMQEUP5"GBB\X<]X&C/@6. M!--M![OUS^2G54\#*B:PQ\!L_OM7 LV*VJK>"4W:78^6 M' L<1!QC\7E&9;RL 4DH[6P;\ N375OP>]9E!OD+8UN.8"[4&<%1>;TB+OE( M -_7/?1R^2?$.T,=^M[^YA%EW'-G9_+/9/QO]U.9# ?U-=32#D +W?G7+G_> M*7T*^Y@Y:+A# C;'5T#E=PI !9%^B$E4"!V9.UBH+6%9@T&ST[!1TUN;GNF( M^GOIF3)[DS9=&(Y"W@S!Q/GGK-$M355*W*H'H*5W0^;&X3UE\3$X('W@VK1Y M$V>:-P3["A-S2V?M7CG5#]ES[+I7F;7/R*T1.=1>Y^S+V61;=$"(Q<+XBRJ-9JX0NN:Q(N9WH7* MPPRLI2S^Z(Y$81F?6\LS%R/#B5V&4C#9ZSKIA5=T++Z"1W!W ^8"8-AH<^,& M$[Q8(UM>H28* +*7I]S0J$D7'>Z!);:SK9R(37<$0K M"..AYBD \(:\"1C@0M'0X$&1.2#!%C8,L["_,@AX, L(X%8.NHN]IJZASV.+ M9IH;B"O)K\HJ2VP$FJ9-<[!Q":*Q/5:%BKA$\7N'L7*(58>L'SL3ME36@I8< M<]MS=]=UL(J4#F+9(]W@+&KJTAE9)M??M9+6Z<2:_*^3KSOZT>Y7^XL6:?(G M&7Q(3!1F"=;,8&'23L!+:4-Q^; M8"6TU&:S-<]28!E5TR=XL((3+$EA-C2LK?(;9Y57K6 MD=WYAM2!;BO'8KAFMLYQ][[5&43?>P96U8G>$$50=FW=]X][9[BG]JWE)Z]! MJ]O?.1%33.@UWVAN>6=R3JJCFU:_M7-]M3J2>0803?.")8+HQ\WGUI>OGTH_ M@O(:<95*Q%6X5!#0Z-P!C"=QGAQPSI7OL:'607EJ-,H9W'7>?&BF/"7Z>43< M,V45!4H7C)3ILJ!I+8U:!E'FLD-XBE54%89MAZ/^&!&7]"DXE!TE DB"_:;9 MY3E-6!.)4M.DW7@.[N=[P=;6.1+B<>_0H59HJ-N,I*-1?+3/H>NU'3A;O=<3 MQ%RVO^D'U5[Y5[A.*L(L,3,X=++!\"04KS3KJJ8UYCJ*L[0_[3DX_E/0XGAX M8%WT*LWQ;76-T&*6_ZT.+;Q7P/#5MC28Y:=ZU M3]$@V.2%HHQW8[$N\F>3GQ)SW/AX4 B19'+HJW;'K#Y2\HDGZP*='$;9O&V: M='MWT*228'B+/Z0S*>F_S/'OGV5SN(;ADW9G\ET??;UN'?[L?ZF]^2@ (Q-8 M#FSR%( Q#D MU6WE4_1,3%&_ML@-+UG'/F*6QTI;=%I!C66%'INQU_.B #^=D4%G+M*T&&#V MV(N<+C%9-L:/"A,T-.D#1@K-0:'2$ MM@EG.1"H XP5U:6('F^]H M83N%4=@%E@IP_!.Z5&33P!7K5\??$\>@6-EJ,@[%)3!K41CI(=O*86\*^'.P MA:4]P3HRX=]/X'BREX0;<'S 'A%M)XD<./"W3^(($J]9F23Z.?!LJNZ85P\E M:X* 9-BO?&$9:\XX]30*FP1;"=)&!J+2"8D"BVW23WIY941R\SNWE!'I*<^? MK*0KH/?V^X2R'LI8^7@D^,7$@:!B'!+59!F)T=@M8WGT"2F>ISNZ/>8%;4"I M4?0S@>Z<*&/VM$-#L=AF?T"G0+,GI!<]BZ#3/)FC/V&5Z@E$W]QH(VMFY6WI MIT;23@<"=;9HTF1,P#,4FI7,N+.0%G@8/2L[JC&XL,+@[,_Y81#;II&T9"5< MZ4*SQ.KNLSH76=52@Q(SJ6?UBJ:6ZM7Y[H0@C:_;RI$KD@VP!*Y+'-*S@H35 MQ_/4[C@K3%V+CW?Z!0\I<0.5]L#Z-OSR>\>4&BFR4*SI1:: M->4>-]ZBZ]V_-4BCM^WGU?9V(U3H]V?O_Z MX1PW"BVYLKU-E<[$W_UF_[HY#&X"Z\W'"!J;&PP>,CVW4%MB@09JP(RFHI11 M! :^(F1(%0;:^P]U=FP+*5IVT&8)Z++'5 "KA\X'4 4#@1E1=(?:]N.I1ZJB MRHI%%2+W"\OEI;_J2L^Z9:THA5%"%\.,(_1>S+F 54!X"LWFI.\PV"!<@UH6 M.O=L&=@\$L$SAK>#W6'31J)P)1@!)B9EPX7& M8*JS)04_._7DOM!-(R9>)G$+O9)HJ.(%(\_ML@QO,:0N?@">#1WI1ZV5^ &O MP5&R^N#,*6OC@K?O\HXL/X$4=GD[EKO%9#(?\6$/ZDS*O\AY;5@];5OV&LK- MO1 M_FRL;273:Q:ZOS/Y<6Q6?E]_WOGUJ]@S'VDDJN=BCR(J!BC/I0*]1X>U9D40 M1*.G[I@WM'K_/)BZ @MOV>B=)OJ=_EC>Q&Y]0QTD"3?2XLN8@O*T_XDY$MX(!TSL=EKT#2ODCNB(FEY0%_3A M%U]5#"PX0/SZ_[TIOXD0OMJJLGS":KH$Q+=V)]]O^C?7YXUIE^(=;LL';7O5 MG (WD__CR>>J[D.:71:5J:;C,]=_AN.>?O2[O%]@G"GG_W3RN:K[<.:@DU5K M=F.,OK7,VW'KLE5@I)&,9D5(4^]D!8)O=\I.>+4;MG?- B--$3@-QM90[7R$ M,B>UM]701_V94?ZID<#9.. R07: &33* _Y!\_B<=@[[YM+.8?LX9"9E9SWD M<8O\DW,08F#S89NNE-0$P'),/OEGP\/98C M>BP_!SV6U49+4[7JW*Z'DB(E1;YNBIS;0VPU%%E3RZVZ6FO,K?R5%"DI\G53 MY-SV;:NAR*I:K534AE99)XK,]A14GL-3X/0MAQ#LG@''=(PE:/RZR%DP[MJ' M9U]&+>WF:J7.@I^L']L36,!*O0(QH!*C&'P.JR?B7FZ9:@$DTQJPT/EF_WW4 M^>A16J6*6JYD]?]=XFGD$F$DJ;UJ4IMOT:^,U%IEM=2H2U*3I/:Z2&V^J;XJ M4BN7&VJ]N@++(/<((TGM59/:?!M\9:36:*I:N59X4LNVO)LKM+SC<2X#:S1B M!_,/6)0V?!0F=VGP3W5P/?3T'X\9(_]"\?E5GIR %36]!QQ:DF=*GKE,HSL: MNS./,!_OLVPTBL\J)85)"GNBK;TR"JMH:KV^@D26W".*)+%736)WS,=;-HEI M#;52D5),DM@K([$[QC,N74]LJ-55I)KDPJ;>>X9H]C?+QW9;ND/<,(I??]X] M"8Q]I__UZV,:(3Y?_'J9IY("1+'XWZ*U*#E$_-5OHJ \=&Z .X-@'YVJ5U-; MM;F3'0O#/"5]2OJHDB"4,K#6DS2P)=,P)=5":5BRN35I.1/>GN=H=[7?VB$O9E M8) Z90IO9INV+5)7KC.O)*5E6V@N"I!VDI]M*M<+=6Q1J7X MKCQ)A)((7SAH_.B0L%K2JFJS*=5O2822"!]E'*?'!#VV@KI1K:OE9D.2H21# M289/"ST_(0&QUE(K6O$+_B*[G,^4OF_V>?N@,_EY_N?HA_E[?V=47M9PL17N M6RJP*#RTZOIKG5^T7BC!%: M@$A=*#P5KR=P2C/N9TZMO913TY9S:N[E[^:QZY%!8.7FU%XZM@!;IG,P)\14 MS- 3,VD#.EP!C]2W;I6A2SNR$^S(KJ1&J*MPOS\B\,AK8H_QKQ%\0>?PPLNV M/-(+'1,9\.:&24:N;^'(7-A(C^ $=1R8A[LBGF)PV/DX5QB><6W!SNG\7@;.%WE+J2?15@)^NIR/>O0?T!-W-MAR2/8Q5:1L&SD-&3&2S M:I6S< B;&T]'"-8!5&MX^G2T*9]=JNCL,.E8TVB J>70[SV3SJS&@=]*^VQ7 MJ9?JV\H%8@=E0>)J/P VI'NFJNC*B'B4"])!XEW8%L4I'%RMX^CJH>6SIT?, M@LT3QR\X?\&!W/"+X_=PACH.JP1,,P*E[[ITKK;/I F]#$>0\]NVE6^N'TQ- M(H\FLT:LB7[2807#T ZL$\N1$OV>>SS^D@< *<-=TT)B#&P,$(3M0X M!B>[WP CI!/>80DFL8'E>F,Z3QWGA@/K!)CI3I^J3X8-\B"(1ZBSQK1TV/F( MS?+&UQBP#]=!;BWFF!N(!(@)\08&.@@Q]AH!C6CC /-+8/Z*;?7@76,#)]7# M,2@]W;!L'*MN$A]P3V$OHY/$F3P%\";6$FV&"ARV5)P[KH,(I)?3[P,=Y'XX MVE;.XR, >X^P^?&P%)R=GGY-!#T\V8SGBM^WE3/8%YWE>O?Y4FR*994X;AW$ MI--/'W<"054E&(_P.$&@)8_:=>"+:(VO2<"Q&=2$*DKDX]__L[6E'%C$-M\K M)WH?S/#, XQ>/AT]-::E3(?6@*;SW#]+5 M2CA)=U86Q@-.IJ.R@3O*-(MCZWJV.WKJ=6]2@!,@^Z"8/< OP#;!C]1,M-1H3^P'.!] M%@BNLP"^0/;NBWM3AD/TQ+? /B_.E#VD)^"H<-H$"7>@>T0!*PPI?-0%0@0XG+/+4)>E5A:B@7>L>FLSP-E0HF,EM.:,0U FJ,'4)ZJ_1 MCPK]#:&5I?# ID*J?";>255XNA(0*-/ZLJH,W!LX*@]7!@^-GMXG#O%0\=G< M0"U-O]8MF[Y?/.U>71H7<-^Y;2L'\+BD:B6TJC2D.$R)#R=UQPF@7\(C8"%0 MR0AG:H#H1CUO-!C[5"TW@#_!(N%=\$3#%X8!UX=5Q0\!"0!](T48"8BB]Q!4 M>YWK]JS9*9[3M6M?$U-HX8BJ0+YP$?I5Q,-]PQT11>CM-KG%Y_+?$D_-@@+N MH4N$CFQR<$7S*^BX"O4>F,!AF@1V/(2G"\\-,70_PE!RBXX@ZJGQ@P@D)#DE M(V%Q,#L'$9UI7_"WHH]@A? V.*'-#<;PU)AF]-B\ ?,1I 3%(W:9CT<+?UO^ M@"T.4 24"'SOMK)'1L0QF<)-U^3H0>A%<)V#4Q1S8DMVJ%-"HZQAV 4Q1PD: M'F%:/8HI 1Q",'!-MK-I2@.2Z,5H-(?[#'0X[8'5'X!9@/1,;X>3"AU^Y^;& MO.,!$CBFR#K-*GR*3?')33&TTTKP"'F MS6%F9$15]'I]B!:_ .ZL8&"HF.;RC&<* Q[()K1[%GK]7H$I5.PM?1+\'=@' MD[O\L%W#"$&?0[D=>2%B+HD';5(AXE,9Q#TR'M,5DIX7)O,3?A /D0>]1(0* M(,8+D>T 88'V.$ >L;G1HS\E4)7ZA1R!G?@SX[4I\4 YF."6 #",$9AIAT.$ MN+%N$@M&FS(5MBW<.=>48.MBA_[T_@3/!^* 4X4S$)#3 T9 ']\J#]@;#2U MFDAJ@LP-7(_R?X]2(MSA$>!R#@(,)0SZ8:P>7(&^-#0R=,91J0A SJ6R M7SWB@\Q-,XO(UX(P\$QV%9P+X=X]?%UZW4$FX*) 7QJR V0$-A,AJ$165E8M%,)MILUYL;\)HDR**MQV[(-G6A[!Y <&%E^TT;)\?M@ @S0I7Y,LI!]1B D<$@96PENQR4&"_F)+CAOV!4D_K M?<+((2:SOF,7BF(##MC,11'A!S$387B6440%(8IKDXPLRKP&[DW"3Z)RHTE% M@0U"GJK.L4^".:%2.J7N#Y2>[=XP@:P#1S9XM@_@KP/&GX&.,6! P+S:IDGS M/J@-B?R/OME"$4TU;8;1_=!BH $AG01,;:M5BB#3TJ:]M:#,).#S5G^'H#!L M%^T(E T50DY8AC@1<*LZ$51##^*8E"7'IP2.BL\=$I2IDQH_BUY\_+HLB$.AJ";--S=^L! M(5\1*N37I' #U]YL;B&Q"$SD+O)._B.\R0.UK>^F 8!UMXE^TZ M_2WT/+Y3 2*]=YR#4 P023B1[1@#"(SWD0N<90LCG]3_X7&#$_Y@B/:V_XX; MMNCQ<8@-]YB6A\DHZ*^/LPF]B#U8J'(,B6GI>+KOI%J?\RWMH+(*R,OH3\=P M ^(NH!BZ#@4YBM2BR-$W%?))Q"R8D$OI2DG1!>R*.XOBX)%PA# N)QJ*,PDX M3*4.W]!@Y9\0*T?D,!3D0D\2TW@T4HR@R>G21HR@T=F\!2 HR_L6*"# M8/#P]X&)1'.[HDN"'$83&TQ(/ C(^ IZ<#XU/5"(D2!B3"Z$') ML_/Y_O39>H8;R[;17L7$D3'1:5@==%T_'5%D7@70LWG>U0+NZ.C]<>)6=#(" M]LS(CB$>Q8=90!:^&<*ZQJ] ;2[VE@11,S2)J%J9(>I*M;0%_RW7MJISH]34 MS><8S*BC&48\:\SMBK2_&*4P)\&A[W%\E@R*]X:8,+*Y$9,GD#VHZ!-&ZXE MXX"%\@,_)LS(*X4B[@:#_S=N:)LL.).(0UI^!LVIMN@NUJ@2+'4K,X!'QF@>(3@.Q9 MFAC6DK"<$]BJ:U@I7R]RT2ZA\7N>;$ ?@*[,&4>=),.<;VEA]4T4)V]NM!GV MXYF++Y6O%MB7MH4Q1*G'%6)+\7ER;N:1'E)S1.;)K$J,:L\1WW%.1EK/BV0Y MX 6RHNT86>P86;CT!^&_N1$IC%R7G'XBRQ!*I@6F\SC"J-Q3\/J9;#NFHD8O MHGDAL7^WFW(2HJLOG0H,R[&"UU5;5^PMS>"XJ)$-G2Y-">:Z/4VP]$@6ZJ,' M@IBI;&1^ZW1N*<]!9WU_*&XR-$.I#R@C(I.8VQIV+T5P@>A!*>T"(Z,I1*AK]MLQMA=A,,V$?TZN5U);S+<74EF3P MU&YCY>Z"ER<] TA?OI\,G<0HF)V>;&2)$9:LQY-+*=U0A=Y)+(8FUYJ$8VZB M?P"7&+';LJO;=)W ])%IS%KL42%2,LL[6G?RV:CBHYV B31<\]]6CE+=3&(. M(KJ:1+O)+EU+MC31NT!0-(B583M3/D U]:A+RC:J;S-4JU@YI_Y%P M+&OEBM:9]*O!WN'/"[O9JN4'CN4MK;Q5T1[?)%6:V1'U&)(B M)>=;.G ]IAHLWD,JTT,4\_NL=G#U12F))T*>1H_-[ 0W^5PO?_6;>[5?5B\B MK=,9Z?8D(II9R6J;BU=K:D.K/XP_/1FJZ4YMDU]F_9S\<_SSRUGCQ:&ZK$:U M%;79:JKU\MP>F;,]T9*YV]CM9DJ?T0/EL^Z$NC=6-*YR'_"2L@5IJ/P2-%2. M:*C,3GO'O?YG_[+QY[*A/<.1+JT!N*:6 (S-REP)Q&JB'J\4S0.?E@;?MW_. MQM[/(?G]]>IYP+>'3&?H$)N"8K$6P>G>V-QSI7L![\*7L/7BLZUE]R^%16+KB M*!/;[<4NC.R /X_"QOG]?$WH(.BZ8;! +@#WS])V/QF 363%XR&Y/HE6GK7@ MV6#K6A6D/2!MMBK39I>;-JO)M-F<9D;*M%F9-EL G8?CQGAS(U'\J$9-<).9 M@_B[P[-T4,3:H,HXOFCO^R>$A8LJUF5%I M*1RH.+0KE66$=C#=:(UV< !SRT(5@N91!2PY<#86XK+8^;TJ -6=L,L,C8%8 M_E5&FA6VSV*M8V#K$Z9*]4([T5B*YP(ZB8Q&!EB6C4H3!FW:V,OA78$"5#G4 M1$>TJ/HYHU4QPL*ZYEF@HBN;.#K:VPR;A&$P)!RYZ=3*N"T>=ZD#"'UB8 LQ M# B)4\6MT=R#@*C8DI!W!F9'3^)^9]W0LNE'R\M>E4\57=K[7@GP/$*O/.R%%^1)Q_)K$T>FH^[/KH:D.'(Y>.)VL2GLZHO*0 M%3E3*1 ]P%X'\\D"T]?Q ) %D256,"C;NX+T &.)3TZ79#'PLJ_0_P'OZBJ&&>A1!)ER\C MJQ<-^/#Q+14.= MF%48T'Y0+%DBH/]K^314KX\4)!=:Z!T]4@ 2C@RW=?TNFQ(G>HV'A%9 MO)ZWW(#T:1<8ULTHLTTZ\E,@O2X1S<)![.(>4EC+F]GITPW;DZ@FJ'7Z-31W M$ZC?UQV+%8KS-].W\-?P5IET[92IC=P;5(QH]>LU13B.55&O'9Y7PCI2Q4DJ MO$M U!4]RDDY"#W$"#7=*D<$A:-:?;Y\S/B(!-ITA!\3M;"N&-M)&2$E"]&P MBQ5D1G@7=6:9%1(B25TP&=X&D$JAR)- G;'3H@5-25#:\*EQIT(V.D20A>#U MK(TF8!F#1M3_A?[(("K]C3G?4MNG%#$_C)C RWN4E[2;"K,?*(>^I2@//&7& M[:_-CC2*G&$)GV;LTIQ*AOCRZZ!L[_[;_/U-SXB)W;W:!0<3W;V>561#X"3C MNEHJS8VA,/\:/ ']P,B@.,@W-Q#D4K7=:^PX4:&CXXJ M!BBVD5N0&Y[2YP^1:7L@:6ZF/'R,"R7K?1*J/ J@ODYU*2&M1+.";(X7S:Q) MI$(MJC1'MD$LD.-U",[H$Z&;4XC0P2FT,S-_F^CMS&!)(R=IDHB<WL;/:'M!0>C#7^8U[/@"]$#;?=LSS&SC!\3D&.?F0 MKO@!Z,TY[K4]VO07E:CT@W;HALYP/\=T.QC7HD\2 ;%H[E>/]"JM>@@:-VW3W[9PKMX='2N5KJ++$6;/8PR1[I6AC,]RE-E/MNHB2\UYE";#BP; M4:ZJ4D\VM,P,N*2\3WF\>?MO3$-;18YJ>MZ!CFK3T1..CCN'%GN<0^, M>>O:,H&8TGAU[$2@%_C3NFC5/]4_6[O=Y\.?F64\&@$:K3L1X&VY_M\H^D); M/7-N\H[A!OKCX^%)B!M./1TM30==+6FMDF^1OR=2*KE*RIKHT(*Q+F%:(_:L9'::3RG# M1\_(6FE=V8ID:J;JPKDWQ ?[$UW]7DC>/(:(]GGPZ)P*Z>/>6:+*Y!P-B'-8 MQ@Z8Y%=O4H->6\V',I'%W]29[/O5@Q;YY'_:N5K6"-F7JQB_/_871?!FFKH+ M"D29P%LIPUML; KW_CDC>L^3^1!AUPXH^+L'QWN'7^OAV0F)<,"T_!'PB/?8 MAXM/IW[T*\^, 1BO-N%]'L49SS$]@7?>0S3ZKO MNB#/7GI5,;#@Q/#K__>F_":BL&IKM[,\:V-RH9\=:G[]+/AB3,>\[XBK/PA: MJ\XS0&CD_U3SN:K[<$U[(JX=N&%D151^AA,S.'#/OM4*C&K5_!]J/E=U'ZHU MDL4(FG5;(VC&V)B:,;YM^^?CB;[]B,TG&S5X@,UUOL>-JI%5 MO_L6A[Z7*TVU7*N]>X+ZD9FFM?P4TGGF!5MW(EU\9G;N"* <>WCO1+>7QK2< M'L)_G@BT].JH&KVRQ/(MGQA;UNW6P#+!FGNO *V6K=NN9Y?JS=:;CUO3J>/+ MV-&RX;V N)*8NLZ8VBI)3)686@A,U8J+J=EJ7?OA:MT)YJ'I]K[(MYO5Z\:F M<[3C?VO5?O96JM?]'%@!>9(RQ_U>M?)_7T"Q8^N>TT1RQ*"<&!:[5,TNVGKY MO\_,D!:UVAZP!VW%IWL?-W1D>GA*WN3L MYK=]?AGHK7Y+^L*C<$EVTO",X50LETPFTRE3IF.Z8=*':CEAKMUY7V=R['X=>@=_?AUZSU_*D&7+W;#XUU);_OQM32?P MUVN=B5.I=*]&9QZY:KWYR*&SN2'@$QTPW+O"7CQS8/4,<,E)O?BS[#4U&?&& MG; O1@GBN?/Z+RO QC,A5OW0=GU8Z:6+&\9BU!C!QCZB3R$VKV,]-;2RZ-S+ M>O\%NA=LA2,L/->:_*?-#?;;0+1UR1JC$+\/6XB81,S[P\J;D6YYV&81*^!4 M-BE^!'*85L[27B%B/V_3I9W1PUECPW>\^+.G6W0GW!%!Z_9$-Q&00MAA1#0P MREXK7.Z96QC8';-Z.XO..+1]5VR#M\")%L;:,_H6G*2.+<1QED^R_]$(9XK$ ME44!T(>\"8F@/1)YG49S,[BW>NZC]:N\,O=NXC0)_ M1$PG9OR0-X\5O0L)V[WDBU),1:>MFPAC*@,+D-.C/5JB-1JV;@U]T3<@P67, MF#3@G2J?:5(N:75UYNYX;$BJ>\7FAD:+>W7'270-X+-0@JCEBQ^SNVUE1T_T M@IG/@:B6@$T,%-TP/'RZE9Z\!4Q$$Y7%=,RIA2/%8HXG5K,]HR+QRN1DLP<\ M+,NA9;\N!RE=G^A#Q.;()%DR=IOUKFDWZ:CS$/93TFT2UR;'Y[&YP2&)Q<9T M)J3H7)4Y$VGN])7IF4@"/O"^V:5%K6_O'!0RA6IM!N[=:)1+]LR5?X[_V;L: M_:DUFO6(/MIWK^0^\VC!A:S$0&I5U&JK.<\\8CV]9J"X^W@H\HDK5_4?OXV) M=_K-[.I=VL.$R2\YWFL)"LL4V; M&VQNTXS,OL-RK+4ZDX.CS[\FIY>-HY^/J:EX+=(]3UV-:[*K\7*[&I=E5^.< M-JZ578U?2U?C%?CT$&!4$T?Q"2=#+>UC:F"T'?-0#!,_ ?'I9WKZDHD9CWA: M9Z(=5CY5FNWSK[M:H5N99+OYFIW)=?>+?GEV==P[;+[YV&9:#>W+BDX5"K(M M9@LE@?:RWK\4I"JE[7)MN?QB#5T/*6,\:E#C\[; ?L![ZZ%I2CUPNFTS=K7% MK$0CC\Q.#+6"A+K;K'?'.?MBK&#@!]9317W1L&< [#\_\B#IZ1L?L M/O-%QD-+L#B"3D3EU*J,;-U)#+CF##RE7_GQPQC7V/N=H0U^<#!Q3QAX0D%"DH6]8IO69LQ"@V<:DJA MPL>!X"K0PK@&\/ ,*+PE6JIX 0H2OBKZO0X[\W2,$V[1UI)P@Q7[11%2GGBC MDGQA8GE;?(BX>'4T^3ER/_+&Q&SUQ@ ;@PF_JAXY0RFJX,G%0$_"H.]B<^B M+RL"QBR8!)JP7LA3D%6G!\U&9S'[H&UE7Z>+'[E> J;3L^)2'JJ1YW:338?9 M;D5'S-@^G-G:MG+(-H1_L'&X<;_ J/O0D 0JFQ.=H"I*AE.#K-&F=,:)L;G8 MCBK^F7E.HNG!%O,F>3X.(#Y,8%G<91 XTA4).%%GG;3H$SZSK"2U;&YD$@M= M;[35*0QA;X[?12^V6#M%/^SZ5&4/['&T!6RA:-%78P(KSAA&7[CE4.A:Z=<^I"^G/Y.?]$^ MO*/"9',CXPK!YWR E-E'DD$NZ?OA4"PJ$K+7+K:6I*W<4^2&Q*%B$O @R[&; M: W.5X'M*K=ZV/%4S!50T!F>VO[%]AE<[=$&YN/T==A+'Z=8X6OQ'CXL'8F= M-[MS;RI[5Z\&R8>.^>$RT+G;PK(=]#%=UW,!Q:R;?0)!Z$AT-P#_3A\4Q09R0 M@D]B(]OW0D_(K44&$&>NFRZ$\L[HH/A0@209$12SR5,1%)0Z$04X+]#E/6> MET_[L>^WY1)MDG?&\24G^IAV3L8U'<"2J>NM'6]/] ;\$;W^%%;<&5EFQQQU MPI/0(]G!-_/WX/>^WM_]W(L'^YYE[N<^=_@S[&?)$X$/CP[ ( ;6@N7SY82/ M'<'UYJ-6*V]C1[9L'_M_/T0(P$+<2)J(KW[6P5>F#[Y[/Z"Z#P'4.:Q ZYC! MK^QCKAZU&V>?OG_2W69TS%$_2;SWT5'5!*2Q!<%[$_@L0"'3#[*23<-!E>9% M'JG^/8?O99S2P:K(\Q36< !+..0K6) X]=^-G2]&^Q^]WHTG#&1OYUFI,VL[ MSTN;E>WJW!CB?Z7V6V@?SUPE=]8;,]\+,ZT"XRQ4:CE3J<;U+#;/>)QP_,32 MGAK-U RF2MA:@7E=,2=KZB_-*3%#./2YSD#A&T.%%/[M$8OE!NI,E4]^Y1I& MZ/$$GLRQ"IB_L[F1L%H EW14OU.I*#3Y!?-[ !W9=!KT8]#14BGMG@Q'MCLF MS$;AT[589@LVT6.*+IV 11_.1JV%MHZ>0#<;Q+ M_GKVLA=%_')CN_D M6ZLT_PP+))EG]VYCE))I\IORL_;+7UFCL27FCS9W]CJ3\%/M_&=[IWRQ4UM] ME_VS!)XDR0?^\*/N5%-,XEG/['7TUY\Z7]EN?PFKNJ\O=8L9EM6TB>E=-L\_ M??HZN#%[1>U0+?OFKPYI=A!5RA'2E!G27!Q_N?#*>O/&*?*PA7+^CR>?JUJ0 MTTP[L_K=RF?O]NJ;TR@PTDA.LUI.HZ4YS9>C _W6O/G6:%T5&&F*P&F27:&6 MU,A)*G!/I9#Z,R/]HXT;G@@]FP:]3) =N!Z#T:+_H+U.&QHIWYB9OH]F>LJB M>\CC%ODGYR!$?\3#-ETIJ0F Y9A\\KDJ2=2K(.HSZS9%TKQJ05+V0S94',J6 MNLE+KRI;>R^L0BZM.(D'13',T+_;-F) M\/_[.P_YI<\WIU!>T@2(E?8$7<$:O,)5 M3X)Z^C!CL=#IE;[48..&MLQA\7D8[";1>JW1^LX*S<5$3&:997FK5-TJ:>P3 MG2?#']J9$3"/[3A:4[52=9VFX$FBDT3W)*+C-6&)(4Y+)[JJVIS?*ED2G22Z M5T=TY8CH5BCIFJW:.A'=_?->EVO=LL$=\%236J-8=M]VS&^T>1I\YD^+#-[ MT[Z>-X^_]WY4Y A9/,($W&@-Z5! CJU75+1*%UHNW%,O9OR6JTLT?G,/=(FN M>477YS-J^9#4A>3*XU7N4K/XPQLE?4GZ>KC]^ASTI:F:-K>GGJ0O25]K0U^S MINIST%==;5;+A:>OYP[("I.5C_3:(]?$=NG\3MH71IBJFGD]))<_OY:_E',> MFUWE>8GAC&8,)=IB75JDZ\HB%[5(EQF.S3W0);KF%5V?W2*]4VP\WA)MU;7" M2W))5Y*N'FV)KH2N*FJM(3T\DJ[6GZ[F6J!27CW0\JRL/A7XC-@X5OT3G>AN MMQVS;0XMQ\*9:#BF:SIJVF_Z.U[K^[@TD$%36@7(P*4[5ZO? \6E*KI-:73:M^%FIM M:FJU67Q?OJ162:TOFX_]3+*UK-8;+4FNDEPEN3XID_MYR+514JO5XNO"V?Z* MUL/]%9-O)[_,VW_:PU^E_BL.;I^[.+=XWCBAE LA-5(H>XA0>H;0&O#9,F51 MIAMV;9(71CNO+F9E&R@.DYWQ-TC/@20Z273/[#9X+-&U:FJ]W)!$)XE.$MV" MUO\C)DW/RKIZ62W798J I#M)=P\WXQ]-=GG9\!.XH$^=BU)T]F-3KWJ0 )T#V03D?C^#];4_O6L8' MY0@(F('UR$4 :I7D77^)V_"G&"\%3O[]%P Z"^8>T:^VN@0H&!X^HF>6'&'" M0!S-04D@7HP0H_33DXO"U;(%);!DJ4-U5X[ACUEIUGFG!L.,@MG1,#-Y]T]C M_]V/N_OMS8U#QPS]P+/@YD/'V.9CNBU^/:MY2@79\H>$I3G*W#:!"D7Y8L"0J%+//]==.V%HX>F!2]Z M]_=?W8]+ 'EQD",_$]8/N3=SP>=EE4YG=Q3=,+P04 ;O M_P];IY!ZK51&W?YP9+MC0G:(0WI6X+>=.8I(Q\@:87P:5D^:!]YNNUY]HP16 M@)!HX[MA8; I@)9U3>Y3@19>PVK];-6Z6FG,58(H\&= 67L"**=FM.X[OW=V M3NU_/[GU%P3EL@RYNX&I*A[Q1\3 +=EC-4)S1&&E[3B NIL;8B_Q[M-CXT]L MW=E60 0+9 ?4[Q+LW.(1 [4+&AS K6P_#[,0 F:UO"*;_4UKN:D_%SYKXAOZ M"-4DP+HW4Z@%0@DWR.(IIY9_M>L1$!SXZ4U*JZXF(V!WW-69.-_']<'QI-_O MDM7HWL_$OD'$_VU]3/.&9KW=F5S]^E'Z\7G2,LM=[*Z; $4 M:RBASV_@CVN=D65VS%$G/ D] MDBE@._.?LS-&JV2ZJ35?X!T# &V/%J.CT>&[N=LI[01R00C_*] M8&OKFW[I>N*M?KJB6WQ][!"1.O_CR_=C_]O9[=DO,Q)RJ94H'BQ%&44PND_@ MW07>!Z8!WP>[*$*!CM>3DHJ,WURO\74RU0?4/U M3'?&__?_V7OSYC:59W_X?U?Y/7#SW/.KI$KV$6A/SDV5O"5.O*]Q_G$A0!(V M IG%MO3JG^X95@FT@@0RW[KW'!];@IF>[D\OT\O_5^?8VC?#Z2,_XL5$>B^E M77MB= C.;F^% 6UI"2YG-X_+?4#;-^]+;R<5X;=06Q^71_7H33'01D?! 6A' MV:^>LU\$R I_BI9X(';,AK+9[!6X@ ML%?G[\7^:6E-+#YA_$6*M7QE3IA=W,[<2 [T*?J;XKYF]?Z<75^L"V17Q(%Q M>U.1Q87_;&_%XTYQA)4UU?.G$@M;<:XQL4%<[L/9UJ%V\=0L'IX]2>OC\JCA M"RG&V7)D!NTT0X+Z^U,M"6Y%5SMYX'SAP#F"U.RA\YD=FO0[,TVZ49 Y09)? M,?EG&0CJW!?KU;\ 1*]K#%LNZ(NX*C:, M/;@3[7E$V62VRD;CS%DLPQOXZ=FC.F#'C##XP4(,[G,U6*[$;@R#^U3]S\[O M'U<"6S\ZKZ3 VV"Y'2!S1E1]98+# 2 [RH)[<7B\&\6&/F7??3@0]E_.E9/C MSJQLR&26#V/6]N4) <:Y0?8 ?H%+8TKLQW%ZDT]HA!7:W"&KG0M=4^%'@>;7 M7VB*+ SH/V_@/7N*)HQF.?JC9?,^ZG%X>7.F/K G5^>:O(&ICWN/P[,_]8/[ MIYJDF-U/WU'Z5%,9;&\=&P8F-'O48H+D6F=:9![)F5*DL+UURNM"EQA[!0)B M1\WK/4:VS_3ZEK'E$,M9=.G%DG6)@<7(IDQ+7 2%-PQ8*NT02WF A($4B3?@ M(V^RV84O*J3PI<_KY'L:+8EH\89,X%"1.KR"O"2I\%5!(DAI2GK/((\%:!!E MDF+K("VOZ[S:(?R%&4;P"_A1).S&8$V,U&[35'3,%P=U)FLB9I(#V54R![0- M#_= F*T4; +0'C1D.*B,F=]RS_TV;H24P@F?!ZVB'0$6G5Y6! /YX]/QNQV^ I\!*@AP[H#/6]TR; 4TR 7!U[+ MFP(C\$:7:2O:&Z5,VZTDZFL&(=%J%4DN7U/ER^4R6LP3)F)GVBYC7P,4F+>N M#/(H2FWTMTBTW%(-R620+Y#] 9NO\(^D'O$*?WF%%88]YO.-U@<]6B_7OWQE MCGA!5F23&G5:>WL+GW1(I(((4?@CX+->;=J5U-=TQ'-$;N8S6C5<\9L-"<6= M8IG\AOWVA6F#NAXW:9#C1W]9WMW>&MDQ\P8FD2>O5A_% 6@#JY! M)P],7U= M>Y5%!!VI!POC]0$(!FX/EMJQ0&QP,P@\/*/(/9G #1%=@AEP3K@>Q"0DZO96 M7S,1QN#++4N'XT>@X#T5A@_Z#/^/=2<=51[B[T@5ETO"+_ WAX8ZTE!W:>A) MI>[0L&"O'Y_C+ALA0I01M+:W4)II61_!.;*1?E\9X!=^-)L7!&LU-(OA]06F M*XD=6A>C4&CHRGV#1ITT6*?.P =5@]JI !5DU4"1UB!BU7*;$23=Y&7@6$&7 M"4 1).U)9I( QT3B&R7)N@%N-<:6 WT;6#B"$'@-7#T) V_[!-SLF_\"8T/- MM04"(,.W*"9):%=V=!Z,@L_75LLDR% N5G8J10"\ ]#(BF: JX8L%?75[:WS M%FR?P!@1L DNND=Q^Q+Y (\ U&LMFVOMF]O=,RVP3+@ +%>P$^/8*R$I =JX3]:\Q:+RVZ3(\6W.J# /;[PN!OC$L55D([AD9JX5EW:90UY7P($0J6+$ MY\&*086#G@C7/> H)*M\XKNU.LNTH%M.V>94=V;/@V2%]47K6=:F+YP?+WF2JZ!/;2KYQDL1G> ?I%%S.?!D?$OL7:V,N0)K<5X@SCT2!,W+H9V&,HW["B,X3!(6Z=M;@;X,H3;MH6ZFIZT80=@ M?'%NP((!X5M%,J7-,LN7[<=4R_LQQ=N/J9SW8TIIRYV\'U/>CRD#B!ZXZBBZ MMF)(&!9#FSYKT1IT0V[2Z=,=&XP<"M@] M+EFZ/ U?=GEQW%MTC:*Y;:L/8/]D>TOG&!8'5O/XVK&E#1H\(_&#EB2I#B8 M&X)X@>]/8SK$LR2?M -)3NC-Y35\K@),9=O-;D#'BY9+HA.I@)6$A2J0]T)- M=W(OXKPI(B*/@3W+H.DFQ&_R7\/;$4)[.3PL%7PJGO1A<(,GJF\EB![P84MU M+F_A4QA(\5;G7LL69@BHP.-$-T0[+BT36KI6]AZ'/X7[IG6B'5V5%YFFDAXF M7%=BS FXYI)T3H]&[9R0N_F(-)A P<;D+SX.BSU]KW9Y<*.;3XD>3,SF(EJ$ MVUL<4?,LZ-R1;!<.6,X4N_U2[?56?>$^?:?[=L\MSV))DU"A:7>WC+QV#S#9'[#^JL"Z2V^+J#]9]DCPJ!ZW]R"X0WA?*X=D=[55)7>T7L8DP:0$<#9:( WY:_T,M-*B1V?I@LN#Y2V#-ILAA>N^$#? OHZ]*K MK%E((9EX*")\'@P40<.KV#<2/WVQX,3; ^(W@ H$=TR1A^1UVUOD-I+L=UQN MQ^G,*X863FRC"[[+#J:DV0^1WJ4>M?J(GZ4H@80W'NTG&3@45HQ?(GE<"L;' MP0I3P8NQZU]IG]2^I:.52?#!3?H8N9\1&"=L&XL>YBD$F M8#.N7O#=8SEL22)JY)8%^1'8H*-+]%H$_IL>]6@)1-4_KA#D^KQ] KSP*!\_ M6M<@*[ITI&DF*7E@BS6N[JLVP"#L>;OI"7BPH@ V90<\!D2#NOWWSL1&73T] MN.M[;8[AO22S$]X\=5Z&N\9@Q4#3.&_3Z[O:#BS33N\/7\0\.?YN8K]'C4_? M6;90;K"1K:(-\E&F+4ET"B$F3MC7:J#0V_!IFL: 87B)^>S#9^0$9\';6V3) MCL& =_7,B6;)QJNL* ">^^>[8Z>Y-\4:/P"[7Y<)%+EG6B9E+#&=[MNP>R/? MR,?]EGNZ[@IL#B2X*'H+^32##T./M3S[ 4_W: [\*T!L]].>.:'Z2.OU,$Y% M;M#.M%?[PH^*GGL7*JL61HSM&)-CL]DAIMJ8PT:99)?!K;D/!?\"'SGZ$"\% MBJ@ !3/R0)HQ\8AO\23E8<^]E_29M:'?DHWQ!N9-'\-<\ .B'XXT_0K^G0R# MM Y_:=S]0ZO_YI404V+C&FUC!"?>3,&!D<6&E@_-S34+CL\I%HJ5RL3&\6\@ MLFZB%\:'1L^A\2@YE#NV/W:LXL;L$JGQ"K383T:XN_]Y+E8NS'OO9)RUT/PV M#!/1Y42=SOYA\^!KZ 96>$!3:K.B2[,PBQ1[SX/ 2*\2")(K\HY<$L]+%9WH M?0AD(+KM,O F3$HVGK>[=W]7=UG">2-C+W&:H(ZL,'&M/2Z>Y4(MNA'-N%V/YZ*Y M>2? ]=);U&$3:QXCK32T">@5(M<3%?(5/IY7;H!K\.Q$P7=\PVOU^O99N^4O M#[KC6(FK@F]-U)Y!\@8(N .\]E6T]#=-%PU)G45C^M;ZZ7L;0P\DDR52P35= MLN",!Q^[@^_)#RBAT18"LO$]6OO8ML/HD@XT-OEWM(5E%=P8O(TIV!JWUT,/ M!VW&'H_Y-JJ=_1]^1IX-;+N?AIV7!)IR>PNSI&@H6I3:O*68&)[VYVW" MZ( M$XM93LX*7O&=^35.ZK=TVT>WWK'BG*G@LP"RFPTG>O5GBIV'A68]^NPC=BT9 M'+BCM7[6YB&^!%+7CWR5^I\B")F-]D*+FQ[BUH;)@;0:(*3[Q$!8<'0V?A=OA8F[Y;W&*9BB,4WZBA&=Z/@(N,G L^UL#)GFIGM.] =0/W-D M4=;S+,IXLR@K>19E2A/E\BS*CY)%F41R!ZB/?=#<-RBX$5D=C5K ;0W]!AB- M3T=_7D^KK9>;1J;S;,BEK&/]H-DU4MI%:Z3]-8^^+*<(F^5-TDG[GK:&=ZC& MUTV:0!CWDURVVSMX'"HGK[]-7?C1/ZZY3"7*1E_AX?D@"_9<]X5?>2UT)=%2 M)'+)2L\*>=L^GQ$I#)[97); O.>Z@UK]*\-;IO:-F6Y&U-"*L+])#&'ZU4]T M_KEG3,R^C%&S@RJ.3X[:G7_\>\+#WD<7U-(4<>VK\H@%)X:__K]/W">7P-Z^-212?XN! MLF'Q[/2!O7XIEG1N 8 .1T9 :1#.#NG1@$BMZ5\9O=/ZS!7+!:Y4+W"5RIY??#DEP3@?7?%X<&4B^,ZQ'^Z?54'PHBMD$R;X_\9%2G:4-+,\01,^^9GAK3+]!F ?HZXJQ;=C[>;T M9U-K\$_/B>+;?1=\ZJ5 ;85 Y@L"TP4+E&)+,DMJT2O=D)4:F!H5H"1PBN6X M E>+;+0>#Q77!DXS7$^>::K@PR=5%9_ON_<_!N^U[-A?ZX0J15,[)($\!ZL< MK(("E01>E=A&@8O.D\V2%AQF-#AIP9C9.WIU/._RP:[8K49D!\\7LK;S MC',4S%Q,!CLMDSQ%[/238]['P+SJK)CG< :5HRT6XVL1THUX/T3@G5.-N#2&2[))U;EN1QS M/M(FDWN)39(2TIGBL9;%AF=^K#2M([;='6$G>=P.)K==R^_,J4;FKQ^.S5\O M9?:\,NFDKCXE %,AZ8(UR\242-KH>Z3V*<\-2"QV[5I5]7JD5>74PH=.@!Y> M_GQ]:%5*%C\(*>TBJ:Z3CG8!)9C*[ 2'1I/&.0>SJ!<+I5>Y AM=Y"6.S]#CL5F]+UX)@2-PB*0FIR75>75K^>+VU>_ESBF-PX-\34_8/IU2: M3WG:X_"">_OQEWO;$_1*9KHS'I'FJ4[?!J8GJW+/&J?(#T> M![1''>++6(DU7K.@J9_(6TA, #,_=/_395/>_5;YQ\.-A:);G MYJS410>SYVBE-MR=@?.8&*A(QQ)31[,5\7"B8:*X6?T![^3H%B02%_(/5TCU M:>82L*0$>*F@I5F=#L>2H]?$P.7G[2,R#0W9B-SY](O]XF.//SD_.;D8GFF@ M9,7RX)=PV^9??BS2QS\E>23^H%V<1T1O$:PWYW>X7;,MEP+OY MDH?JTI-FFI) V>*"&T\NJGT[&A9*JU4:&QE*"X H-R^('EC2&2S\YDU27B5Z M-Q,!H>S?:^%EKW3U?EWZP(5!P)3E5&O7E-(M$[DGRT-;B#@E"VPL5R]4RQ/R M/M*8\#$SG+$+P!DJDYLW+*B.-;5)2D"R6[YU[-+]KGW9T_\V/98-8>O'+YFD*.D :Q:*-'\?62Q;&RC6N4"QM:BN>VJPX=JN*=GF;)!Z^"_#1 M)ID?\2B?.: FRH_#X]^";G!O%Q>U^?.:-M*T0Z+BG'O+I&,UP= S,M9!++?R M5HF)GY< Q2@A318A2\5"AM<]7'X=[M ]L3.J7] M8>?3=Y<([K&UQLIUXBJ@VN6 X1(GPJH* )V:J/.V2T.[0>W$JK\#_RS@&1_Q M..2DX=NU\O+G_CY9;DP:(MQ]XI!/U9#)Q$-[(B*MWP.ELXD5?%[%7?-Q^/2S M8QWUE+\_6BL8F3,FX4E)6GIK_.KKKO%;MZ6=SDDA\\S>:2GZV=[Y^?W96!Y& M2EJP!&HGTT_[=*YJ&D>PR!$FK;*RNM[(Q M7, 2F:#1J!?*EP;@ M/0GMR2:A.5.A+@_#U.45_W;*F_!HH$906UHG-[U>Y:#1Z+:RXS$G.GV*?V-Z M#JUR&/K0,.07FT0&WY:*!;9>S#P2Y9*12T;,^KE<+U2+"32&3X6.KH;IZ#M> ML7C_1&R] 4R93 _1U-K\L$6.45**L$O"D5*-'BF8Q!P!;*63,( MEFV2F8M7+EXSBM>25D6M6&@4,S:W?9;:K= 0^9EDDAK\GNF8#Y?#ZZM7[OC& MK.?EJL&$Z *C2IM0IYJ7:ZW1)P*!2^:NO%;8A'!E+E&Y1,4D44N: :5RO5!F MV9'FL"D?-)=,J=+$'=FOID5N=+Z ]/V__]G9 M88YD21&_,A=\!^3N6GJQ)%7 ]3>^,6CLPH\ %92L9QH2D*WZO_6O\S7\DR)^< MF4UEV)9#8I>_?%SC\6(_^'3_HG"U=$$^+HF595,I7&'G[:S&I;3 M-*WO^X?-[:UC5;0,4Y?AR\>JL,O\U]*9?V%C6+)K .LR^QI*MB&)^!.1,Q[+ M(X]DE5<%F5>8:Q-^0?LZV-\-#D)T?OM95IG;:^8 !4HW2'P2);>+@Q)!1[4D MW?CB?O96Y2U1AA=]2;+V-Y7,D9XBT7- LJ[$B]M;TGL?>8#,X_O?8.UHH]CT M>=G[FF&>MTER7U,5X<&OLB 9UYHB.@\+GR[%4<)]_^_.3C7/+996>BU;M^[UN'PI_GE9./H^2+ MX6Z+*]1JD3%>YDW2\>J"Z ALHD7*L]VK#*;%*^3N(V06:X$0WC]8#'_-%1A= M,OH2O.554@:[&R6Z&XA&3?$5#WA[RS^0USO_OJ4+71XQ"A6*+@EHR8DTU5/J M\[(G!\!VIJQ0,2%7988E=/U/X@V#ZC[DL'VM!SL8[#(7(X_9WG*9D>_W=>U= MQO0893 NX0VO@[+]$->3.[0?ALE'@@>'^DOM5_GBY8D[\.39>;^WT&F"39K" M1KTQD6N:8J%8C);@*/B;E3@VV)4'Z@]!X]H5MK%2XBP+;P6V5IU('^!5GC*Y M-W0:^=/;%/X7,F4?9 1@.FPTVSC8;6^M&^TVH9_/A:X!U0F^$[/7[*4_J]W/+O??,%_;OX+"+S>,H M40CKNA3)F__$Q:)1;7^JLS"FCQW/+L33_6+G6C46Z5&='E/"V>OV%C*(7JG!3 M;/TY4;N_1F= IZ3;0=X): 4<<> +R5R;QZ7KR>U=')$W@DH!\6X1&#. M[+N42$#>"2CG@\QW N)F\>%^Z!IM!]"=_MF] =XK-]]EX_'1_?21I:NR:>D2 M?/)(?L>?C%.B/AZ'\DFET1KL72I'VC.HME(#W[Y(.G12Z9&DLQ)%W2DDH M]VO^A:ZY4\ID&9X4M7>D]3%:6!=OJE(I-!H)C''+^Q+ETI8Q:;.O@1*5MGJA M5$]@YD3:6ABQ*[%=[J2N+"B>O:*4ZG+OHM6]JX[VZ$USM6@"EHE#F U(1\_K MU+("GZ/&2E ZETF\BKY9STSF>BY\N?"MTG;)A2_F^$J/O[AH'IX-]\V?CT-9 M$UYNSZ[%_8-25B(CB5TSQWD%[%W?XRX#5_@%IH-'$4]#O]1Z>:G72EG#Q27S M'KE&,9GP2.H/.A>1CR(BR[9E;I22B6FDPDCP#U!O"H+5LQ2LDCJ0^CJ0A,>= MPL^*A#\ N9L]#73[D/P^\BB\-E<^DZ+V8+2'0YUE[Y(U*5(?N_!1&=C.(W.V M\"QWIU:)B5-Z[L0EN(E8&*5:H5;-&'SF#;!R84RE,"YKRW#E0KU6S;(PAILQ MQ5EB'5[_+)]=PAV]_V2/N8>[RB*%*BEHH96 B1)(3O5^MO M0S+Y; M0GVV*J4"Q^5MMG(!RP4LF;9;U7JAPI8R+V!S=]VJ/0ZESKUU>_^C^U-<))R1 MFH*Z#>RVX#>ZW?XOS!MOC%?P^ZM(_5\+[_1RKE^4;@Y^WQQWZF[UOO];,[$C\NF"<5^6D[ M<5!=S>&'))Q,VZ;S MN;'E+][XH5:.C-P0D>(5!4D(C&!JL!G#Q/IC ]\,WL(8,QQ$,4._7^P7T\@2 M3H,/M\^&PP_ZK?SV]OY:[IZT4LL/=/&/(VN?G1D,<&RE$+8HER([;H\SA=<" MY$TVNP1$=*G'(_SK7K,;^)8A*8JL=@I,1U(EG5=H.Q!>[.'<35/GL?V'0]6\ M"'[ M^]]W51O0A_&)A!A9YM$C(]& M*V@6LC%]0IP6"N?M6;CO!O\2U4&DX6/E91X+JF#O:4_^:;3W:]5,]Q9Q]D[Z ME+D$U6?;WWVZ^9\R#5?M:/1$=\IJ;3.NY"L@"/V?%U(7KF]V\[K M_E7M+[L81R31<21O-I)CWT=L,I$W&\GY(-O-1@ZB(Q?[EJZ3K%4L@FE>-)LG M0_/M['%8?%>&ZM7=I?&TB%^7LO8@L8]L=;P2VU?,.Q0D?4D]_T+7W*$@7,P2 MR3&M%PNU:@(7T7F3CUR$,B)"RTY08]D"6^4V281F,@0PBD9N2O>U7D\V#-AS ME#UP\OZSTM0>:I=:)T,5+'$3FA +&-"A5EP60&HQ*P/ OUZ$BA:A1'1]H5C- M_J#'7#YR^4BHQ*-2:%2R+R#3RSP.>WU%&TC2E41J;7PW85$*_!8.@Q?UU^%) M9KI:).[$DUM$T."ZIBC^.]XJ3^K',I^4!2LJ1> M+U(&=&H)5^S[P?I-T1+,>U[7>=4<$"7%*_L*#Z936Y;$*/7>>I4O_Y[V MN?-^_0/[YS;UF#>;?#2!BU=RJ/J(4#6C+"4R4K-1*I0;D:4GF0&L7%9R69DJ M*\M.6*T7"^5*9%5%9F1E>LC]W.Q*^GA.=91.E_3[\^.SUX-N1D!O4&Z/_GLB\I[R6K4WS5C;/II*F,&3JF3S7.Q$?Y&,[,6(Z7.!R@5N-P"T;JRAPQ1HXR=F/[,W=]ZGX..P\/-\8O]^OBX=\ MIHN]0ZMZ: A'*SZCEZ3P'".23[QF"3FJ],4P<9%;XQ9R#2E*QG&A*0K?F_]:_S-?R3QZP. MH_[W+Q ZC.:ZQ#_OM"00;'AXGYR93678ED-BMR3?QXT>0_2#3_F-K?I:"O?S7^KY_V-S>.E9% ! =NS0QK""F&).)/1!))IYXC6>550>85QNV$9#C?#?3XZ'4S0!%@$L9NK@L^?SG.=[T./PST6E]JX4C[O)JKY$^O94(_OV[#T. MV]72CX=K[D4XJ'[Z[J,*:;41H,OF-NO)=,]'..;_Y.\G8/IV>#I+0U[]&>6] M.N?>$D+@]I8)'T+5A/\N,*!6L*60BLZ) H!IZ8:$?89DD$?L=T<.&)Z)'P)9 MA:4,&-E@#*OU) DF/D=Q^0"V:H)JH((L*+S<,W89CTT8 ?;1OR $;H\()-#LK:%(YRQEQ[^EX\*I(W[*T$TG>:LX2=T"=YNJ6U-$7>9 M&Q\UG5M%>_5M"7[D81VR*J!;.?)IVL,//N&F#P](6U'!P4V3 4V"CWOK2@"\ M)IX6J.0NDJ5%S'VSRYN![W=A#RT)/VV_TB4.WT/?ES1&(IN$)^/SGE7M3=UE MFBINB'_5=/)'+5GJN6+&P)(&I[R\$HQ!/ %SQ AN_H$O%O"$JAU,+CK#8O '@"7A&D MT1"?)09##M(N ]:ZI".( !.@-JV I@AH&8P.TK#[PF8:.;18T"DE4 *P#E;2F]IPZM+DL M'4PG0_)U)T:Q1Y.*5PRTR;176<0_BU)/E0$,J*;&E[W"NP$GMK<, 50X-4PD MO4>>2SLNPUL+##Q7U/ '!19&?G MR#ZOFRKY$,$:DM&%O\.@#6F2#%9"W[9E M!4DW>=DU9-$\QK@;:933-LM%QQ;B]=E ]$,3""G2>>H_8+1 M0J%+&G9;\&\7%^$EAJ2_ @"2/8%];)-#9%H#_Y,*:-&TB0D/1)84!=9L47.7 MC@^2U39"*D5;:G[#1H"NY#FR+CK;WF6.T>H2;9/)?XH(W>0DX?7D*$?.Q+?N M[2U"/81T40:S%,[5MOQM(CI>!$%W^V^270)@,3H=0 8[ T%3[A&0,2O.F M92!=[2- :][=3,%=.B&]N_2@08[-M?'5WA>I6V-_%U9L6#J8J>!KO75E.'GB M2: ;PX0MVN$D/&A*OI;B.!:^XQA,I3L:[6&$IV* EU&P F^#OET'SPF>Q@OD M@$3B9_&J+)&#<-\GR+I@]8"6L,D56]>;$&"\-C7AN0MN(9P#]I0W!VCU3(\M M^F?)SOR,Q^'=WGVSU[FU6I6G[,45:Y%QQ8/'H5X3Y'+CIWRBECY]]U/$QF"& M4H;)HXJIM#B:!+)&1YP$E9,X M ]R7[J_^2>F$;8B<.T^"?ANV E\OT)L5 SL;VT^8EB4Q).(>-: MW , <[!KU[M@I?'M]<.%0N;@+!"Y&=L[ KOCV M3G)G/^5;"@?N&1F?\L.Q85ACJ%*J&L;/WO6+>->:#-(R^;:S)>^5H[>O@5>> M6R::K.C;C;SWQYX^J)T-?\E[4]ZK>8^86SO0'2<&8G.NQD>,Q)94+Q1KU4*I M%M9Z(BJU;:(*>P,OU3Y[ZMI[FR#_K6H3@'K"ES?-ATR$;A2L Q."4&SW>$,2\4N2 M:I#3;F*E, UO[0V\CUSP _Q5\XW713^V'JM@R,B:2*"=Q/S46AI11/J(1OC_D*5V0*.FUD\(&$R:9\V[3% +-7,4++M"R)" M34ER+SIH)HH%%'"CZO 2&D/'+YA @RXL0Y4Q[0/5A/- QGL>F6S9P1.2Q-P> M2ZEZ9VL3]#N\[^KZEIXA\M,D?W!A945UY'G;#@Z]\K*"J4A'FDZDVW'L ,+8 M6K3.=W]_)6$RMV#:>NL6!,Z 322C\UGE_=?KH']Q=?OL0B#=1\'A_,24_!2Z M110R K8L<(ODI$2Y4RR#LJ-^XO3\N9*R3ST7;E@L85J/;+@-TJP M0@P/^!M5!L2(<#),Z71J-$%&Y:B:83F*@_7CD,JN+DF.)+TU]INGUUR_+RB; M*TGSD7AV\?,(N;0L10[.F2)+VKCE5=H=DQIN5&I:TX^K%>$AW9$7!\_.%1?. M<0XW4G!0/\L,O M1_V6@&6'GNF;Q@2,.\QR,B03SISDU-&/;6\!Y>SLL@C_FF?:ED[RUHC S[*\ MJ4L97W\)$P''UV>K5#!L\YO3E&]I/%9>6LB7/EBAJ52:'#]?CR]=/]FK-H:# MBYLAO^[X^2*F3LF.(*;4M>8:A5IT Y*X?&N2L]K6+)TDN0+)4>A\4722=4N@ ME^"F;;)BQBY&T^G3=0FCBR1/&<\",\\-"X4&ZQU#DK(%W]DR?5Q0&_-W0Q=@ MUZ?ATL<4"8)^N,N#;_725,BO?BD&*' X"!+!(%)T48-UU>#5@3 M@@FB""*T7G[6!7E5UFT>"4HH>Z5[-(2'6VZS0TK0TL]^BD/ MV+?[.R4,""BG.B<%1TZOMY+"@CD/(]2HH]C ^5#"EO_1 Y@*"SXZSP0TR]EK M;*-0+$6.&?&!1F@1;J2=%&KQ("I\ &-GCH9!;-XP*-Z&0?6\85 Z.KXL(]9) MSVR/: L4=XK2"K9!&AAM;\W9P2A[^\2DU>TM)VLU@QOX3_[^608WYI7T*@,4T%)_UW%"PS+YH\E$?L;,9Q/6MOJ-MJV. M:W\37A&=Q;&GH=\,=K7K7H!330Z=_+F/_P'>!08Z1:UOVD6A 1\:/779H.ZT M8?6QMXOH?%TA_5[H%^'C3:MC8?DN1P&8I4X^B0Q@ I#G<8-CKVL\^5FA#6]( ME!1;W BT^6IXU, I=HWXJX1%U+@4G>'[?0WKJH&YO7RG0W(L0JXN1)D[9 M=$FP^Y,0[I.Q;)K6UY,"=XRT][$[@?&5%EV/G[OC9A*^M%135I@CJ:43Z6GX MA4?D!YB\J.E.O$FQ?1KH/5 GY=%T@<@"OHPRQ);1 B\T<7&8J%9QO[I#J>\RM.0UI$D'=+&9.$W MOI-"A.1OCOYP(G.U[GFYWM=^7G)=-S+7#"YO6APN;'4S7H3"DAZ#*UJX(7=E M4FEH :<[DQC)"T@IJ!$%^W)@BS/LCN $A-NR#L+J=B@!V" 5="02;G^O@(%M MV)H!2$6+71RM)]OM2P2Y3W^/C/M9_L+0]G ="YP TM*B+Q'_K"=))NF%9X.0 MK>%U\GG:J<64)-JB3FN#]H/_5$4W/FI@BY#/LOU\$S1FOZNILN \=[;'XL.\ M'%^'1Q&,>7@0G@=YB?T6S,FW'X^A0!6[N/'T]H;T' D+Y?= QAT2X<_MX:GS7:Q\CLHE@[S['[_NUW>1G82 V0 MH1#ZI]$5-]&K8?8=4@5:$MK4I3 !$GW&XYC2@!Q_!ENAO,IW'S[2U$+L.U S!*[AH 1)'P MG0X !MH,I-+:'TYW*@*I2*]?:(RP']'*;;]P^;!XK=+8]1:6!?& M>A\T/AQKBL9T(5T=O:@C5\@*[?_E,B;E/U'"\A70GZ)]!K9JQ88WJ)7W 4.>%KZ =B1R,)YV%TNR*CU5B;@,5UB.E$RVW7!O[^F. M$Y_+5QVO78?]6CI=!;2?9 BZ3"XI/\W0]&C!S+.Q5DCQ4>[3=V='?E!#_(+_ M:VN*HKT9U&RJ%/\)!3O'C+ _$C#= M5+[=%+_K&F48%R]NS& #==>V//0Z\M M7J2MCB?N!,^(_L8JN4FJG'2Y(YT.;:4^5:=C(@Q5ZN1J>T%EC:\-4]7-#5;5 ME^>7!WO'M7;#X')5O195S?@T]?;6VE0U8VOJ&VSC;N?L.A+1MA3XEIT&Q)LC M7\E=K2R =:#C- @O=<='?&K/!^>]CJ?@C]EQL:B06"7VD)B#MV1][O*YR]=\5X>J-]8K=O/>3Y=K3 A(,E=EY9)-6NG#L;&);MM>M;W/[ET_M]FT]S*^>],09II(,9_9[K+-.&<[8$!9$@$ M+84DWS> + F*\T8E#JY$: ]Y;"'EOPK&01QXXXVLX*1XV6$91R^0ZEHX9%FE MH\;X=]_,A-%I'OA]+!NA;!32 !L_\$K#Q'1H0["T)/:RDG0=P*8S6,"WT"6Y MU\()-E$* !E.L\P=K;W3!_Z03&\PGSL6#U&)9$<@MSG.A^@S5MQ<"_PU"8F9 M_#/-8@A.EHF:2NKS2SIDNL_L##111/UI@3D%Q82'K=5?N*]*@P!PB,Q68 M*TDV5)+R UQS"FC&FV##H$6B2_Y)FTX.XBA[;)IE.D>=&_>-L4LIO^);KVF: MA5O\QM;SZK>\^FU1R; KW<;KW+)N^N65;WGE6U[YEO[MY95O:3;UJ ,;FO&Q M F>6S-RD.20D29L[._VU[6]/Z'R>.R"9W=^A/;G1"ZT8 MS$CDVY#ZO$XJA? NS0M]^^]BO+X[FTNJ32O-Q4K+[2V2#L1<]Q797%E1[@9G M'JZT>;H;!PHIP^7[6+J""4M8D8MG;6.V@4=-Q\V12J&PWE*'$X>%VKQ#!T+A MTT)OP8=O7?/WY6EM:%:]YDI7XTM9*&%X^E34L45^^JZIT@[ UP[\F^D"4NCV M,*>VW#8'$5FX]C2.,!)B=K ,\$EL>GC4>,,OSCXTFI'ICJAS%;P])HR*(#X. M89E4+M<;BIP?1G,._'J_ $RID]E2!;?G+#)S'ZN0262*[P$"FC@>R<2U@9^/ MF5(RO>_IPWLEVH<$SJ0STOS$MDF<@("C3 C^$RL$XPFTJZ7A/2J'SY1L@[IJ M^UVL%R'=N[UYU@RM4MGG^[+)*WD[I?4=$I:! 9RH=LFV6_/"X\U5CU9KP7E% M:KUY?#EJZ8#^HM7A5%%Z0\1A(90?1G1H&%Q/U'11H]NGIZ:1U9^WW;6/9C=K ME4:/O;IH_J[)DZ%^]L'O$U8_:3HQ25B;O-SEU"B="C_C9/BQ9*.0@GFO9?+$ M4?=Q']F+=")?:>K^FV_RF+N"A4]M\A[6>G"5.^RK5;5J1Y8X MMFQ'ECBV\C@<].O7FE$7^UZ5\YE_*<07-GAE+.]U.HI/6554D(G;8CF\1\4=) IP"($/AHI5?=1S9U[_*MS6>'8G^WN<\P'-\_^9CM#M]1\ M;!]+:>-*HW#PI+1J4BMZ_(2A*=-' M3B1WFH$E+QD,KM2X0KT8'1#V );4:=C_B=Y+W](%+-1A\.Z&AD5&CQNE>Q* MVALQFJI(>[[X D(WDMY#LUD4W(..X7BKO3_:Z^"V\^=WQ3W>>V=/\,:)-U]- M=ZSAC,>Q8TC"5]'2WS1=-"1U](9LVO8_??=&>$?S( M#JDZ7G'!^:N_)<%2MWAC9%H&U)UB[_$-+SD&K%BH5*)G;$\'^^VM:+2?&6\: MZ<*;Q5GO_>_57K%3:HL1,)42;(J9FX*HQ5:YR*N5@B-\Q+,CPD)81E*QU,+N M'>\UX$;K4'KOR[I=^;VHZ7#*F]B;>X"=OXD)(::!6V[NWNZ,$EOYW>%&30_L M?4N73!H9+6V$S'K@^#*07[,K\@.T,N8S4?QD_O3='P\@5[NUJ/2=S(<_-BKL M9I_P]I:#._G%U9K3"RW0L!P;%E2S;9:%33E8"/F38\)5N:)MPE4Y]G'X5[UK M/.F-9K,E1ON^,PY?G6D94292=0?^[?RTY/5_M5&HE&:Y-L#.$L$T%I4)NT3$ M[A(*-I+T9^-/"FJ$:GDW)N#.D=CG%442]P98E!#\K&?ND&,ZMQKLTX75/^4Z M@"YDA\RPPRB19_O1JQ4*I'AU&[(=LVPL*)Z]IDH>P M41TZ-2_7[@)B:M[MW"=&,@2^C[6ENB6-JO@#V<"HN:73*+';4>=*4K!:;E\S M3&.L)Z9Q Z_=4VA4L^\R?CTPR'K))S\.3Y2AU-,[W=XM_RG-1V<7'6YOU1F2 M,\!^&P&$.E=]'-X+PXZ^U_S[]ZC\Z7OH,&7#/?V,J5\@@,.^V5LY&$%)3AH\K)0)8>/\#^L3U-I$5SI(*O1\>ET'DB MKK5%9TG)6->GT7]_QC_;LQA\[]G>PL<[@QDBI[#YOTW^[,Z&^FS?@@4:FH4W M4"LP-KB1^P8UM;]$.U(%"P((3G>F#LA1D^FR[1[PS5^*Z M>65XRQ^=0D&K$_U3*)J3/HU*W%Y)^.0*-S/%/P">:6FJ93!DSANCR))%:QQI M*RCR,!H?L&?!X)MV:"_BOJ03"P.K*NE;:;@T(--D\!?8+YH FF<\&!I+\W]J MM%S8D3(,!9)?AS<4FWW6.KC>U](K9H%*ZM@8\.&K5OHK#D2U^,J%V.Q.]JK_ MNL:P;:N$)J9'4&'&CF7C(] G;7\IV[)4*A7@_Q>;;Q[T%-PY;.7AL9WNDUCV%8>$%;PA+S @V>2064 M(B(G;^B=T-;=6"R*+HQFF8'E&);0=6+B=!WVZ[#C7L&Y7X!SLZN>R>?M5UKX M+O).WFZXK[MO(__-=[!A$L M_\K+"N\44OOWSH1N?7,UU[+M6>Y,].>K)]2^U[DNOS2-[=Q4BL1#HP:H!8#?[+54J':B+YO MM"G9Y5\EI@5+'0C(F=#ENMG7YL]2?W!EW=Y(D<%*I^/_''T% M8B?FQ%+'.9G5_OA$RBS'L^5:@2U%\ZQCD8W3M1!:CU$+KT*VR]KI6T'R)/V5 M1'>/+(P#.H5&F6##TQ-K>/+^9!V5GH,3)HV10&6;["VH:^8H?9Z-9)EB-HXK M5(J-:?AHL]IT8N:&?YINC9V[<([=I+OPU>8FK")#\)37A2Z#R8%X5O[[YD!7 M"M)>*?0<1RZRO8\%[[%I22V9N.T\U[XB-WR]_; D /P_9>"NR+E_#3X7+VI[ MF&3G+1?;XY * ]M\ B/ ZH=UQJC$Z3C:;I(#3@#(/W 1CNIBBR6.FT=UW;S! M&P;GJC3N*QYUN+IQ_5(T?]2C[7)* EFU,^03=Q@C]A_1@:E8V@%RC.NAR%TO M5Y!8K1:JU>@*E?"ZTG"&V]Y"II5%KT.N36I,]G3E(9 L ;\W:8P+F)!V5A[8 M+J@]F((I7NH%VGO>W[2TO4\/_"9I;82MH15:?,3>#_AG(H5GP-[LU,2P-F 5;R-%R M(?RVUV^87EP'-#WS6?YB7T\;@>MI\)2<^VG#O: &_PI+0(B'Y639DMD]./89 MO_Y9AL?)ACWMB?R)#'W[#/H+APJBHJ*X2$'*[3< T@Z90)H+E,Z3S7N6=K=@7F@)Y&D M1SN$1BQ(PPG[_M U(VY0:I1;S"+[CC%1PBS&?SM[U+EO%1X$E]1V<-;S2R=3^1AHTVL\3"Y 8]T7:D8.F MCL]4\%Z<1]*,N1CE7D)_0!*;KY+.=Z1 \?C\HXPGR4R\HCODM.M!A[T_[3RW M(JKG9^_QL4*:9D@F_77ZQ=UZHQ+= GE[JZDZTU*GMH@YL-LK^FE](O,M6<$J M>IRSZ@53.-I-NFM>%-5S@SLN>B6+34'04=1M-]%?^S#MO&=9041-XCP-I<>F M8-<;A48MNI;4PR&WL;J;:MWE1>K/\O:VX<.T*UT3;3!WE,&D0Z@_2HZP.?Q! MH_MOJJ0;7;F/O.2E TP::#[LB8._Q_5&K5[S[D":8\N(.HC]P^;!USG6,$EJ M@I6*BQU,"8SS6G5"7Q.\DQ"TCDIR"BCI2XS5QVK1GC>5'1&]12*3;?#U%7E( M[60"]"0"ZK7QS>\O,KZ_>1.7',F;IFMFC+Y&M0:.Q6EO/E>>BD+IZN!OI'4[ M2XH2D?*X]SOG=>=:P\P1>4C!,/.X8\6F-?DHFF46SCRZY4[-8D/B3*FQ&9E' MT31*,.T(]%>E.C6X-)IV-"FRY(_Q&V/Y2=.ZSZ3^_7FG9T_D-K=#X4 M>T;39"G>+!<+=3;:88BZ'IXUAZZ^EARZ"1;ACZ?&H;K'OAIZ/7LI;\G8@%RC M4F#9R%QTMX=UGLRV^<[@#8[OPL91QGC4Q5]*X(8\:(_7G[F95[?JKZ82*#UR)3H MCR/W*Z'&BK%B/+14+-0JT14K@ S6-#H2Q+!L,DPW>Z*4#V\&HQ7 KS1!#Q-0 M6I(_PJ6]8M>4P"2+J;=_K>E60&NZ%3 2.[\BX F_WX=#1-K!QK&U.?ONDR"H8.^!/[;@!V^TM=!B\A"8Z^,0V_=S])VZM MK2T"$7\WY&NA*XD6&=T5ZL[Z7=,F#O0&L_X&K8^(ALB-P&7@T@]_')YVM'Y<++P?D<42!*&'[88A_%MD@4%/V$\F63X\!X?MOLC[1IXO(<<5L3!'GT[T;7 MV=(4,:V+]4@+YXN__K]/W*A3/L'QGW.#R9I0]#:/[@@D=-2DR-K19&JQJ^6C MT TFS5Y.+))NU0G(NOG?)-4ZL^>7J<5N$FB%-4I)JF0@*Q1-'>/-<,3K7F+J M:):Z!>6'N $+R@\Q'39"6(!2[[0^<\5R@2O5"URE\F6ID)4=7BN7_XFU"9L_ M__= $DA*#U.R9[8N>8KNHKE8USQ)"!9=(?M/:$Y(PE+AYK#5N60+ JX7+Z!W MZ[>;JKCOW3Q,J[::4JNR0"E^>+O0)J:F^3\S(96NSKZ(6KG9.KUB0RH/SIW, M11_]F#VI(ZOH<2\0*W=3AD9XB_0]B_7>(@6%$78]NI,Y.)EK)A?LC'PJ1A98 ML@B(*Q1KD?FS2X/D>B HA_1%U_R_T6B^EPR:3^R0DF,\P?B3A^[ULS X.#IK M1*=+!Z/S.>(OQG(?3 _XF]#4=QOE7!'DBB !>JX /$;J9X[26C_SP537CTOM MN#7\>](4.HM4^A1\JFN9HI\,0';JRHQJN]710J/1G-5<*7PHI3#!.QC#VWA, M-?<&EUS@HC_0%_O%'%FQM<_S3WZH5V_$TY+7(LZY_QZ]^LZB.^!_$H+CCOR^ MTY5%48*W =-Q\GM+5UBPSC]]W\D^,*TH?']/\XMC2#.E>; A9[4497[0!/%4 M7[4L0;QUAN/KZV@H_<% ^?7E]OGYS^^CPS-N4C3>YO(%X#?#$9BE6VAGP(B/ MN2'WXHHL]6;UAX3H"0;T7-W3TM"$?(-0^^?=T+K^,_RE_R[/'E_?3 Q?5ROV M#<+V8&/W1F2'Q1S<-PO<8XHVK3I,'NB:S<5D/6VWF9>S[J_KV; MH(8FQ,_1UL/"G[]7D@N6IQZP/B?9CIGRZ@'XG:VR7Q?3E9$.A MCC6=!T,3"(969YWBZ5=O[HGDY@IF'A=_'A\^G?THF^*D6*=+M-1YRC->,)6* M,5XPYNW.DZ6U)SK-W$G%88YE::!MR]D%9NF>( M/LIGCZ*[EFO)TJ9Q/]6I?;TV9D?DXVC2>$>3[L5:^;QE.H1(\K M3:<:^Y*#=*QQ@F:<<8(0&'[^]M!?+YO%T4Y[/ MLW(V)NT0\HR>CX3Y>50TDU'1A#-Z5M#P^?"]+^M+1TW7W#SQ)GIQ 1,1C[I[T:T?L66_[RW$F M&,TP+R25)D?4^V(;1N^:#022 L(!==,VH?K M4 NIIO/JNZA.GK&0ZP;4#?%/ M):OL5NJYSLAU1BKHO.(TM?(ZT]3R[#1;W?%#^>ZD6Q'.+'&Q[+00W9>GJ:V* MC;'?5"6I[+0-@[=I17,\#A,!_@X$"P^/#GXM>Y>*:>SSN_(5N^QHS7 MQI4DLV#6@V%9SH!,#$-M'Y!O*5)^+9'V:XFYNA_-UOP(#SZ_EO K@H>]Y^O^ MV\_FY45[AD9J2+_\6F)&%OM@,2;W6J)8*C2*^;5$RM1"JNF\HFL)GXCFUQ+3 M=<-=G^/.C%^GPM$<5>T3-$7*?855:8?\7B+B7J+*YDHC5QJIH/.*[R7V8YP8 M'8TT41%=-K^9L#5>C_O9[.Z_L?7#RF(W$R':[P/>3,0U.GH!5L;;B7)^.Y$K MD_@\D&(RX!R\G6#)]42_F-]/$"!N58[ERT'G[K#1F.6"(K-.!Q6;R?^<^1*C MOKF7&/^:>+;P\_;6&+CW75FM-XN/P[/6@_SK\/SAMK=(<6./USLR;*X8W*N MS*S;OY-5(#T\K[A;D=6P2Y$W6J"1&&GZE!"SVA6FYED6GQC)$/@^+,C4+6E, M80M=2;008P ,7B4#%"Z!LR9X8Z\@HC=X"C?PECT%\.%3@/:-P(SGN1[T.#0: M8NW]X?K'CP$?WZ$] 3+)[<':3JVYO658/5C< &/I<%0[E!+DQQ<':N%50 )& MHV#+\#:%T,9B) ?1&4!,/&$'T\&%%B6=,;L2PQ79&ODS'#++4"AE$$L-\@CX M""Q#?F=ZL+RNP4CP1=&]^R+77@4&3H;I@Q>.7 ZJ3R4/)B+'M"1%>_LZRGK] M%4A68A?!<8ABP(&K[S4?AP^_]/I[F;.:K:[+PJ)L]!4>W@(G#JQU3;EA>PO8 MXO=$=>3>8F3V:3"UVD_C("3C0 M/3FQ'S)S<^< G9 C7M:I_Y'9\\K48C>)N5Q7EFYJQ)_-[!%E:K&;Q$\>+-%= M;0(V)9# N(09N7)[<=5+FDL\TK'$U-$L=0O*#W$#%I0?X@8L*#_$=)@ B=